Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGRP,Agouti-related protein,40058,0.303664605757333,0.00469889980581937,0.294454762137927,0.312874449376739,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL27,C-C motif chemokine 27,39868,0.27553598881849,0.00576405588229964,0.264238439289183,0.286833538347798,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN1,CCN family member 1,39758,0.398207978734227,0.00682721573064504,0.384826635902163,0.411589321566291,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD4,T-cell surface glycoprotein CD4,39839,0.111499447437234,0.00270711949438718,0.106193493228235,0.116805401646233,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES1,Liver carboxylesterase 1,39854,0.323258330970722,0.00742665338647883,0.308702090333224,0.337814571608221,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F7,Coagulation factor VII,39899,0.126331399944821,0.00277785947774457,0.120886795368442,0.1317760045212,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FURIN,Furin,39913,0.135296247700049,0.00316358386592254,0.129095623322841,0.141496872077257,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCG,Pro-glucagon,39477,0.513959643083018,0.0113861777329264,0.491642734726482,0.536276551439553,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHR,Growth hormone receptor,37124,0.112336633616205,0.00266916494948992,0.107105070315204,0.117568196917205,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.309176306547864,0.00708816322424434,0.295283506628345,0.323069106467383,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF9,Protein turtle homolog A,37437,0.32142310504195,0.00765451605729385,0.306420253569654,0.336425956514246,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0860312409324169,0.0020281390196256,0.0820560884539507,0.0900063934108831,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LDLR,Low-density lipoprotein receptor,39882,0.449155766460537,0.00377366947065639,0.44175937429805,0.456552158623023,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPL,Lipoprotein lipase,39868,-0.198370725395864,0.00438895663455382,-0.20697308039959,-0.189768370392139,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFGE8,Lactadherin,39858,0.258113541835873,0.00380598359208,0.250653813995396,0.26557326967635,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPY,Pro-neuropeptide Y,40030,0.383589512375006,0.00579360162180945,0.372234053196259,0.394944971553752,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.122185144503383,0.00284700546092442,0.116605013799972,0.127765275206795,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRAP1,Proline-rich acidic protein 1,37437,0.16179937100309,0.00372670770023401,0.154495023910632,0.169103718095549,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROC,Vitamin K-dependent protein C,39908,0.0957768714638378,0.00242466853741603,0.0910245211305024,0.100529221797173,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTH,Parathyroid hormone,37039,0.315105794046771,0.00738478223536099,0.300631620865464,0.329579967228079,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,39949,0.204548435212704,0.00436442922595378,0.195994153929835,0.213102716495573,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.140040416049234,0.00302889586739945,0.134103780149131,0.145977051949337,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.164416032642633,0.00398651135154583,0.156602470393603,0.172229594891663,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INHBC,Inhibin beta C chain,39858,0.153195545212745,0.00390734333158636,0.145537152282836,0.160853938142655,1.1125369292538e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR37,Prosaposin receptor GPR37,39585,0.231065809987263,0.0060741618852713,0.219160452692131,0.242971167282395,5.43742504996517e-303
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APCS,Serum amyloid P-component,37333,0.124665509071337,0.00326551963380703,0.118265090589075,0.131065927553599,6.91987545678857e-303
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL23,C-C motif chemokine 23,39931,0.14716830896957,0.00388870884740971,0.139546439628647,0.154790178310493,2.63224258401401e-300
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADIPOQ,Adiponectin,37453,-0.234885192710507,0.00620299357761409,-0.247043060122631,-0.222727325298384,2.17019109397247e-298
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.301049947886765,0.00799003650505055,0.285389476336866,0.316710419436664,1.59635398456901e-297
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.292452762801277,0.00780960888692671,0.2771459293829,0.307759596219653,5.4689505581465e-294
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPM,Carboxypeptidase M,39955,0.120445335945059,0.00326142649038673,0.114052940023901,0.126837731866217,1.19646088039091e-286
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC39A5,Zinc transporter ZIP5,39866,0.184283766610476,0.00500456984766326,0.174474809709056,0.194092723511896,5.29158220841462e-285
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.301283340378364,0.0082125228569827,0.285186795578678,0.31737988517805,6.3024637078375e-283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.495119297211601,0.0137053352249369,0.468256840170725,0.521981754252478,1.29403325672839e-274
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS15,Enteropeptidase,39788,0.300627122853471,0.00844760910900222,0.284069808999827,0.317184436707115,5.57658427626823e-267
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,39749,0.0981152344111507,0.00276047811694996,0.0927046973019288,0.103525771520373,2.54912297516683e-266
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.223638147295809,0.00630799748164305,0.211274472231789,0.236001822359829,4.6253366731003e-265
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG2,Desmoglein-2,39858,-0.0896336769465762,0.00253622823411778,-0.094604684285447,-0.0846626696077053,1.64962241852626e-263
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLTP,Phospholipid transfer protein,39976,-0.119312625038045,0.00341448891052789,-0.12600502330268,-0.112620226773411,6.27676210064452e-258
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.263161193789648,0.00754135770612268,0.248380132685647,0.277942254893648,3.73560054695953e-257
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTA1,Glutathione S-transferase A1,39841,0.281089524310018,0.00806925988120506,0.265273774942857,0.29690527367718,2.52752395264425e-256
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTR,Transthyretin,37309,0.0828266344662858,0.00238061221694789,0.0781606345210679,0.0874926344115036,4.87020503660181e-254
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRP1,Neuropilin-1,39949,-0.0912627577834352,0.00263408699451717,-0.0964255682926889,-0.0860999472741816,9.53609394581027e-254
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.111628909223269,0.00322410120526987,0.10530967086094,0.117948147585598,1.84191034595512e-253
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRIP2,Cysteine-rich protein 2,39749,0.116718026843557,0.00341591067430872,0.110022841921912,0.123413211765202,5.5243552741532e-247
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.345309763507835,0.0101310325689055,0.325452939672781,0.36516658734289,7.77257568427257e-246
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCS1,Neuronal calcium sensor 1,40030,0.0908302764003612,0.00267844023150582,0.0855805335466098,0.0960800192541126,1.4035500738265e-243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL6,C-X-C motif chemokine 6,40058,0.247363776508101,0.00731345305829869,0.233029408513836,0.261698144502366,2.23906505708546e-242
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCHE,Cholinesterase,37208,0.0880782080661784,0.00261630114661263,0.0829502578188177,0.0932061583135392,1.51884322292065e-238
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP5,Retinol-binding protein 5,39788,0.178448421232106,0.00532874779854938,0.168004075546949,0.188892766917263,1.16069624059426e-237
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAT,Tissue-type plasminogen activator,40002,0.157174405721379,0.00473289639616821,0.147897928784889,0.166450882657869,5.54201954128281e-234
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACY1,Aminoacylase-1,39868,0.195386620890594,0.00588545076140063,0.183851137398249,0.20692210438294,8.92711099617213e-234
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFPI,Tissue factor pathway inhibitor,39843,0.0993978628524127,0.00299866879334569,0.0935204720174551,0.10527525368737,4.46049856112174e-233
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFH,Complement factor H,36763,0.0741356888661864,0.00222934612847516,0.069766170454375,0.0785052072779977,1.00276973500756e-232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTA3,Glutathione S-transferase A3,39477,0.241423764786875,0.00729225774807555,0.227130939600647,0.255716589973103,2.34350479210039e-232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFI,Complement factor I,37453,0.0628087455918374,0.00189505883315302,0.0590944302788575,0.0665230609048173,1.03086276021036e-231
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F9,Coagulation factor IX,39908,0.0572088821212865,0.00173427928170466,0.0538096947291454,0.0606080695134277,5.95473291497189e-231
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUSB,Beta-glucuronidase,39919,0.184104057765683,0.00560386553797807,0.173120481311246,0.19508763422012,3.69121648683464e-229
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0604666530528127,0.00184195024553247,0.0568564305715691,0.0640768755340563,9.08690792235378e-229
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.354750053358364,0.010821337140374,0.333540232563231,0.375959874153497,3.4963294724073e-228
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0935766376927001,0.00285630950788812,-0.0991750043281608,-0.0879782710572394,1.93741863062726e-226
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINF1,Pigment epithelium-derived factor,37254,0.079530656117744,0.00242847555253521,0.074770844034775,0.084290468200713,2.31720923397207e-226
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.192904815445459,0.00593368397780249,-0.204534836041951,-0.181274794848966,1.24479340703801e-224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.3815725705872,0.0117371090741481,-0.404577304372531,-0.35856783680187,1.24620283776107e-224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,39868,0.0935873416541232,0.0028833706358201,0.0879359352079158,0.0992387481003306,7.12637614275834e-224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",39489,0.158065278461692,0.00487707220964737,0.148506216930783,0.167624339992601,4.48125168440235e-223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0960356924040094,0.00296743013157931,0.090219529346114,0.101851855461905,1.16530540218636e-222
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAMR1,Inactive serine protease PAMR1,39858,0.0853171968820527,0.0026502059053858,0.0801227933074965,0.0905116004566089,2.24916921275041e-220
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA4,Kallistatin,37241,0.0715697184919821,0.00222530701524008,0.0672081167421116,0.0759313202418527,1.13970636920855e-218
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON3,Serum paraoxonase/lactonase 3,39931,-0.0860092060132094,0.00269357792687622,-0.0912886187498867,-0.080729793276532,5.57902745306602e-217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPB1,Beta-ureidopropionase,37437,0.279034347659614,0.00876493545146315,0.261855074174747,0.296213621144482,1.46329031064129e-214
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA5,Plasma serine protease inhibitor,37283,0.096396485746538,0.00302887994844097,0.0904598810475937,0.102333090445482,2.36292540085529e-214
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN3,Contactin-3,39858,0.0991528238173253,0.00312562800149963,0.093026592934386,0.105279054700265,3.10099667874925e-214
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPIND1,Heparin cofactor 2,37424,0.085267926872086,0.00268131667807074,0.0800125461830674,0.0905233075611046,4.13978297421928e-214
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.17951273775719,0.00566107980006919,0.168417021349054,0.190608454165326,6.43769630943649e-214
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KYNU,Kynureninase,40058,0.137339896176217,0.00435025659422269,0.128813393251541,0.145866399100894,2.41264654607259e-212
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFM,Afamin,37453,0.0571366311802336,0.00180721729100462,0.0535944852898646,0.0606787770706027,9.44196980213512e-212
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFP,Properdin,37453,0.0693581072015263,0.0022054358851895,0.0650354528665549,0.0736807615364977,1.28685063723485e-209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.156376559185475,0.00500915901807591,0.146558607510046,0.166194510860904,8.59327801475749e-208
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0573979250605802,0.0018443406333922,0.0537830174191315,0.0610128327020289,2.56821685973829e-206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C9,Complement component C9,37445,-0.157618651157812,0.0050568477479481,-0.16753007274379,-0.147707229571834,4.57311837818495e-206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNCA,Alpha-synuclein,37124,0.343373880278192,0.0110635017050231,0.321689416936347,0.365058343620037,3.15762256795083e-204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0891317838006866,0.00288051695376942,0.0834859705712985,0.0947775970300746,3.32196518669559e-204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMBP,Protein AMBP,40003,0.0571622514976516,0.00185162010214516,0.0535330760974471,0.0607914268978561,2.24546011745112e-203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.161466519037075,0.0052306050349957,0.151214533168484,0.171718504905667,3.35786840305512e-203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.100269423245367,0.00325505817150447,-0.106649337261516,-0.0938895092292187,1.53552850617597e-202
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,39477,0.323425178288795,0.0105537968164032,0.302739736528645,0.344110620048945,2.47021992151003e-200
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.246777442716772,0.00805813068770216,0.230983506568876,0.262571378864668,3.41289993489084e-199
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHMP6,Charged multivesicular body protein 6,37437,0.165233556663147,0.00541493827022237,0.154620277653511,0.175846835672783,7.43360609208977e-198
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR2,Cadherin-related family member 2,39788,0.211375588408223,0.00698812069319554,0.19767887184956,0.225072304966886,1.79688101881519e-195
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL16,C-C motif chemokine 16,40052,0.150926883888622,0.0050014931046693,0.14112395740347,0.160729810373774,1.13953639072855e-194
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.133416880833015,0.00445881293789776,0.124677607474735,0.142156154191294,2.09136175007072e-191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300LG,CMRF35-like molecule 9,39858,-0.10518399072391,0.00351843731087878,-0.112080127853232,-0.0982878535945872,3.94985852115971e-191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGR3,Anterior gradient protein 3,39464,0.168928149760179,0.00566033100196389,0.15783390099633,0.180022398524028,2.23327589337749e-190
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRP,Gastrin-releasing peptide,37043,0.148300108216269,0.00498127052447179,0.138536817988304,0.158063398444233,1.47397038869221e-188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHBG,Sex hormone-binding globulin,37445,-0.146570785358081,0.00493067515950563,-0.156234908670712,-0.136906662045449,3.4802557725874e-188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELN,Elastin,37437,0.0951232411040691,0.00321314820566921,0.0888254706209574,0.101421011587181,1.0520164115174e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.204118142695029,0.00691486230183408,0.190565012583434,0.217671272806624,1.76677536906219e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.176418390296958,0.00599577507694256,0.16466667114615,0.188170109447765,2.97396667386536e-185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,39913,0.0607776865859784,0.00207126617189514,0.0567180048890639,0.0648373682828928,2.07758284997702e-184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.208738088384664,0.00711439703623284,0.194793870193647,0.22268230657568,2.52596167626982e-184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F10,Coagulation factor X,37445,0.0743360133570869,0.00253778358166685,0.0693619575370199,0.079310069177154,6.05063298333989e-183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROS1,Vitamin K-dependent protein S,37453,0.0679564868801852,0.00234584149048887,0.063358637558827,0.0725543362015434,4.23472863088326e-179
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.058734568136347,0.00203763307809047,0.0547408073032896,0.0627283289694043,3.31405831240423e-178
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.186796823198333,0.00650037953238845,0.174056079314851,0.199537567081814,5.24206350878776e-177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0689399749347267,0.00241146703251765,0.0642134995509921,0.0736664503184613,2.25126907967514e-175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,P4HB,Protein disulfide-isomerase,39776,0.106827167438163,0.00374167835316239,0.0994934778659643,0.114160857010361,6.8471500474408e-175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAB2,Stabilin-2,37437,0.0767538466614235,0.0026876637138389,0.0714860257822992,0.0820216675405477,3.01316969783655e-174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOST,Sclerostin,39846,0.104468375509843,0.00368041433598288,0.097254763411317,0.11168198760837,5.86809207500183e-173
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPPC,C-type natriuretic peptide,39866,0.124691871091398,0.00439743128705411,0.116072905768772,0.133310836414024,1.28195662793992e-172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEG1,Protein HEG homolog 1,37124,0.0737984350604512,0.00259784696696135,0.0687066550052069,0.0788902151156954,2.23574371635084e-172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,37056,0.234316033737685,0.00825667931784243,0.218132942274714,0.250499125200656,5.09671502121545e-172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM20A,Pseudokinase FAM20A,37437,0.07682362288838,0.00270859437708243,0.0715147779092984,0.0821324678674615,5.69406510046291e-172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL13,C-X-C motif chemokine 13,40009,0.159819205342342,0.00566403863520476,0.14871768961734,0.170920721067343,5.03511673198622e-171
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF21,Fibroblast growth factor 21,40011,0.322981944830491,0.0114744912850314,0.300491941911829,0.345471947749152,3.18711931295672e-170
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.186768533690343,0.00665484228979688,0.173725042802341,0.199812024578345,1.70145408916932e-168
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0698598203253187,0.00250123389231489,0.0649574018963815,0.0747622387542559,1.24606437816395e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO3,Beta-enolase,37043,0.162065794186431,0.00579400876783515,0.150709537001474,0.173422051371388,2.65099192125735e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCLY,Selenocysteine lyase,39984,0.131984590124367,0.00473823722447466,0.122697645164396,0.141271535084337,8.08685077961938e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MME,Neprilysin,39788,0.210145411764473,0.007569139066981,0.19530989919319,0.224980924335756,1.03039152829826e-165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPY30,Protein dpy-30 homolog,39979,0.158195880456147,0.0057060908437857,0.147011942402327,0.169379818509967,2.64013104104209e-165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.157220412429494,0.00568475265102197,-0.168362527625497,-0.146078297233491,1.78477599849089e-164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,39913,0.0679161010484288,0.00245923722681726,0.063095996083867,0.0727362060129907,4.67110550295783e-164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.0735631276869669,0.00266646286026488,0.0683368604808477,0.0787893948930861,9.80251605377921e-164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL16,Pro-interleukin-16,40058,0.109436585234267,0.00396739714791587,0.101660486824352,0.117212683644182,1.02741570677971e-163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,37124,0.200870288066182,0.00727547967474851,0.186610347903675,0.215130228228689,3.38398247500832e-163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAT2,Linker for activation of T-cells family member 2,39788,0.329875606028544,0.0119821401131084,0.306390611406852,0.353360600650237,4.83256939452149e-163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.131881472771201,0.00479243584814978,0.122488298508828,0.141274647033575,6.48318912453616e-163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA1,Ephrin type-A receptor 1,39904,0.0885430002782087,0.00321889455104645,0.0822339669581577,0.0948520335982598,8.39847333268582e-163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTYMK,Thymidylate kinase,37437,0.181600159365939,0.00659486702881856,0.168674219989455,0.194526098742424,1.78621575316328e-162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOMO1,Nodal modulator 1,39858,0.062736377520581,0.00228809627704611,0.0582517088175707,0.0672210462235914,8.83246902950802e-162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUMB,Protein numb homolog,37056,0.223287359113529,0.00812856063872996,0.207355380261618,0.23921933796544,1.36366014776163e-161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.169926097914398,0.00620132145125282,0.157771507869943,0.182080687958854,6.02040381101111e-161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLA,Alpha-galactosidase A,37088,0.099266109027393,0.00363034056535184,0.0921506415193034,0.106381576535483,3.51007383154873e-160
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS8,Prostasin,39805,0.105499331338446,0.00386849011680788,0.0979170907095027,0.11308157196739,4.26076785796762e-160
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F11R,Junctional adhesion molecule A,39858,0.148638910810546,0.00545812274156174,0.137940990237085,0.159336831384007,1.14188697182911e-159
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL22,C-C motif chemokine 22,39686,0.131853365947218,0.00485901152768007,0.122329703352966,0.141377028541471,1.54460532151217e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTSS1,Protein MTSS 1,37382,0.28841790258848,0.0106120052625414,0.267618372273899,0.309217432903061,2.02615546294201e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORD,Sorbitol dehydrogenase,39963,0.178401844267984,0.00660646442622031,0.165453173992592,0.191350514543376,4.08726419716253e-157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORT1,Sortilin,39846,0.0970474391498415,0.00359590820805954,0.0899994590620448,0.104095419237638,6.51692589246244e-157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKB,Creatine kinase B-type,37437,-0.150965022047936,0.00559385797767481,-0.161928983684179,-0.140001060411694,2.6443737594809e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18R1,Interleukin-18 receptor 1,40058,0.0845226151593835,0.00313891889083004,0.0783703341333566,0.0906748961854104,2.84352813621043e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EEF1D,Elongation factor 1-delta,37437,0.236777529653544,0.00877554263761817,0.219577466083813,0.253977593223276,3.09326073036513e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATRN,"Attractin, Isoform 2",37453,0.0422181856865488,0.00156593477564715,0.0391489535262804,0.0452874178468172,5.26327853398405e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.365209012418032,0.0135525870005762,0.338645941896903,0.391772082939162,7.66706116262984e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GH1,Somatotropin,39846,-0.46590059194114,0.0174103776140404,-0.50002493206466,-0.431776251817621,2.33142029727225e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YTHDF3,YTH domain-containing family protein 3,39587,0.220088478542602,0.00822508264894615,0.203967316550668,0.236209640534537,2.7610197979666e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP29,Synaptosomal-associated protein 29,39913,0.235504527365937,0.00880663938052465,0.218243514180109,0.252765540551766,3.60536830960984e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH9,Myosin-9,37437,0.287055039442418,0.0107181259009574,0.266047512676541,0.308062566208294,5.04514155201648e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MLN,Promotilin,39866,0.229335533221744,0.00859470577449507,0.212489909903734,0.246181156539754,1.64260756663999e-153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MVK,Mevalonate kinase,39587,0.20348350551328,0.00763376796821977,0.188521320295569,0.21844569073099,3.80129078495784e-153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.137408843192096,0.00516837575151913,0.127278826719118,0.147538859665073,1.992574117574e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KHK,Ketohexokinase,37043,0.165887960552696,0.00622971386498724,0.153677721377321,0.178098199728071,3.24614932545819e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR5,Cadherin-related family member 5,39868,0.0992720431516981,0.00374294302830531,0.0919358748162197,0.106608211487177,9.94957711294881e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0577551415237975,0.00218061050792236,0.0534811449282697,0.0620291381193253,2.50042883762804e-151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.125074781777719,0.00471184199931244,0.115839571459066,0.134309992096371,2.55199299834978e-151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA3F,Semaphorin-3F,39868,0.0651791721376017,0.0024633020070795,0.0603511002037258,0.0700072440714775,4.85584160842913e-151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTN4R,Reticulon-4 receptor,40030,0.0844813005493228,0.0031990257882047,0.0782112100044416,0.090751391094204,1.67397675105484e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL17,C-X-C motif chemokine 17,40058,0.109297297025065,0.00414258125782987,0.101177837759718,0.117416756290411,3.08301442512542e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAPIN,SNARE-associated protein Snapin,37411,0.14735414026325,0.00558026973653347,0.136416811579645,0.158291468946856,6.95951041470047e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.17314941671165,0.00657546320026599,0.160261508839129,0.186037324584172,5.65810809302024e-149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYAP1,Synapse-associated protein 1,37124,0.145629814393518,0.00553653425631419,0.134778207251143,0.156481421535894,1.10105406350652e-148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.202273197028325,0.00769917117830455,0.187182821518848,0.217363572537802,2.07223260109859e-148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAA80,N-alpha-acetyltransferase 80,37039,0.305359816312119,0.0116286727816041,0.282567617660175,0.328152014964063,3.51282928896499e-148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGRN,Agrin,39931,0.0825520227312306,0.00315157011779313,0.0763749453003561,0.0887291001621051,3.93851028129888e-148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.132219393678081,0.00504145580708486,0.122338140296194,0.142100647059967,6.48976497802366e-148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0544835135782961,0.00208070554644179,0.0504053307072702,0.058561696449322,2.11626032734223e-147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,39788,0.172217814612774,0.00659546746166987,0.159290698387901,0.185144930837647,3.31911224334955e-147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLUL1,Clusterin-like protein 1,39840,-0.113658792296512,0.00436578184599988,-0.122215724714671,-0.105101859878352,2.26251251254611e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0981638254208923,0.00377661168005242,0.0907616665279895,0.105565984313795,6.51656252294234e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YES1,Tyrosine-protein kinase Yes,39788,0.285031023430932,0.0110007681379204,0.263469517880608,0.306592528981256,5.09377703034006e-145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACE2,Angiotensin-converting enzyme 2,39585,0.124658036303471,0.0048227764768684,0.115205394408808,0.134110678198133,2.61556088725214e-144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.117852544902026,0.00456823758402978,0.108898799237328,0.126806290566725,3.08706168654045e-143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCN2,Ficolin-2,39810,0.100641536761096,0.00391385618812466,0.092970378632372,0.108312694889821,6.5250532240343e-143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINF2,Alpha-2-antiplasmin,37224,0.0334457446258687,0.00129994515629025,0.0308978521195398,0.0359936371321976,1.60416114561195e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,39877,0.0973795068921729,0.00380776377496526,0.089916289893241,0.104842723891105,2.019097715064e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFB1,BPI fold-containing family B member 1,39786,-0.156179453277823,0.00611966148450822,-0.16817398978746,-0.144184916768187,7.70414780183097e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.107456191729354,0.0042132151043762,0.0991982901247767,0.115714093333931,1.15059206945751e-140
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0720549484005584,0.00282252085639078,0.0665228075220325,0.0775870892790843,1.90235100292196e-140
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FN1,Fibronectin,37453,0.0655118495499456,0.00256731060788127,0.0604799207584983,0.0705437783413929,2.45941212618993e-140
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FYB1,FYN-binding protein 1,39836,0.225975341817171,0.00887940235013157,0.208571713210913,0.243378970423429,4.36718248855094e-140
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLKB1,Plasma kallikrein,37187,0.061333212626193,0.00240956296291727,0.0566104692188751,0.0660559560335108,1.33936022624849e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0487756623067628,0.00192548431051583,0.0450017130581518,0.0525496115553739,7.82645239674318e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK1,Dickkopf-related protein 1,40009,0.145968706521117,0.0057761408129497,0.134647470527736,0.157289942514499,3.19008827326179e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0632410599444214,0.00250082835379798,0.0583394363709773,0.0681426835178654,6.75294061704954e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",39788,0.198138359141012,0.00785606752006372,0.182740466801687,0.213536251480337,1.16695768263493e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.13966534520135,0.00553455499228612,0.128817617416469,0.150513072986231,2.90674950267455e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCXR,L-xylulose reductase,39913,0.130736641497551,0.00521062762730511,0.120523811348033,0.140949471647069,2.64413016954597e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.205829828864978,0.00819032919442471,0.189776783643906,0.221882874086051,3.57804189069188e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0929519071084744,0.00371793595815656,-0.100239061586461,-0.0856647526304875,2.27620140331545e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.215746780551558,0.00866204331151858,0.198769175660981,0.232724385442134,2.34616247547617e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEP,Leptin,39868,0.16304321333958,0.00655600445763608,0.150193444602613,0.175892982076547,5.51632281704229e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.174153764107542,0.00700986166267454,0.1604144352487,0.187893092966384,9.68570348154276e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP20,Centrosomal protein 20,39477,0.176684135178534,0.00715150109597922,0.162667193030415,0.190701077326653,3.1542280739766e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPY,Pancreatic prohormone,39826,0.23904268379858,0.0096870683191462,0.220056029893053,0.258029337704107,5.61223265825275e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.130710704356842,0.00529702801121966,0.120328529454851,0.141092879258832,6.13994759743894e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0829732368550644,0.00337057134024345,0.0763669170281872,0.0895795566819416,2.24309294439713e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SARG,Specifically androgen-regulated gene protein,37390,0.26074377631664,0.010575415672093,0.240015961599338,0.281471591033942,2.47915824144145e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0662253004254688,0.00269259373915377,0.0609478166967274,0.0715027841542102,3.80790541934705e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGF,Hepatocyte growth factor,40058,0.0807421003927128,0.00328822279174599,0.0742971837208907,0.0871870170645349,9.31439333754081e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUOM,Fucose mutarotase,37124,0.150423960364045,0.00613110601910381,0.138406992566601,0.162440928161488,4.89396297566619e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0699143627376918,0.00286114074045699,0.0643065268863961,0.0755221985889875,4.39535878593208e-129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.12158195102213,0.00499594139706241,0.111789905883888,0.131373996160372,1.97176755570253e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL17,C-C motif chemokine 17,39836,0.212565065997703,0.00873989150312877,0.19543487865157,0.229695253343835,2.49071689839062e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.128542368479555,0.00528431476042347,0.118185111549125,0.138899625409985,2.60753966731228e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NHLRC3,NHL repeat-containing protein 3,36838,0.0749048318758964,0.00308018729963066,0.0688676647686203,0.0809419989831725,8.88456068012379e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0657512387187646,0.00271653128682982,0.0604268373965781,0.071075640040951,3.84667181796506e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSD,Cathepsin D,38721,0.0919976606570705,0.00380088559370512,0.0845479248934084,0.0994473964207325,5.67826721038501e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPL,N-acetylneuraminate lyase,37437,0.102668309577415,0.00425193236178005,0.0943345221483263,0.111002097006504,3.66833353529493e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THOP1,Thimet oligopeptidase,39798,0.0710531772135182,0.00294743812854335,0.0652761984815732,0.0768301559454631,3.81051548048765e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.212871206684065,0.00883371189808824,0.195557131363812,0.230185282004318,5.05177517571032e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PYY,Peptide YY,37021,0.215182160945716,0.00892223000059287,0.197694590144554,0.232669731746878,8.60683436845914e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSO,Cathepsin O,40058,0.0697493719373972,0.00289975468991652,0.0640658527451608,0.0754328911296336,1.21298596232639e-125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EZR,Ezrin,40009,0.055967965084926,0.00232851394104442,0.0514040777604789,0.0605318524093731,1.85516545948566e-125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUCB2,Nucleobindin-2,39995,0.086873901517915,0.00363216435220372,0.0797548593875957,0.0939929436482343,2.87402616492866e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTD,Biotinidase,37453,0.0474627835563933,0.0019843254571835,0.0435735056603136,0.051352061452473,6.95421793551744e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.164008940217155,0.00687121797043009,0.150541352995112,0.177476527439198,2.20138910186525e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0949668103481131,0.00398422033314284,0.0871577384951531,0.102775882201073,4.81592404308011e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EHBP1,EH domain-binding protein 1,37437,0.17285758838042,0.00725925564477055,0.15862944731667,0.18708572944417,8.12165240326345e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HJV,Hemojuvelin,37411,0.102125718670682,0.00429040129552042,0.0937165321314618,0.110534905209902,1.00246211536003e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXLNA,Alpha-taxilin,39749,0.205387248729146,0.00864205698181195,0.188448817044795,0.222325680413498,1.02945409635573e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD63,CD63 antigen,39720,0.11850479018972,0.00498778941534093,0.108728722935652,0.128280857443788,1.22079471794044e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.188471494726047,0.00792913878150948,0.172930382714289,0.204012606737806,2.21390866489987e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0899369850445971,0.00380592168241348,-0.0973965915421275,-0.0824773785470667,2.21397787068317e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.188389407560542,0.00798243421696709,0.172743836495286,0.204034978625797,4.23828669484904e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAMDC4,Apical endosomal glycoprotein,37368,0.127379282890636,0.0053933959871912,0.116808226755742,0.137950339025531,7.03944342739824e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TJAP1,Tight junction-associated protein 1,39913,0.189755458883417,0.00804947413322239,0.173978489582301,0.205532428184533,8.04368422027619e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,40009,0.219690746684651,0.00934082461053335,0.201382730448006,0.237998762921296,2.69564754218112e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD2AP,CD2-associated protein,39868,0.144371884799762,0.00614125155446265,0.132335031753015,0.156408737846508,3.59386202852956e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE4,Ribonuclease 4,37051,0.0591789587169341,0.00251476435950573,0.0542500205723029,0.0641078968615653,5.51524182564184e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL10,C-X-C motif chemokine 10,39931,0.150111316293999,0.00639333807925026,0.137580373658668,0.162642258929329,6.86188059449034e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5E,5'-nucleotidase,39913,0.125715666472379,0.00536063574352967,0.115208820415061,0.136222512529698,1.29440107178253e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0888639172804157,0.00380253749677775,0.0814109437867313,0.0963168907741001,7.99956722687501e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.236147216179445,0.0101123755557527,0.216326960090169,0.25596747226872,1.28328064669632e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,39489,0.179944670690848,0.00772475087206354,0.164804158981603,0.195085182400092,5.11303403622686e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELP,P-selectin,39931,0.129445829077417,0.0055631164737508,0.118542120788866,0.140349537365969,8.11441420883252e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES3,Carboxylesterase 3,39788,0.154757193540114,0.00666945251312952,0.141685066614381,0.167829320465848,3.62231932547221e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.219383540588266,0.00945924978838284,0.200843411003036,0.237923670173497,4.67989723878729e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.082633623576269,0.00356803987000755,0.0756402654310542,0.0896269817214838,9.63691802993448e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,37388,0.105625556501585,0.00455591537563658,0.0966959623653378,0.114555150637833,1.21532255898749e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.219083637171378,0.0094614836887557,0.200539129141417,0.237628145201339,2.29976349389735e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST3,Cystatin-C,39897,0.0595158770051065,0.00257652165468927,0.0544658945619155,0.0645658594482975,3.67616078034659e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0874605171931288,0.00379011853538657,-0.0948891495224865,-0.0800318848637711,6.25237748518359e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.119541617901031,0.00518249241770947,0.109383932762321,0.129699303039742,7.98250902984415e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.158635917714315,0.00688623255106891,0.14513890191422,0.17213293351441,1.67157088832066e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTBS,Di-N-acetylchitobiase,37296,0.0615865205816463,0.00267486092881043,0.0563437931611779,0.0668292480021147,4.44106800738084e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLIN1,Perilipin-1,39489,0.0770239833190663,0.00336076180416171,0.0704368901829093,0.0836110764552233,2.30966670561905e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FETUB,Fetuin-B,39908,0.0748020244709114,0.00326466208640819,0.0684032867815513,0.0812007621602714,2.36095628267003e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0855441566926966,0.00373413153272072,0.078225258888564,0.0928630544968292,2.49082453189429e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.251647412136169,0.0109663306701118,0.23015340402275,0.273141420249588,2.559000374412e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,39866,0.0965083300013131,0.0042150417384386,0.0882468481939735,0.104769811808653,3.44094315455895e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.149381728632447,0.00652660185976444,0.136589588987309,0.162173868277586,4.55832769060176e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BECN1,Beclin-1,37043,0.134191168347781,0.00586338958991917,0.122698924751539,0.145683411944023,1.03181359417773e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.107442447531829,0.00471060836135276,0.0982096551435772,0.11667523992008,2.28845028337714e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN1,Dynactin subunit 1,40030,0.14374234874319,0.00631081510453795,0.131373151138296,0.156111546348085,4.61644884347653e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.183519767427846,0.00805853479020919,0.167725039239036,0.199314495616656,5.78534040183262e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.182269380239959,0.00800556529193168,0.166578472267773,0.197960288212145,1.35658446987986e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STC1,Stanniocalcin-1,40009,0.0925036305691495,0.00407008988195668,0.0845262544005144,0.100481006737785,1.38432108775677e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSP1,Lymphocyte-specific protein 1,39866,0.0888998484260901,0.00392453349024195,0.0812077627852159,0.0965919340669643,7.53718517687603e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.238247861395995,0.0105130771534295,0.217642230175273,0.258853492616717,1.25503932301729e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTSS2,Protein MTSS 2,37368,0.21879424335724,0.00966363040981798,0.199853527753996,0.237734958960483,2.00232236564927e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL5,C-C motif chemokine 5,39931,0.221485433677521,0.00979892633133776,0.202279538068099,0.240691329286943,2.19143235035023e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARF6,ADP-ribosylation factor 6,37382,0.233195321420147,0.0103073731474815,0.212992870051083,0.253397772789211,2.88095139601258e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,37021,0.13415018767236,0.00594102281574499,0.122505782953499,0.14579459239122,8.49944230806364e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL5,C-X-C motif chemokine 5,39805,0.249184432386694,0.0110573566994395,0.227512013255792,0.270856851517595,9.90024089178242e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFC,Vascular endothelial growth factor C,39913,0.121494551643278,0.0053940363459163,0.110922240405282,0.132066862881274,1.24740441591147e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.15890350022131,0.00704710402336018,0.145091176335524,0.172715824107096,1.67595520207372e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP85,Centrosomal protein of 85 kDa,39477,0.139589650029292,0.00620342399099992,0.127430939006932,0.151748361051652,2.23847589758401e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.063182784724854,0.00281140921606226,0.057672422661372,0.068693146788336,3.61248182252425e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.214007938231959,0.00952630802100913,0.195336374510781,0.232679501953137,4.57137502235501e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAB2,Disabled homolog 2,40030,0.242837454244173,0.0108302461547821,0.2216101717808,0.264064736707546,1.11789123408386e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPB2,Carboxypeptidase B2,37424,0.0490335293265138,0.00218742430029123,0.044746177697943,0.0533208809550846,2.6204809776601e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.230884597937559,0.0103237153982912,0.210650115756908,0.25111908011821,4.0741299989683e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAXX,Protein PAXX,37124,0.0991740033315136,0.00445521955072341,0.0904417730120958,0.107906233650932,8.37099832384743e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN2,CCN family member 2,39880,0.126165696040836,0.00568131314089957,0.115030322284673,0.137301069796999,1.22660755042365e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AXIN1,Axin-1,39866,0.205700121326549,0.00926978597659433,0.187531340812424,0.223868901840673,1.7663809429994e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD6,T-cell differentiation antigen CD6,40040,0.112911203654239,0.00509149547900691,0.102931872515386,0.122890534793093,2.29481047360814e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH2,Cadherin-2,39868,0.075525678043947,0.00340827672600097,0.0688454556609851,0.082205900426909,3.43658560568043e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.0440805886882192,0.00198953334855707,0.0401811033250474,0.0479800740513911,3.75328685796537e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNA4,Plexin-A4,39866,0.174743836777279,0.00788788592294121,0.159283580368314,0.190204093186244,3.91650333210666e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREG1,Protein CREG1,39660,0.0809637147188984,0.00365523130891284,0.0737994613534292,0.0881279680843675,4.41328180352522e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.234097690856727,0.0105850185254444,0.213351054546856,0.254844327166598,1.71061154232214e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAO1,Hydroxyacid oxidase 1,40030,0.276269412645602,0.0125267202879864,0.251717040881149,0.300821784410056,3.17399668717053e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBIN,Erbin,39788,0.219509500852155,0.00997124142653684,0.199965867656142,0.239053134048167,7.91583177163594e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0792341106072169,0.00360905742125119,0.0721603580615645,0.0863078631528692,5.77481956335887e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA5,Integrin alpha-5,39858,0.0527883711844165,0.00241112457874779,0.0480625670100709,0.0575141753587622,1.02366996928677e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0499771843765732,0.00228341302998086,0.0455016948378107,0.0544526739153357,1.17862376375085e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A4,Protein S100-A4,39913,0.120652254674265,0.00552362220951657,0.109825955143613,0.131478554204918,2.97631395917125e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0886695550300149,0.00406494836758701,0.0807022562295444,0.0966368538304854,6.00928205069448e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGF,Placenta growth factor,40058,0.0545001971464713,0.00249932311075851,0.0496015238493846,0.059398870443558,6.33194647037189e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA1,GDNF family receptor alpha-1,40011,0.0568419493611455,0.00261370236801958,0.0517190927198271,0.0619648060024638,2.20112514194751e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KAZN,Kazrin,37382,0.219805193169189,0.0101071939589961,0.199995093009557,0.239615293328821,4.23283364676348e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD5,Programmed cell death protein 5,40009,0.122410750265099,0.00563690337879339,0.111362419642664,0.133459080887534,4.30811872757273e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,39931,0.266669362105312,0.012282558735246,0.24259554698423,0.290743177226394,4.83912461834834e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATG16L1,Autophagy-related protein 16-1,37382,0.180903152307196,0.00834547460308417,0.164546022085151,0.197260282529241,1.86775158008315e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.103465180121917,0.00479522642630182,0.0940665363263657,0.112863823917469,9.06041048854938e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.176917713717571,0.00820796350427939,0.160830105249183,0.193005322185959,1.35563175863908e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP5,Fatty acid-binding protein 5,39972,0.142663710533159,0.00663289118685344,0.129663243806926,0.155664177259392,3.41782348547519e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,40052,0.141464258236759,0.00657886347317298,0.12856968582934,0.154358830644178,3.78952186798469e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0693713062802029,0.00322602914435546,0.0630482891572662,0.0756943234031396,3.82807657835658e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLSCR3,Phospholipid scramblase 3,37373,0.124359059543324,0.00577578000198804,0.113038530739428,0.135679588347221,3.94791186357727e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINH1,Serpin H1,37169,0.268102710356558,0.0124590209462398,0.243683029301928,0.292522391411188,5.41652746834664e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFC,Platelet-derived growth factor C,39477,0.0609477183703384,0.00283631256798265,0.0553885457370924,0.0665068910035844,5.76969347055804e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.155727884590786,0.00723751317651049,0.141542358764825,0.169913410416746,5.85884619410286e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,39866,0.131953485401457,0.00614544777936533,0.119908407753901,0.143998563049013,7.53974882027299e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCR,Breakpoint cluster region protein,39866,0.191855771959906,0.00893746752714961,0.174338335606693,0.20937320831312,8.42116375609791e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCTN3,Tectonic-3,37437,0.061367370647411,0.00286273725049747,0.055756405636436,0.0669783356583861,2.77534857535069e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.127725112759294,0.00598703767578974,0.115990518914746,0.139459706603842,1.44915700543413e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL13,C-C motif chemokine 13,40024,0.142228282149394,0.00668993623033784,0.129116007137932,0.155340557160856,6.00346340823273e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,37388,0.182281816283184,0.00856314324492109,0.165498055523138,0.199065577043229,6.26142127552738e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP23,Synaptosomal-associated protein 23,39868,0.17974744446984,0.00845850136231585,0.163168781799701,0.196326107139979,7.53489191539925e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OXT,Oxytocin-neurophysin 1,40009,0.286322034952024,0.0134830988366067,0.259895161232275,0.312748908671773,9.98265943962891e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0908084552610155,0.00427862671466074,0.0824223469002804,0.0991945636217505,1.33174925351222e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAT,Linker for activation of T-cells family member 1,40058,0.15645637187372,0.00737671145142857,0.14199801742892,0.17091472631852,1.69834288593082e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFA,Vascular endothelial growth factor A,39993,0.117561167891934,0.00554431238654413,0.106694315614308,0.128428020169561,1.92938815467354e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.154283158145978,0.00726527658929311,0.140043216030964,0.168523100260993,1.98600418179558e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.195088158230893,0.00920432936314065,0.177047672679137,0.213128643782649,2.34277303414276e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LBR,Delta(14)-sterol reductase LBR,40009,0.137491935063796,0.00649743062200857,0.124756971044659,0.150226899082933,4.67109758619556e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R9B,Neurabin-2,40058,0.194720121184932,0.00921003419510455,0.176668454162527,0.212771788207337,6.82161204770529e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS9,Galectin-9,39859,0.0647101259794386,0.00306517773497016,0.0587023776188971,0.0707178743399801,1.33505796762161e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.221027159881073,0.0104572002518533,0.200531047387441,0.241523272374706,1.36527011242792e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.173437624012447,0.00820898924491221,0.157348005092419,0.189527242932475,1.63937188329399e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0464174008090173,0.00220026079202563,0.042104889656647,0.0507299119613875,1.91319441831656e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANG,Angiogenin,39843,0.0692334191425215,0.0032854801098085,0.0627938781272968,0.0756729601577461,2.97636729099008e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.11893999353918,0.00564448612437277,0.10787680073541,0.130003186342951,3.0702762591514e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTUD7B,OTU domain-containing protein 7B,37411,0.131354172640426,0.00623018046331346,0.119143018932332,0.143565326348521,4.05673445993655e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFX1,Transcriptional repressor NF-X1,37021,0.137746778422135,0.00653619639395253,0.124935833489989,0.150557723354282,5.41745022088381e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.203547771545176,0.00968964922940076,0.18455605905555,0.222539484034801,1.1046016670565e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,39931,0.17436346973528,0.00834019093889723,0.158016695495041,0.190710243975519,8.78790213019531e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRPK2,SRSF protein kinase 2,39866,0.17078103649926,0.00818237456836533,0.154743582345264,0.186818490653256,1.79956975791127e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOLM2,Protein GOLM2,40009,0.0449128690977911,0.00215469791097345,0.0406896611922831,0.0491360770032991,3.08065940562983e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CMIP,C-Maf-inducing protein,37368,0.168214481267969,0.00805994747316408,0.152416984220567,0.18401197831537,3.14392927630707e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.142790043125187,0.00685031006163283,0.129363435404387,0.156216650845988,3.3132731576427e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.210436346307828,0.010110150140658,0.190620452032139,0.230252240583518,5.78981482336275e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,39788,0.278349387632714,0.0133790493101938,0.252126450984734,0.304572324280694,7.11916040299911e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLA2,Src-like-adapter 2,37411,0.212686381436372,0.0102398848613873,0.192616207108053,0.232756555764692,2.35118577653896e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.208015099298861,0.0100155995744938,0.188384524132854,0.227645674464869,2.64575937194406e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BACH1,Transcription regulator protein BACH1,39866,0.149621163233559,0.00721496377023247,0.135479834243904,0.163762492223215,2.7447773358625e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F13B,Coagulation factor XIII B chain,37380,0.0514061855638644,0.00247691262188474,0.0465514368249703,0.0562609343027585,3.28783059764514e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTBDN,Retbindin,39788,0.0589279472769057,0.00285007342430675,0.0533418033652645,0.0645140911885469,9.6791885721729e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELE,E-selectin,40052,0.100018632990491,0.00484594266962896,0.0905205853580184,0.109516680622964,1.92292761548129e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISM1,Isthmin-1,39866,0.0800678505510776,0.00388071919402001,0.0724616409307984,0.0876740601713568,2.30585514381721e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MINK1,Misshapen-like kinase 1,37388,0.186525384250791,0.00903005768366224,0.168826471190813,0.204224297310769,2.3599811896863e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0735411251166832,0.00356094646854689,0.0665616700383313,0.0805205801950351,2.55355350644568e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD5,T-cell surface glycoprotein CD5,40003,0.0659942420464126,0.00319974880220476,0.0597227343940912,0.0722657496987339,2.61488890249704e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.128388561969584,0.00621788456358335,0.116201508224961,0.140575615714207,2.72704850484289e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.194804255289612,0.00944699606763328,0.176288142997051,0.213320367582173,3.05002823078961e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0804436305646453,0.00390232935349193,0.0727950650318012,0.0880921960974895,5.46413774767696e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.152773658914021,0.00741936646725739,0.138231700638196,0.167315617189845,8.55858517667691e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGLN1,Egl nine homolog 1,39866,0.106741307521906,0.0051929870699892,0.0965630528647276,0.116919562179085,1.09174615742394e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCK2,Cytoplasmic protein NCK2,39931,0.212561502388171,0.0103444761796168,0.192286329076122,0.23283667570022,1.23247852743877e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.129654247673881,0.00631275211640882,0.11728125352572,0.142027241822042,1.62352727376877e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,39908,0.104005915545386,0.00506824924628695,0.0940721470226636,0.113939684068108,2.13644206669954e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.141119482340234,0.0068954244335332,0.127604450450509,0.154634514229959,6.83696926105559e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP2B,DNA topoisomerase 2-beta,37056,0.158543778879486,0.00773787357962003,0.14337754666343,0.173710011095541,7.16370308841917e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK11,Serine/threonine-protein kinase STK11,39585,0.146019166435113,0.00714068163922578,0.13202343042223,0.160014902447995,9.55852997221732e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC27,Cell division cycle protein 27 homolog,39477,0.121671878424201,0.00597333215210492,0.109964147406075,0.133379609442327,4.76955151129582e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSME1,Proteasome activator complex subunit 1,39738,0.0732198764708179,0.0035969748439502,0.0661698057766756,0.0802699471649603,5.9373258017862e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.179720476455637,0.00881970283461363,0.162433858899794,0.19700709401148,6.14712504385768e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AAMDC,Mth938 domain-containing protein,37043,0.105779702258551,0.00520020613810037,0.0955872982278738,0.115972106289227,1.35048966595687e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.186968685302641,0.0092086240583663,0.168919782148243,0.205017588457039,1.67503469398066e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PXN,Paxillin,39489,0.102261420984587,0.00503636692420754,0.0923901418131398,0.112132700156033,1.71630117700248e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USO1,General vesicular transport factor p115,39788,0.176858062239485,0.00872882509973523,0.159749565044004,0.193966559434966,3.84671749388783e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPD52L2,Tumor protein D54,37124,0.215338770335463,0.010615165032155,0.19453304687244,0.236144493798487,3.96355894457277e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IKBKG,NF-kappa-B essential modulator,39866,0.181678417636865,0.00897251191121925,0.164092294290876,0.199264540982855,4.9185320346987e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.152174305152399,0.00753365406341909,0.137408343188098,0.166940267116701,2.04769135756969e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0999364199125548,0.00494775575440787,0.0902388186339153,0.109634021191194,2.2909920007205e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0510393090525499,0.00252791907081904,0.0460845876737446,0.0559940304313553,2.65554816119411e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOK2,Docking protein 2,39868,0.240819883565484,0.0119473645208909,0.217403049104538,0.26423671802643,3.00113438759859e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,37411,0.224413292204748,0.01114361789728,0.202571801126079,0.246254783283416,6.77926260906468e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC13,Mucin-13,39489,0.0990512859395771,0.00493565094458027,0.0893774100881998,0.108725161790954,1.805072940654e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0636318137644238,0.00317285646213395,0.0574130150986412,0.0698506124302063,2.23266505905618e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PENK,Proenkephalin-A,37124,0.0568733019900862,0.00283330872187076,0.0513200168952196,0.0624265870849529,2.58430194601907e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0531667264254588,0.00265186624196984,0.0479690685911979,0.0583643842597197,2.65795465140199e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.104506241424112,0.0052142334054421,0.0942863439494458,0.114726138898779,4.65016315236147e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP43,Centrosomal protein 43,39476,0.13619538259311,0.00681853294799602,0.122831058015038,0.149559707171183,1.14373836337273e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.222169183062392,0.0111390707826964,0.200336604328307,0.244001761796477,2.96951901323492e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXO1,Forkhead box protein O1,39866,0.166798127033297,0.00837623956658198,0.150380697482797,0.183215556583798,3.54273360114958e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGFR,Opioid growth factor receptor,39788,0.0633129479520979,0.00318072448425327,0.0570787279629615,0.0695471679412343,4.19277861662103e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEC31A,Protein transport protein Sec31A,37043,0.149413642732552,0.00749824890052759,0.134717074887518,0.164110210577587,4.56478614661282e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0519096306720346,0.00261040377742274,0.046793239268286,0.0570260220757832,6.11553568316833e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.108479597291619,0.00545759738109522,0.0977827064246727,0.119176488158566,7.00117925309462e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.134127032469997,0.00675251003989948,0.120892112791794,0.1473619521482,1.44268984317108e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,40052,0.0414938468694751,0.00209270809251646,0.0373921390081429,0.0455955547308074,1.81492036645433e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.130075656068404,0.00656259354036661,0.117212972729285,0.142938339407522,2.26240064625367e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEXIM1,Protein HEXIM1,39866,0.157532955487381,0.00795389307661514,0.141943325057216,0.173122585917547,2.85973794856764e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BID,BH3-interacting domain death agonist,39866,0.127419444152573,0.00644394355443628,0.114789314785877,0.140049573519268,5.34008458549616e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.217984659486845,0.0110323449238552,0.196361263436089,0.239608055537602,7.11461203789881e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,39788,0.0681049601258786,0.00344823795494716,0.0613464137341822,0.074863506517575,8.40454195148754e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.147107273547589,0.00747099458840004,0.132464124154325,0.161750422940853,2.68604000162444e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.207460635204548,0.0105376117505421,0.186806916173485,0.22811435423561,4.2618645002575e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VNN1,Pantetheinase,37445,0.138604330472165,0.00705233201077585,0.124781759731044,0.152426901213286,8.06994022840771e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCBP2,Poly(rC)-binding protein 2,37411,0.138709574520865,0.00705863589810834,0.124874648160573,0.152544500881157,8.54574727899162e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0585229988445442,0.0029817260644124,0.0526788157582959,0.0643671819307925,1.35453127039018e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP3B1,AP-3 complex subunit beta-1,37382,0.146422764287375,0.00747088544909269,0.131779828807154,0.161065699767597,2.32095900064922e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QDPR,Dihydropteridine reductase,39790,0.0829861305966207,0.00423947386282681,0.0746767618254802,0.0912954993677613,2.48712525840138e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLK1,Protein delta homolog 1,40052,0.106304180818466,0.00543416199504386,0.0956532233081797,0.116955138328752,3.04340318750193e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0812844836215047,0.00416053197786204,0.0731298409448951,0.0894391262981143,4.95481440569517e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.133290383146446,0.00681584878738368,0.119931319523174,0.146649446769718,5.65927095549584e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.04942516260051,0.00253147359805168,0.0444634743483287,0.0543868508526913,6.28641847935474e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,39713,0.0447722552315496,0.00229473355713651,0.040274577459562,0.0492699330035372,8.51526727857973e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAG1,Dystroglycan,39931,0.0923301727563497,0.00473294771529499,0.0830535952343715,0.101606750278328,8.73425796506858e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COCH,Cochlin,37437,0.0869000676014313,0.00445081805910883,0.078176464205578,0.0956236709972847,9.52876127957051e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIAE,Sialate O-acetylesterase,39875,0.0895617359582554,0.00459987772808783,0.0805459756112033,0.0985774963053076,1.80073793594224e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMOX2,Heme oxygenase 2,39489,0.0897445823267607,0.00461089401704289,0.0807072300533566,0.0987819346001647,2.16615353330638e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNMBP,Dynamin-binding protein,39749,0.117546419934748,0.00604324160797324,0.10570166638312,0.129391173486375,2.66049778142054e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NIT2,Omega-amidase NIT2,37377,0.142635789053878,0.00734075852567342,0.128247902343558,0.157023675764198,5.7319720047252e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNB3,Plexin-B3,39812,0.0901372715318181,0.00464467878298457,0.0810337011171683,0.0992408419464678,6.13043786621704e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0375693334558876,0.00193421755340626,0.0337782670512113,0.0413603998605639,6.54638172865544e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBPL,FK506-binding protein-like,37382,0.112542918383255,0.00579845907775635,0.101177938590852,0.123907898175657,8.61397222475294e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTDH,Protein LYRIC,37056,0.174673743857534,0.00901534556626111,0.157003666547662,0.192343821167406,1.74264850399264e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EREG,Proepiregulin,39713,0.150469387181854,0.00778177198361444,0.135217114093969,0.165721660269738,2.36452427395978e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.193023371365961,0.00997355474358307,0.173475204068539,0.212571538663384,2.46418664633673e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.11794229319794,0.00609965999325829,0.105986959611154,0.129897626784726,3.43373326233906e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDUA,Alpha-L-iduronidase,40030,0.0862432539075431,0.00447310127314951,0.07747597541217,0.0950105324029161,6.50665402366391e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.170774029474151,0.00885428548881995,0.153419629916064,0.188128429032239,8.60881245942334e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17RB,Interleukin-17 receptor B,39644,-0.101157669497448,0.00525187501858098,-0.111451344533867,-0.0908639944610294,9.83178385686778e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.101284650947543,0.00526724411281733,0.0909608524864209,0.111608449408665,1.77570317504089e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0947184716674143,0.00492698270477625,0.0850615855660529,0.104375357768776,2.00955909801554e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYTL4,Synaptotagmin-like protein 4,37437,0.135403346115825,0.007037191195928,0.121610451371806,0.149196240859844,2.02598797127486e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,39866,0.106015706567946,0.00551558390839964,0.0952051621074822,0.116826251028409,2.03444939134308e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.209805883703828,0.0109188846412904,0.188404869806899,0.231206897600757,2.33122367201808e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,37437,0.169694502511232,0.00882502815109083,0.152397447335094,0.18699155768737,2.55368494188083e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS1,Galectin-1,39868,0.0627093101298367,0.00326839386361589,0.0563032581571495,0.0691153621025238,3.89636290774082e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0548556911694537,0.00286091287086256,0.049248301942563,0.0604630803963443,4.90778158108886e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYN,Tyrosine-protein kinase Lyn,39788,0.157864441151593,0.00824537272263485,0.141703510615229,0.174025371687958,8.46630933546702e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,37124,0.145189629163334,0.00759021281897747,0.130312812038138,0.16006644628853,1.76527330097379e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.111133246026934,0.00581226631465556,0.0997412040502088,0.122525288003659,1.95852417974589e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0835765181229155,0.00437638652588936,0.0749988005321724,0.0921542357136587,2.10802519622462e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,39858,0.0978047495175173,0.00512921484002035,0.0877514884310774,0.107858010603957,3.59313889990864e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARSB,Arylsulfatase B,39788,0.102614316846201,0.00538323801519639,0.0920631703364159,0.113165463355986,4.0820279605462e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASAH2,Neutral ceramidase,39749,0.0971489624239518,0.00510664896673238,0.0871399304491563,0.107157994398747,8.30921335680463e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.113867352041255,0.00598622099548531,0.102134358890104,0.125600345192406,8.59588320041149e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.101418176918014,0.00533906792342558,0.0909536037880995,0.111882750047928,1.39364658158984e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESM1,Endothelial cell-specific molecule 1,39862,-0.0631423514069736,0.00332407673065811,-0.0696575417990635,-0.0566271610148837,1.395068657115e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP10,Stromelysin-2,39857,-0.108701999643286,0.00572651294502518,-0.119925965015536,-0.0974780342710371,1.78567491386474e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMN,Protein amnionless,39587,0.0882322339264873,0.00464829978687502,0.0791215663442122,0.0973429015087623,1.86879119037877e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.106424624022939,0.00561009474099599,0.0954288383305873,0.117420409715292,2.20063367319318e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNCG,Gamma-synuclein,39749,0.120045002680663,0.00633456427563386,0.107629256700421,0.132460748660905,3.24788563246549e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0829455571606366,0.00437700114579082,-0.0915244794063866,-0.0743666349148866,4.60738226518857e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDRKH,Tudor and KH domain-containing protein,39489,0.157511179367815,0.0083231128120282,0.14119787825624,0.173824480479391,5.4633055967663e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNST,Consortin,39868,0.199174340850122,0.010535013626932,0.178525714141335,0.219822967558908,7.35913051838494e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1R2,Interleukin-1 receptor type 2,39830,0.036177990387274,0.00191357827594187,0.032427376966428,0.0399286038081201,7.39379951004375e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0640753831834737,0.00338954370428978,-0.0707188888438817,-0.0574318775230657,7.65365461508663e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP2,Methionine aminopeptidase 2,40011,0.106419087331621,0.0056316066275405,0.095381138341642,0.117457036321601,8.57657975306195e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,39788,0.109792094087032,0.00581252567480802,0.098399543764408,0.121184644409655,1.0195561111275e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.157669263413158,0.00833749944482154,0.141327764501308,0.174010762325009,1.0244342560531e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0927754355801197,0.00491770119300064,0.0831367412418384,0.102414129918401,1.55516573992758e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,39585,0.139610634398296,0.00740974342212287,0.125087537290935,0.154133731505657,2.51214074056639e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.191270966525755,0.0101573410322777,0.171362578102491,0.211179354949019,2.93423463081536e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0515170114825579,0.0027386261644835,0.0461493042001702,0.0568847187649455,4.24166994691982e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,37411,0.140542652130886,0.00746547107543382,0.125910328823035,0.155174975438736,4.59519285671435e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0512845011177028,0.00272936129648853,0.0459349529765853,0.0566340492588203,6.34728407837917e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.159352242321252,0.00848278543042789,0.142725982877613,0.17597850176489,6.80597461476292e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NSFL1C,NSFL1 cofactor p47,40009,0.11895187330278,0.00634078231092764,0.106523939973362,0.131379806632198,1.07703947761632e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.120298880000453,0.00640811697294443,0.107738970733482,0.132858789267424,1.21230771957669e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.133126421834835,0.00709248742586252,0.119225146480145,0.147027697189526,1.2859890917209e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH2B3,SH2B adapter protein 3,39477,0.180214025332194,0.00961735504785627,0.161364009438396,0.199064041225993,1.70125514523163e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,39858,0.0940820889703251,0.00503838634619802,0.084206851731777,0.103957326208873,5.39395505336553e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSNL1,Visinin-like protein 1,37388,0.0686997735433208,0.0036809104157853,0.0614851891283816,0.07591435795826,8.95683246488839e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,40030,0.0677481426627872,0.00363459888450811,0.0606243288491513,0.0748719564764231,9.72756286393494e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD36,Platelet glycoprotein 4,37056,0.083181608371659,0.00445753133086763,0.0744448469631584,0.0919183697801595,9.97276161650259e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAX1BP1,Tax1-binding protein 1,37388,0.114665520636158,0.00614933466721619,0.102612824688414,0.126718216583902,1.22088060550435e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,37382,0.174950184355685,0.00939837267801094,0.156529373906784,0.193370994804587,2.1839944975056e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,A1BG,Alpha-1B-glycoprotein,37453,0.0309826010838996,0.00166465330082616,0.0277198806142803,0.0342453215535188,2.27656388121326e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,39931,0.235047766064845,0.012649811288006,0.210254135940353,0.259841396189337,2.8728034037061e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL11,Eotaxin,40058,0.0690899649039208,0.00372356942355676,0.0617917688337495,0.0763881609740921,4.58009028160317e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYDGF,Myeloid-derived growth factor,37437,0.183208392542371,0.00987350583493373,0.163856321105901,0.202560463978841,6.3717086124463e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMPR,GMP reductase 1,40058,0.0896795600690936,0.00484122489711697,0.0801907592707444,0.0991683608674429,7.99826131156285e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.115215551640635,0.00622484863111464,0.103014848323651,0.12741625495762,1.12577426170227e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELOA,Elongin-A,39788,0.0921437821339518,0.00498130801455584,0.0823804184254224,0.101907145842481,1.32790383538316e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C3,Complement C3,36816,0.0831647865054942,0.00449184527296423,0.0743607697704843,0.0919688032405041,1.48048056091062e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,37056,0.159682918488644,0.00862824477158279,0.142771558736342,0.176594278240946,1.63248602532961e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAMBP,STAM-binding protein,39713,0.116158820786981,0.00628330843489144,0.103843536254594,0.128474105319368,1.63587479241598e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX15,Sorting nexin-15,37124,0.0971868397927982,0.00525306488973842,0.0868908326089109,0.107482846976685,1.8002898507813e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,37445,0.0480487398744752,0.00259871087135757,0.0429552665666144,0.053142213182336,2.1080174481136e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0915563204341695,0.00496221210410943,0.0818303847101151,0.101282256158224,3.23890889899122e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.102700947857656,0.00556245138545788,0.0917985431421581,0.113603352573153,3.42526545447472e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,39585,0.0619405747918434,0.00336001242335065,0.0553549504420761,0.0685261991416106,4.27981784742948e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES2,Cocaine esterase,39788,0.0972328281525715,0.00527700807183322,0.0868898923317784,0.107575763973365,4.91206031091163e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TALDO1,Transaldolase,37415,0.0803414996131295,0.00436128006781914,0.071793390680204,0.088889608546055,7.21784960339026e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SULT2A1,Bile salt sulfotransferase,39866,0.1002511757536,0.00545063014446606,0.0895679406704469,0.110934410836754,8.87024075630651e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AZI2,5-azacytidine-induced protein 2,37411,0.0994402934571456,0.00540533105779047,0.0888458445838763,0.110034742330415,1.12964393290576e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL3,C-X-C motif chemokine 3,39859,0.169821175675354,0.00925186663663347,0.151687517067553,0.187954834283156,1.73847475338095e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,37026,0.103123933478994,0.00561217034914285,0.0921240795946738,0.114123787363314,1.77058658978766e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C19orf12,Protein C19orf12,39489,0.116187888776451,0.00634055412431386,0.103760402692795,0.128615374860106,3.15279335808838e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.181408707006196,0.00990375809757124,0.161997341134956,0.200820072877435,3.4556578171067e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM2,Paralemmin-2,37388,0.067632521695169,0.00368906136187754,0.0604019614258891,0.074863081964449,3.54526319574034e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0495551265503271,0.0027038355345869,0.0442556089025368,0.0548546441981174,4.0775019219341e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,37056,0.174456625164619,0.00952650571320485,0.155784673966738,0.193128576362501,5.38756859433253e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.134111721677145,0.00733412081770853,0.119736844874436,0.148486598479854,6.05122209464454e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OCLN,Occludin,37411,0.0765806614233688,0.00418495752631469,0.068378144671792,0.0847831781749456,6.52604591019367e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM5,Tripartite motif-containing protein 5,39866,0.153928872992125,0.00842487877261818,0.137416110597794,0.170441635386457,7.95697738918722e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDC4,Syndecan-4,39868,0.080776516939656,0.00442810482650465,0.0720974314797068,0.0894556023996051,1.33766107353249e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3GLB2,Endophilin-B2,37388,0.117792002197928,0.00645289183822326,0.10514433419501,0.130439670200845,1.46177289834302e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.121984961522044,0.00669122070224349,0.108870168945647,0.135099754098441,1.61048489463835e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL7,C-C motif chemokine 7,39866,0.103679199970307,0.00568924167589331,0.0925282862855562,0.114830113655058,1.84878407675476e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THPO,Thrombopoietin,39585,0.0678149381204058,0.00372357467077946,0.0605167317656781,0.0751131444751335,2.33683793663239e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0897692654013216,0.00492759249726911,0.0801111841066741,0.099427346695969,2.80545718466366e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.183154851948657,0.0100641254598933,0.163429166047267,0.202880537850048,2.85582490607902e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASHC3,WASH complex subunit 3,37388,0.134554932652401,0.00739243325993407,0.12006576346293,0.149044101841872,3.72563214524321e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.142453943282166,0.00783681233836243,0.127093791098975,0.157814095465356,5.71110148780931e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.106169054566825,0.00585585480387832,0.0946915791512238,0.117646529982427,9.65471161346259e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MITD1,MIT domain-containing protein 1,39749,0.171834080987624,0.00948462253964222,0.153244220809925,0.190423941165323,1.25571532233553e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0553296612464354,0.00305211319262438,0.0493475193888916,0.0613118031039792,1.44626521303821e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGCC,Regulator of cell cycle RGCC,37411,0.133625595726435,0.00738809659290386,0.119144926404343,0.148106265048526,2.87022447844447e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0520299647783367,0.00287961655736112,0.0463859163259089,0.0576740132307645,2.95200222866566e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.165968586211188,0.0091984521775674,0.147939619943156,0.18399755247922,4.75936067741552e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.126848184605164,0.00703815336140606,0.113053404016808,0.14064296519352,9.22041283140627e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.216266085655261,0.0120111649283172,0.192724202395759,0.239807968914763,9.48553507968197e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUS,RNA-binding protein FUS,39455,0.069028708991923,0.00383421402557517,0.0615136495017956,0.0765437684820503,9.75469051489697e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSZ,Cathepsin Z,39865,0.0544828827835188,0.0030267535290526,0.0485504458665757,0.0604153197004619,9.84664909581241e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIP,Gastric inhibitory polypeptide,37043,0.0766637047077645,0.00425466002451305,0.068324571059719,0.0850028383558101,1.00438194155837e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS8,Galectin-8,40009,0.10748404197448,0.00597362711730571,0.0957757328245607,0.119192351124399,1.10530975904092e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0832343772396636,0.00462648095635778,0.0741664745652024,0.0923022799141249,1.56458215728631e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRAP,BRCA1-associated protein,37249,0.193234240592728,0.0107523395347098,0.172159655104696,0.214308826080759,2.2472096495619e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD1,Sushi domain-containing protein 1,39585,0.0852711772319013,0.00475126413077912,0.0759586995355742,0.0945836549282284,2.6019382093426e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0665294569071977,0.00370769372518448,0.0592623772058361,0.0737965366085593,2.66968581028324e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.137033214800461,0.00764337682178788,0.122052196229756,0.152014233371165,3.65804758723366e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D23,TBC1 domain family member 23,39788,0.157374104362161,0.00878209732106703,0.14016119361287,0.174587015111452,4.11570503084045e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.155949546703472,0.0086955690530004,0.138906231359591,0.172992862047352,4.22815768825276e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.185544938773509,0.0103628383118906,0.165233775682203,0.205856101864814,7.31506064217251e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEP1A,Meprin A subunit alpha,37382,0.124969740036033,0.00698422706202774,0.111280654994459,0.138658825077608,8.71880544883116e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GASK1A,Golgi-associated kinase 1A,37021,0.0746797838837356,0.00417368900782534,0.0664993534283979,0.0828602143390732,9.19559595519949e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCC,Tubulin-specific chaperone C,39749,0.141713366389074,0.00793692105816515,0.12615700111507,0.157269731663077,1.2943669004689e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD99L2,CD99 antigen-like protein 2,39858,0.0420312523018938,0.00235433276685046,0.0374167600788669,0.0466457445249207,1.33178569558803e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.185338591471092,0.010408007774343,0.16493889623338,0.205738286708804,3.89819994919829e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0808966600288204,0.00455022445658968,0.0719782200939046,0.0898150999637362,4.88072932652923e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMMD1,COMM domain-containing protein 1,37043,0.107516217535005,0.00605209780177009,0.0956541058435352,0.119378329226474,8.55199497043162e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM13A,Protein FAM13A,37382,0.117434374549587,0.00661382360638728,0.104471280281068,0.130397468818106,9.5875149998696e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.190747530493646,0.0107556966634101,0.169666365033362,0.21182869595393,1.04634827030228e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL4,C-C motif chemokine 4,39882,0.107957473820141,0.00609236988853087,0.0960164288386206,0.119898518801662,1.35241703093695e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINC1,Antithrombin-III,37424,0.0251785592165516,0.00142018115073281,0.0223950041611152,0.0279621142719879,1.51914649143914e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.255081722477447,0.0143972924665461,0.226863029243017,0.283300415711878,1.87446590640197e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB27B,Ras-related protein Rab-27B,37437,0.141444613229729,0.0080039573546275,0.125756856814659,0.157132369644798,4.09864764605416e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRKL,Crk-like protein,39881,0.184576482912464,0.0104605543433273,0.164073796399542,0.205079169425385,4.99712822425595e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1S,Complement C1s subcomponent,37453,0.0360653716655899,0.00204247597571846,0.0320621187531817,0.040068624577998,5.22751172475915e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0917074336187103,0.00519786985913023,0.0815196086948151,0.101895258542606,6.76889230107826e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.200980755437715,0.0114149050997128,0.178607541442278,0.223353969433152,9.76542388186995e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18,Interleukin-18,39795,0.0782142789020426,0.00445095908684924,0.0694903990918181,0.0869381587122671,1.77064490782745e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.045681785399136,0.00259970257257748,0.0405863683568842,0.0507772024413879,1.77657585978183e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBKS,Ribokinase,39504,0.0849100369035478,0.00483742669466932,0.0754286805819959,0.0943913932250997,2.55866464304112e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,37056,0.0855846979430737,0.00487460261678166,0.0760304768141816,0.0951389190719657,3.11645388649492e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAT2,Signal transducer and activator of transcription 2,37056,0.134893113257266,0.00769282743771583,0.119815171479343,0.149971055035189,4.57721345787381e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.155694468311878,0.00889835175674145,0.138253698868665,0.173135237755092,8.77836123388825e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.143009803228761,0.00818189668271839,0.126973285730633,0.159046320726889,1.15231237789303e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,37411,0.204145704140171,0.0116870771205616,0.18123903298387,0.227052375296472,1.38792616539108e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOLGA3,Golgin subfamily A member 3,37411,0.132410432748119,0.0075818042649975,0.117550096388724,0.147270769107514,1.47135671291925e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDHD2,Phospholipase DDHD2,37411,0.113755371194075,0.0065136992642627,0.10098852063612,0.12652222175203,1.47687033646843e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,39866,0.0565518855221446,0.00324260222343582,0.0501963851642104,0.0629073858800788,1.71612485516949e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGA,Protein O-GlcNAcase,37382,0.121130049298212,0.00695087313932248,0.10750633794514,0.134753760651284,2.81263437808568e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP5,Microfibrillar-associated protein 5,40052,0.0684120574003348,0.00393012375402182,0.0607090148424521,0.0761150999582176,2.98344634147091e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAX,Protein max,39489,0.179440337707174,0.0103076357045641,0.159237371726229,0.19964330368812,3.06316797103657e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IST1,IST1 homolog,37287,0.169823115048289,0.00974853062791666,0.150715995017572,0.188930235079006,3.16493370639404e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA2,Apolipoprotein A-II,37445,-0.0809077335671056,0.00464872959877077,-0.0900192435806963,-0.0717962235535149,4.08771486681712e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCAM,Cell surface glycoprotein MUC18,39931,-0.0555116968290284,0.00319296512236159,-0.0617699084688572,-0.0492534851891997,4.35546768564917e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0990770360188027,0.00569513894099865,0.0879145636944454,0.11023950834316,4.8348023234323e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPHN1,Oligophrenin-1,37388,0.183212788901039,0.0105413770356539,0.162551689911158,0.203873887890921,6.19171946057181e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNLR1,Interferon lambda receptor 1,39866,0.0634170547263998,0.00365451198583333,0.0562542112341665,0.0705798982186332,7.64225721297159e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.130829168945783,0.00754082363795936,-0.145609183276183,-0.116049154615383,8.10188688039535e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBNL,Drebrin-like protein,39931,0.157793633644393,0.00909633541945699,0.139964816222257,0.175622451066529,8.43985882014315e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.05897657672289,0.00340087272266989,0.0523108661864571,0.065642287259323,9.29707571607792e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.122925503816726,0.00710029965737945,0.109008916488262,0.13684209114519,1.51600026844675e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0556509973023365,0.00321151231744989,0.0493564331601348,0.0619455614445383,1.6000531051004e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0575021584087872,0.00332222104912024,0.0509906051525115,0.0640137116650628,1.63333538739642e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.105465594372439,0.00609998438125881,0.0935096249851713,0.117421563759706,3.03911548269987e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",39585,0.157589751040459,0.00912410018339406,0.139706514681007,0.175472987399912,3.13059248486317e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,40052,0.121128478012754,0.00701827191216974,0.107372665064901,0.134884290960606,3.73889901523163e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS1BP3,HCLS1-binding protein 3,37043,0.15453618979451,0.00894774234466858,0.136998614798959,0.17207376479006,4.1483582193577e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.123334600770955,0.00715605150491136,0.109308739821328,0.137360461720581,5.71066716368153e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.125812767640722,0.00730490817373195,0.111495147620208,0.140130387661237,7.06052765249238e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0952913655665986,0.00553524675309915,0.0844422819305242,0.106140449202673,7.97858701590378e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCG2,Secretogranin-2,39949,0.0523341579878896,0.00304033610251918,0.046375099226952,0.0582932167488272,8.19918038265307e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGKA,Diacylglycerol kinase alpha,37056,0.0921937270042728,0.00535210072103447,0.0817036095910452,0.1026838444175,8.9094310616999e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,37124,0.139128087348237,0.00808384234793944,0.123283756346275,0.154972418350198,1.13976804228643e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLB1,Beta-galactosidase,39749,0.0706942577365053,0.00411894718231186,0.0626211212591741,0.0787673942138366,1.94735670564596e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,39826,0.108552032459344,0.00633169192810051,0.096141916280267,0.120962148638421,2.66508117849349e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL16,C-X-C motif chemokine 16,40034,0.0388916480390573,0.00227051699784651,0.0344414347232781,0.0433418613548365,3.38974090611526e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEFTY2,Left-right determination factor 2,40011,0.0892779183694365,0.00521336057099281,0.0790597316502906,0.0994961050885824,3.64262084620435e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.0445855460426781,0.00260873693499431,0.0394724216500892,0.0496986704352669,6.52570305411724e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.113157992661886,0.00661987554350324,0.10018303659662,0.126132948727152,7.89927719547287e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPC5,Glypican-5,39749,0.0931849035399204,0.00546336523663283,0.0824767076761201,0.103893099403721,1.17982049187639e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNMT,Histamine N-methyltransferase,39669,0.0770258679116058,0.00451853312258926,0.0681695429913308,0.0858821928318807,1.39707996873072e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS2,Trypsin-2,39931,0.085485627696097,0.00501665893552482,0.0756529761824684,0.0953182792097256,1.52022650370248e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GTPBP2,GTP-binding protein 2,37039,0.134725015397735,0.00790207428057305,0.119236949807812,0.150213080987659,1.73491466848026e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,39868,0.134398809233183,0.00789153726111049,0.118931396201406,0.149866222264959,1.79517330895402e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0754803999701038,0.00443151099167648,0.0667946384264179,0.0841661615137897,1.79585686594327e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.141599696133871,0.00832123562510345,0.125290074308668,0.157909317959074,2.34816849912091e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASC3,Protein CASC3,37039,0.0697435926813949,0.00409633868761432,0.0617147688536709,0.077772416509119,2.56979044738059e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.102191250785079,0.00601654514303997,0.0903988223047206,0.113983679265437,3.86346157384047e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.130517626691977,0.00768404380906138,0.115456900826217,0.145578352557737,3.86744489371022e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA11,Annexin A11,39829,0.110825834279255,0.00653345920683802,0.0980202542338529,0.123631414324658,5.62039551540974e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.138015919352481,0.00815610117250385,0.122029961054374,0.154001877650589,1.11142486178485e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNPY4,Protein canopy homolog 4,39788,0.124964133910806,0.00738715687135702,0.110485306442946,0.139442961378666,1.22380785335367e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.11334767066563,0.00669920614478597,0.100217226621849,0.12647811470941,1.51045790456408e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,37411,0.0997150272311324,0.00589583093724176,0.0881591985941385,0.111270855868126,1.62107183113413e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD22,B-cell receptor CD22,40058,0.066169492699862,0.00392014048070349,0.0584860173576832,0.0738529680420408,2.22117364066143e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",37411,0.103477169068445,0.0061287120918697,0.0914648933683806,0.11548944476851,2.61546263326476e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0797739605852963,0.00472745665927842,0.0705081455331106,0.089039775637482,3.07085843723602e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.112125136027189,0.00664863990980521,0.0990938018039708,0.125156470250407,3.73806254577517e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RWDD1,RWD domain-containing protein 1,40009,0.10510071448915,0.00624181638134482,0.0928667543817141,0.117334674596586,4.42303524310617e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPBP,Platelet basic protein,37371,0.139706103763242,0.00830140120153008,0.123435357408243,0.155976850118241,6.50990294744364e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,39477,0.152156328824324,0.00905460541100724,0.134409302218749,0.169903355429898,8.08414623024229e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NIT1,Deaminated glutathione amidase,37043,0.0774658633303716,0.00460626734149957,0.0684375793410324,0.0864941473197107,8.19332052116797e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0783118238367291,0.00466018867204601,0.0691778540395189,0.0874457936339393,9.76488145903544e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0918276712353907,0.00547230602040399,0.0811019514353988,0.102553391035382,1.15173235507951e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST13,Hsc70-interacting protein,37124,0.090606803236989,0.00540065870054005,0.0800215121839305,0.101192094290047,1.58429318920938e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.151751363394523,0.00906293212403068,-0.169514710357624,-0.133988016431423,2.1196375158917e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL18,C-C motif chemokine 18,39715,0.115460347529246,0.00690633007579565,0.101923940580686,0.128996754477805,3.3005056289005e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPT1,Angiopoietin-1,39794,0.137879295016434,0.00825012340588662,0.121709053140897,0.154049536891972,3.60127185519727e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.129018765249256,0.00771987759726494,0.113887805158617,0.144149725339895,3.67299785369752e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLG,Plasminogen,37162,0.0369564120593372,0.00221091348562617,0.0326230216275099,0.0412898024911645,4.34423839687737e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.141400926694277,0.00849020972303902,0.124760115637121,0.158041737751434,9.58658289067975e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F2,Prothrombin,37453,0.0239030591145764,0.00143444857596673,0.0210915399056816,0.0267145783234712,9.86766423742739e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0633265678686444,0.00380005343949553,0.0558784631272331,0.0707746726100556,1.00371988495794e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.140662761764349,0.00844285220286803,0.124114771446728,0.157210752081971,1.07721927106913e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YJU2,Splicing factor YJU2,37368,0.0528604909790325,0.00317436128827307,0.0466387428540173,0.0590822391040477,1.19714526249501e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TWF2,Twinfilin-2,37437,0.137596997805672,0.00826347953293764,0.121400577921115,0.15379341769023,1.21040619550072e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0711856688629265,0.00427518737039765,0.0628063016169471,0.0795650361089059,1.25195868658971e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPART,Spartin,37124,0.126940290482597,0.00762688481015317,0.111991596254697,0.141888984710497,1.41228357343523e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.143959010081777,0.00866644607491211,0.126972775774949,0.160945244388605,1.90453621073675e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.126710279142431,0.00762761863789381,0.111760146612159,0.141660411672703,2.30371846433505e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0644867547329218,0.00388526422327818,0.0568716368552966,0.072101872610547,2.40386334524837e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESYT2,Extended synaptotagmin-2,37388,0.133576308261891,0.00804740018183749,0.117803403905489,0.149349212618292,2.87148697912288e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRY2,Protein sprouty homolog 2,39587,0.150140475798084,0.00905904593000972,0.132384745775265,0.167896205820903,3.57360284490475e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,39749,0.129024004025562,0.0077862325079095,0.113762988310059,0.144285019741064,3.69347290039462e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK10,Kallikrein-10,39856,0.0638243219445073,0.00385248539735686,0.0562734505656878,0.0713751933233267,3.89556456863352e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.045927029519214,0.00277288020222105,0.0404921843228608,0.0513618747155673,4.19539700590394e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD72,B-cell differentiation antigen CD72,37124,0.0672328330765037,0.00405676945839259,0.0592815649380543,0.0751841012149532,4.48699771488805e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICA1,Islet cell autoantigen 1,39587,0.129874932014072,0.00784478908889236,0.114499145399843,0.145250718628301,4.79354195852803e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PF4,Platelet factor 4,37385,0.156044874945395,0.00943407517974566,0.137554087593093,0.174535662297696,7.40838279169252e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2,Microtubule-associated protein 2,37388,0.0743112581081762,0.00449956990996334,0.065492101084648,0.0831304151317043,1.11872559589073e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0465237699457057,0.00281991042263957,0.0409967455173322,0.0520507943740793,1.17867088086235e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSS,Cathepsin S,36543,0.039394014460924,0.00238760454763117,0.0347143095475669,0.0440737193742811,1.58133038872106e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK24,Serine/threonine-protein kinase 24,39489,0.100349981622132,0.00608940812013009,0.0884147417066772,0.112285221537587,1.66954572876143e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.117133209265025,0.00710344310160686,0.103210460785876,0.131055957744175,1.75512578025609e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPARC,SPARC,39913,0.113381195347274,0.00689538572331212,0.0998662393295826,0.126896151364966,2.92386382616058e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD69,Early activation antigen CD69,39785,0.141341862833449,0.00859712343457332,0.124491500901686,0.158192224765213,3.07018943234531e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MENT,Protein MENT,37124,-0.0357150564410815,0.00217195613794397,-0.0399720904714516,-0.0314580224107113,3.65935604387172e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RILPL2,RILP-like protein 2,37437,0.15850629136398,0.0096509385329273,0.139590451839442,0.177422130888517,4.88607593521054e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGXT,Serine--pyruvate aminotransferase,39868,0.124922671627251,0.00761560592773765,0.109996084008885,0.139849259245617,5.56820051088394e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0875105002989561,0.00534504485811157,0.0770342123770574,0.0979867882208548,9.28181043292849e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FMNL1,Formin-like protein 1,39489,0.0975598384840351,0.00596376021105261,0.085870868470372,0.109248808497698,1.17884617910758e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0943264298921151,0.00576752836051972,0.0830220743054965,0.105630785478734,1.2600788955421e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPSE,Heparanase,37306,0.150463937440697,0.00919838190035104,0.132435108916009,0.168492765965385,1.44126788360871e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0475001706413014,0.00291050263819194,0.0417955854704452,0.0532047558121576,2.16143672537571e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKD2,Polycystin-2,37021,0.0950721566579001,0.00582345236615296,0.0836581900202403,0.10648612329556,2.47657422476563e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA4D,Semaphorin-4D,40009,0.0477818955574861,0.00292955252081024,0.042039972616698,0.0535238184982742,2.48438866111732e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0916122969958221,0.00562005627677327,0.0805969866933465,0.102627607298298,2.93930011415193e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMA,Granzyme A,40058,0.0538244515673462,0.00330622628313059,0.0473442480524102,0.0603046550822821,4.05063696337419e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGF,Pro-epidermal growth factor,39808,0.165154478822321,0.0101442268316381,0.145271794232311,0.185037163412332,4.05903910983868e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.153541379788028,0.00943327108143611,0.135052168468413,0.172030591107643,4.3156542566522e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMOT,Angiomotin,37124,0.0657835980395141,0.00403898134309719,0.0578671946070436,0.0737000014719846,4.55103216355063e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0519135036954582,0.00319428352698716,0.0456527079825634,0.0581742994083531,6.40326368846935e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRG1,Scrapie-responsive protein 1,37437,0.0420395831206017,0.00258490968926603,0.0369731601296403,0.0471060061115631,6.45788409458236e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.050753715955615,0.00312535364004913,0.0446280228211187,0.0568794090901113,7.82057420183096e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL3,C-C motif chemokine 3,39866,0.0997052610343661,0.00614144598332522,0.0876680269070486,0.111742495161684,8.43655260953219e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDT,D-dopachrome decarboxylase,37437,0.0637699496667095,0.00392549091645394,0.0560759874704598,0.0714639118629592,8.6655568681885e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CETN3,Centrin-3,37382,0.125405905615195,0.00772363804572087,0.110267575045582,0.140544236184808,9.97050586832321e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF2,TNF receptor-associated factor 2,39866,0.112753284408258,0.00694968089369106,0.0991319098566237,0.126374658959893,9.99544765091708e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0945521941865937,0.00582747840690026,0.0831303365090692,0.105974051864118,1.0025548097452e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.113377057328503,0.00699187446293792,0.0996729833811444,0.127081131275861,1.1459999423814e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX8,Syntaxin-8,39866,0.0773605882576438,0.00477171556410173,0.0680080257520045,0.0867131507632832,1.20975177413482e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.135538475688815,0.00835439383165841,0.119163863778765,0.151913087598866,1.22927552731942e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOD,Apolipoprotein D,36780,-0.0688889199343244,0.00424718376400104,-0.0772134001117664,-0.0605644397568823,1.38112775363938e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD207,C-type lectin domain family 4 member K,39496,0.0595571010511404,0.00367557420294183,0.0523529756133744,0.0667612264889064,1.42906627260869e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMPR2,GMP reductase 2,37124,0.10590132057872,0.00655375235091524,0.0930559659709266,0.118746675186514,3.52984988254484e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.165456920998429,0.0102525232286324,0.14536197547031,0.185551866526549,3.95542889485653e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP2B1,AP-2 complex subunit beta,37039,0.07746982808365,0.00479758933223975,0.0680665529924601,0.0868731031748399,4.25412092887916e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0881834216792981,0.00546546123743773,0.0774711176539202,0.0988957257046761,4.26013939126896e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CETN2,Centrin-2,39489,0.106985035520007,0.00663089361428924,0.0939884840360002,0.119981587004014,4.31189735253191e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOK1,Docking protein 1,37388,0.216377709733594,0.0134182592318833,0.190077921639103,0.242677497828085,5.84438445540885e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.153113115343561,0.00951156896549382,0.134470440171193,0.171755790515929,9.41686664100885e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDCP1,CUB domain-containing protein 1,39749,0.0784580380833107,0.00487927859995681,0.0688946520273954,0.088021424139226,1.00817802117254e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0783325064348668,0.00486771559183702,0.0687917838748662,0.0878732289948674,1.0123797453558e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,39892,0.0554055087734292,0.0034459072199337,0.0486515306223592,0.0621594869244992,1.01814306032964e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTNB,Dystrobrevin beta,37348,0.0691254981088411,0.00429999087511914,0.0606975159936076,0.0775534802240747,1.29382212809167e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN3,Ataxin-3,37388,0.0963037946902121,0.00599467816832524,0.0845542254802946,0.10805336390013,1.53074563817697e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RFC4,Replication factor C subunit 4,37368,0.0335485309589167,0.00209033221761492,0.0294514798123914,0.0376455821054419,1.95966377357042e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMPER,BMP-binding endothelial regulator protein,37124,0.0352663973214827,0.00219719816960387,0.0309598889090591,0.0395729057339062,1.96461761066404e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBXN1,UBX domain-containing protein 1,37124,0.108941475317301,0.00678766538693648,0.0956376511589057,0.122245299475697,1.98658889198839e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUB1,NEDD8 ultimate buster 1,39866,0.131993768436176,0.00824444427182884,0.115834657663391,0.14815287920896,3.02617086051689e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,39931,0.043907241170712,0.00274353727679737,0.0385299081081891,0.0492845742332348,3.32149865569107e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF19,Fibroblast growth factor 19,39931,0.119841272572261,0.00749017188514607,0.105160535677375,0.134522009467148,3.54268350617116e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD226,CD226 antigen,37056,0.0656574302034746,0.00410148837820203,0.0576185129821987,0.0736963474247506,3.86236180662779e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARA5,Scavenger receptor class A member 5,40009,0.0456511592837039,0.00285632081310339,0.0400527704900213,0.0512495480773866,4.63387736698597e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0464221667646155,0.00290943082429782,0.0407196823489918,0.0521246511802393,8.65020915371835e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPB1,Carboxypeptidase B,40052,0.0895613301535856,0.00561885024785377,0.0785483836677922,0.100574276639379,9.1163591691055e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM17,Splicing factor 45,37411,0.119425875518403,0.00749093148220336,0.104743649813284,0.134108101223521,1.04835549692385e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRAS,Ras-related protein R-Ras,37039,0.205365304326499,0.0128820848107985,0.180116418097334,0.230614190555664,1.09723178046982e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APP,Amyloid-beta precursor protein,39829,0.103775314794346,0.00651949323655237,0.090997108050703,0.116553521537988,1.30146678674898e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0617236171363889,0.00387969694803889,0.0541194111182326,0.0693278231545451,1.5060049447926e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.119646632888198,0.00752686313434116,0.104893981144889,0.134399284631507,1.87310433052416e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPP,Lipoma-preferred partner,37021,0.104385797459314,0.00656441256503127,0.0915195488318528,0.117252046086775,2.06307480052369e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.119677506220062,0.00752681367940792,0.104924951408423,0.134430061031702,2.11180186207363e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0878256869577255,0.00553027739648273,0.0769863432606193,0.0986650306548316,2.37285652856314e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPACT,Protein IMPACT,37388,0.0860381702034767,0.00541561568325092,0.0754235634643049,0.0966527769426485,2.51529979970858e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0954749773345922,0.00601703817642953,0.0836815825087903,0.107268372160394,2.85126248332286e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0696850227903375,0.00439012280538341,0.061080382091786,0.078289663488889,3.14072040803997e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0908961514131403,0.00573294844988679,0.0796595724513622,0.102132730374918,4.27148518369157e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRAP2,GRB2-related adapter protein 2,39868,0.199110267923316,0.0125689609293021,0.174475104501884,0.223745431344748,4.29788115946386e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.12368153435745,0.00781062808534375,0.108372703310176,0.138990365404724,5.85359725228757e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0712258857945755,0.00450119165341811,0.062403550153876,0.080048221435275,6.96526549285483e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.131838795314674,0.00835203528357357,0.11546880615887,0.148208784470478,1.05967451895189e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDC,Nuclear migration protein nudC,40058,0.0993144365627277,0.00629771819346425,0.0869709089035378,0.111657964221918,1.29925527592883e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53,Cellular tumor antigen p53,39477,0.0681355863390446,0.00432408996977646,0.0596603699982827,0.0766108026798065,1.64000605257516e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JAM3,Junctional adhesion molecule C,37124,0.0780289737040784,0.00494965209360352,0.0683276556006155,0.0877302918075413,1.73907257315942e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0491748260514474,0.00312335255832728,0.043053055037126,0.0552965970657689,1.94431723671497e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAS6,Growth arrest-specific protein 6,39947,-0.0393310506129304,0.00249914793165438,-0.044229380558973,-0.0344327206668878,2.15690569505953e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARB2,Lysosome membrane protein 2,39486,0.044254319096759,0.0028147766797283,0.0387373568044915,0.0497712813890265,2.82817081076925e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,36874,0.0823567193012986,0.00523505643993683,0.0720960086790224,0.0926174299235748,2.95556086012724e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINE2,Glia-derived nexin,37437,0.0992952442988286,0.00631631138891221,0.0869152739765607,0.111675214621097,3.35788462096881e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEXN,Nexilin,37445,0.105776516268249,0.00673283010563871,0.0925801692611969,0.118972863275301,3.91152078187617e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.132284885161078,0.00842112242320046,0.115779485211605,0.148790285110551,4.13459622364295e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0761531952261402,0.004849061448499,0.0666490347870822,0.0856573556651982,4.53725671981041e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLG4,Disks large homolog 4,37388,0.110075656255679,0.00701307255294125,0.096330034051914,0.123821278459444,4.94001363245032e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSL,Cathepsin L1,39868,0.036634614677874,0.00233757998824176,0.0320529579009201,0.0412162714548278,6.01625011544385e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX4,Syntaxin-4,39788,0.0907755036883126,0.00579459817002159,0.0794180912750703,0.102132916101555,6.68352380123288e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2,Complement C2,39908,0.036214739959297,0.00231238929734012,0.0316824569365104,0.0407470229820837,7.10086762291257e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,37124,0.193999501600254,0.0123823916344278,0.169730013996776,0.218268989203733,7.83452915349173e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL8,C-C motif chemokine 8,40003,0.0923502554966755,0.00590706739386147,0.0807724034047071,0.103928107588644,1.07786470118858e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0937346635768728,0.00599677900824824,0.0819809767207062,0.105488350433039,1.14345967835614e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6AP2,Renin receptor,39477,0.0622453808111727,0.00398946744160085,0.054426024625635,0.0700647369967104,1.80589617100199e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP10,Caspase-10,39489,0.10909253021702,0.0069987322971702,0.0953750149145662,0.122810045519473,2.27271931103961e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATOX1,Copper transport protein ATOX1,39913,0.11101820076676,0.00712423455637071,0.0970547010362736,0.124981700497247,2.36915148838085e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0788884799634316,0.0050603435836187,0.0689702065395389,0.0888067533873242,2.61340065351793e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0516216791546402,0.00331494060854865,0.0451243955618849,0.0581189627473956,2.78079666400322e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,37382,0.127396552086522,0.0081965120586616,0.111331388451545,0.143461715721499,5.21896953140715e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRADD,Death domain-containing protein CRADD,39713,0.115985437809874,0.00747291559211806,0.101338523249323,0.130632352370425,6.25751011988399e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFB,Complement factor B,37220,0.0501255254126232,0.00322898471257395,0.0437967153759782,0.0564543354492681,7.09003964999376e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0945787419585715,0.00609748653047388,0.0826276683588427,0.1065298155583,8.44174470255063e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,39698,0.0418897960459086,0.0027024681165741,0.0365929585374234,0.0471866335543938,8.53869925916762e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXJ3,Forkhead box protein J3,37056,0.068089933986305,0.00439245610690913,0.0594807200167631,0.0766991479558469,1.00681625745555e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,39832,0.054265346404139,0.00350717471281061,0.0473912839670303,0.0611394088412478,1.29947119520511e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0584585929155318,0.0037753381741695,0.0510589300941596,0.0658582557369041,1.30695282733011e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA1,Carboxypeptidase A1,40052,0.0895249566506001,0.00578892296745774,0.078178667634383,0.100871245666817,1.44659329441506e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,37135,0.0985825845681392,0.00637544156453152,0.0860867191016575,0.111078450034621,1.80640382439148e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0542045375208155,0.00350749875531007,0.0473298399604077,0.0610792350812232,2.03350246831023e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0695497340414386,0.0045046532384605,0.060720613694056,0.0783788543888212,2.52753411112698e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,40058,0.102280114447442,0.00663452490153714,0.089276445640429,0.115283783254455,3.03560685812569e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KITLG,Kit ligand,39868,-0.0559189675401662,0.00362757439738338,-0.0630290133590376,-0.0488089217212948,3.13153111384369e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP7,Matrilysin,39563,0.0746169276716363,0.00484261653448829,0.0651253992640393,0.0841084560792334,3.52129951437385e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UROD,Uroporphyrinogen decarboxylase,37124,0.104635487601517,0.00678965162604378,0.0913277704144716,0.117943204788563,3.98128802584301e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.102007138416038,0.00662666557274204,0.0890188738934639,0.114995402938613,5.24381290397772e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0489566165286679,0.00318675689078609,0.0427105730227272,0.0552026600346087,6.99096007047586e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIFBP,KIF-binding protein,39788,0.124499786565731,0.00811913767544745,0.108586276721854,0.140413296409608,1.07623024569017e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0700457011855995,0.00457028424698724,0.0610879440615045,0.0790034583096944,1.40435303727692e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0865028687656651,0.00564795105540591,0.0754328846970695,0.0975728528342607,1.41557865586057e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MGLL,Monoglyceride lipase,39908,0.131004694271303,0.00855526842952286,0.114236368149438,0.147773020393168,1.4785346543551e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0472187219813994,0.00308686592909015,0.0411684647603827,0.0532689792024161,1.89883474637323e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.147348278678882,0.00963555054699029,0.128462599606781,0.166233957750983,2.06749893841268e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0952120884178357,0.00623156009608923,0.0829982306295008,0.107425946206171,2.4485672851983e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.066444211755403,0.00434885484831787,0.0579204562526999,0.074967967258106,2.5022595321576e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP7,Caspase-7,37388,0.126152617108197,0.00825643345238841,0.109970007541516,0.142335226674878,2.86775301564884e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,37039,0.119338351166322,0.00781497027562431,0.104021009426099,0.134655692906546,3.36329846316176e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0573770779907465,0.00376030370353272,0.0500068827318224,0.0647472732496707,3.91690217562369e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.146359203736918,0.00959200539254898,0.127558873167522,0.165159534306314,3.92703437424744e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED8,Protein TMED8,37382,0.154553226333087,0.0101334123116809,0.134691738202193,0.174414714463982,4.34019773159234e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFB2,BPI fold-containing family B member 2,37405,0.0916709740276247,0.00601316587831512,0.079885168906127,0.103456779149122,4.80008639241881e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNM3,Dynamin-3,37411,0.0818912809885216,0.00537201209409411,0.0713621372840971,0.092420424692946,4.86944861323193e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTF1,Cardiotrophin-1,39585,0.126478808643292,0.00831279140254445,0.110185737494305,0.142771879792279,6.58996347892543e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.115765084649324,0.00760987949479908,0.100849720839517,0.13068044845913,6.74404566469123e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0611938962020946,0.00402520844516085,0.0533044876495793,0.0690833047546099,7.7878322541844e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADD1,Alpha-adducin,37124,0.102682883477172,0.00675208425485279,0.0894487983376609,0.115916968616684,8.60575045750293e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0840807684472563,0.00553404118832263,0.0732340477181439,0.0949274891763686,9.02231880316796e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.127155275106302,0.00836666761835869,0.110756606574318,0.143553943638285,9.75369551959008e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK13,Kallikrein-13,39490,0.0626655357918417,0.00413112465708543,0.0545685314639543,0.0707625401197292,1.31956408719031e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RILP,Rab-interacting lysosomal protein,39984,0.0880850068083078,0.00581194062619516,0.0766936031809653,0.0994764104356503,1.56928746652848e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMT,Catechol O-methyltransferase,39403,0.126139436873821,0.00833442421076618,0.109803965420719,0.142474908326922,2.21979987266119e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSTN,Growth/differentiation factor 8,39585,0.0767944634450517,0.00508079058429964,0.0668361138998244,0.086752812990279,2.96965637970415e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.085498104744374,0.00565669492131789,0.0744109826985909,0.0965852267901571,2.9941710716241e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM106A,Transmembrane protein 106A,37368,0.105125900963499,0.0069759898181642,0.0914529609198969,0.118798841007101,6.64377759687662e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.111612676889817,0.00740732274563644,0.0970943243083692,0.126131029471264,6.79076790351439e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F12,Coagulation factor XII,37453,0.0610444496558979,0.00405749783325684,0.0530917539027145,0.0689971454090813,9.55490014932398e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCB,Tubulin-folding cofactor B,39749,0.14916816433173,0.00992224729001662,0.129720559643297,0.168615769020162,9.85941000959078e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.137788908299769,0.00916934894368949,0.119816984370138,0.1557608322294,1.24697939644724e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD83,CD83 antigen,39866,0.0482530645893785,0.00321330267703161,0.0419549913423966,0.0545511378363605,1.26333670504397e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.141490770706847,0.00942814054356861,0.123011615241452,0.159969926172241,1.45435910851285e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12A_IL12B,Interleukin-12,39788,0.108098366882371,0.00720516640955292,0.0939762407196471,0.122220493045095,1.55607263004666e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN2L,Ataxin-2-like protein,37411,0.0705565202290608,0.00470307913484655,0.0613384851247615,0.07977455533336,1.80476382070945e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0692484660492424,0.00462538818584196,0.0601827052049921,0.0783142268934926,2.45772992395127e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPI,Mannose-6-phosphate isomerase,39788,0.126249392422626,0.00844681004426703,0.109693644735862,0.142805140109389,3.59714622666639e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APPL2,DCC-interacting protein 13-beta,37124,0.165544276367501,0.0110683278581932,0.143850353765443,0.18723819896956,3.61601646890388e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,37382,0.0854166486110419,0.00571200138953747,0.0742211258875485,0.0966121713345353,3.69606545177084e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YWHAQ,14-3-3 protein theta,37124,0.108601554073934,0.0072698799627128,0.0943525893470168,0.122850518800851,4.71776668031626e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EHD3,EH domain-containing protein 3,37043,0.171696920047481,0.0115161663779211,0.149125233946756,0.194268606148206,7.31365795755825e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD164,Sialomucin core protein 24,39858,0.0382644874905399,0.00256906954773272,0.0332291111769838,0.043299863804096,7.74350241644191e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REEP4,Receptor expression-enhancing protein 4,37411,0.0909724721497185,0.00610598300806729,0.0790047454539067,0.10294019884553,8.30081320171785e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,37445,0.10628755145225,0.00714589556369946,0.0922815961473987,0.120293506757101,1.19602546060021e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BGLAP,Osteocalcin,37437,0.125885245769666,0.00846669457174635,0.109290524409043,0.142479967130289,1.30013914551934e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FIS1,Mitochondrial fission 1 protein,39855,0.113827530233704,0.00766979673384918,0.0987947286353601,0.128860331832049,1.69788483624724e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,37124,0.173673692294572,0.0116951195589242,0.15075125795908,0.196596126630063,1.7340402796652e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.111592089521154,0.00752105796989594,0.0968508159001575,0.12633336314215,1.78900196201567e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0989028577565896,0.00666876801941911,0.0858320724385281,0.111973643074651,1.97297563474015e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB6,Serpin B6,39970,0.0874175508406689,0.00589689049928633,0.0758596454620677,0.0989754562192701,2.15749067806549e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARF1,Scavenger receptor class F member 1,40052,0.0621006898997038,0.00418980856710919,0.0538886651081698,0.0703127146912379,2.22988759813229e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3C,Protein FAM3C,39846,0.041996289314353,0.00283503298457478,0.0364396246645864,0.0475529539641196,2.55085202857227e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BIN2,Bridging integrator 2,39858,0.130060302222046,0.00879318041625048,0.112825668606195,0.147294935837897,3.53546101981395e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LACTB2,Endoribonuclease LACTB2,39868,0.0964844418814297,0.00652496434636142,0.0836955117625613,0.109273372000298,3.75123103525367e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH9,Protocadherin-9,37382,0.0481515837110753,0.00325563373327849,0.0417705415938494,0.0545326258283011,4.0966518044565e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D5,TBC1 domain family member 5,39866,0.112718289645674,0.00763365093318251,0.0977563338166364,0.127680245474712,5.10192193972869e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.106191334612517,0.00718778922379827,0.0921032677338726,0.120279401491162,5.27762748380124e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.106383062306834,0.00720463414608645,0.0922619793805041,0.120504145233163,5.97552624452745e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.107628809874345,0.00729439954676578,0.0933317867626836,0.121925832986005,6.0979637651193e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0539719609347761,0.00366137093076612,0.0467956739104745,0.0611482479590777,7.45637380867354e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPB1,Heat shock protein beta-1,39617,0.100640588170794,0.00682815359399653,0.0872574071265605,0.114023769215027,7.64932093938474e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEMIP2,Cell surface hyaluronidase,37056,0.0462523725030334,0.00313643134612399,0.0401049670646303,0.0523997779414364,7.88864762590678e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0969066780803637,0.00657264840892018,0.0840242871988801,0.109789068961847,8.16564669794762e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERMAP,Erythroid membrane-associated protein,37056,0.0643078096834632,0.00436527588396247,0.0557518689508967,0.0728637504160296,9.83567006498202e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.143528870644684,0.00974533139357722,0.124428021113272,0.162629720176095,1.04267253724804e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACYBP,Calcyclin-binding protein,37088,0.149334630750186,0.0101650207785306,0.129411190024266,0.169258071476106,1.77224767935254e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPI,Glucose-6-phosphate isomerase,37445,0.068296601272786,0.00464954393095497,0.0591834951681143,0.0774097073774578,1.78711963653379e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL7,Interleukin-7,39866,0.0937405028893951,0.00638880502264445,0.081218445045012,0.106262560733778,1.99171403771356e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSC22D1,TSC22 domain family protein 1,37411,0.097449085649574,0.00663759563085261,0.0844393982131028,0.110458773086045,1.99694625005496e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0733365028242477,0.00499859175814857,0.0635392629782765,0.0831337426702188,2.31341059498599e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NID1,Nidogen-1,39892,0.0539323006956942,0.00367952861095795,0.0467204246182167,0.0611441767731718,2.48225514699048e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.126120185323209,0.00860371904419934,0.109256895996579,0.14298347464984,2.76667749597077e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TADA3,Transcriptional adapter 3,37368,0.0568885115329762,0.00388116408053676,0.0492814299351241,0.0644955931308282,2.82769137831733e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F2R,Proteinase-activated receptor 1,39908,0.0838605868376707,0.00572509662720032,0.072639397448358,0.0950817762269833,2.84768872062342e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",39818,0.157683992255804,0.0107673503192035,0.136579985630165,0.178787998881442,2.99719277825284e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYO9B,Unconventional myosin-IXb,39587,0.0948327118872716,0.00647570236491746,0.0821403352520334,0.10752508852251,3.03990571185235e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA4,Protein disulfide-isomerase A4,37437,0.0882201760301388,0.00602148578515437,0.0764180638912362,0.100022288169041,3.10231436930535e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0888000554707598,0.00606069916640362,0.0769210851046087,0.100679025836911,3.14047792513134e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS3,Galectin-3,39901,0.0423032262857386,0.00289031284442083,0.0366382131106737,0.0479682394608034,3.37488728757387e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0740562584891657,0.0050603892578257,0.0641378955438273,0.0839746214345041,3.46574083441033e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.127642633069019,0.00872569830036776,0.110540264400298,0.14474500173774,4.29956244380819e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0930552206743197,0.00636389991533401,0.0805819768402651,0.105528464508374,4.70527846253035e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMVK,Phosphomevalonate kinase,39480,0.15901319621618,0.0108885449482567,0.137671648117597,0.180354744314763,5.50867902136702e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0938064980597174,0.00642614975991965,0.0812112445302748,0.10640175158916,5.87608727773108e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,37368,0.078718779743254,0.00539015002902034,0.0681540856863742,0.0892834738001339,6.12334336899822e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASSF2,Ras association domain-containing protein 2,39477,0.0787733797543902,0.00539953195543329,0.068190297121741,0.0893564623870395,6.82354043194755e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.034280898432276,0.0023498987260147,0.0296750969292872,0.0388866999352648,7.67598605650289e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0600242135737803,0.00411749538931257,0.0519539226107277,0.068094504536833,8.95581812431881e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMMT,MICOS complex subunit MIC60,37368,0.0624557088006893,0.00429923741639637,0.0540292034645524,0.0708822141368262,1.85770336177479e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.14884393627701,0.0102498083493734,0.128754311912238,0.168933560641782,2.0416241470127e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.134662575960432,0.00927805391148352,0.116477590293924,0.15284756162694,2.24113028874462e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.159561321080606,0.0110025312054957,0.137996359917834,0.181126282243377,2.33458591715006e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.0913298334723837,0.00629334782277867,0.0789948717397375,0.10366479520503,2.34026444567294e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MIF,Macrophage migration inhibitory factor,39826,0.0969569899412306,0.00668581432317236,0.0838527938678128,0.110061186014648,2.35670701499734e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG6,Large proline-rich protein BAG6,39585,0.0525509255746755,0.00362378946463302,0.0454482982239948,0.0596535529253563,2.39012761373884e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL32,Interleukin-32,39866,-0.0608327545866081,0.00419544081563265,-0.0690558185852481,-0.0526096905879681,2.42716518378875e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOF,Apolipoprotein F,37445,-0.0367616336279108,0.00253573318582859,-0.0417316706721348,-0.0317915965836867,2.83338091020451e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.145483826915947,0.0100374094626319,0.125810504369188,0.165157149462705,2.9808538680327e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP1,Guanylate-binding protein 1,37376,0.0901117815897035,0.00622656977625083,0.0779077048282519,0.102315858351155,4.08828709149396e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0754225237406131,0.00522098699080399,0.0651893892386372,0.0856556582425889,6.03038630813681e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0426468574010807,0.00295598815301444,0.0368531206211724,0.048440594180989,6.82457672377198e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM1,Intercellular adhesion molecule 1,39822,0.0401550376899323,0.00278578110049963,0.034694906732953,0.0456151686469116,8.27893653440922e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,39811,0.12650578973724,0.00877664725306705,0.109303561121229,0.143708018353251,8.32726587450485e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0402950252876327,0.0027969051065169,0.0348130912788596,0.0457769592964058,1.03315440723089e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THTPA,Thiamine-triphosphatase,37345,0.124668362602865,0.0086545207538608,0.107705501925297,0.141631223280432,1.06883034213181e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHRL,Appetite-regulating hormone,39868,0.108199990579749,0.00751742956852493,0.0934658286254405,0.122934152534058,1.1164899539845e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIF1,Allograft inflammatory factor 1,39477,0.0744323542319448,0.00517196488654784,0.0642953030543111,0.0845694054095786,1.16332005737576e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CERT,Ceramide transfer protein,39489,0.086928365578327,0.00604204410250805,0.0750859591374112,0.0987707720192428,1.2355761496109e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB33A,Ras-related protein Rab-33A,37021,0.0946742090618234,0.00657851332705889,0.081780322940788,0.107568095182859,1.3221649848751e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIAPIN1,Anamorsin,39913,0.0888952696778461,0.00618614328451755,0.0767704288401917,0.101020110515501,1.55060513993498e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0938792105747625,0.0065350976281525,0.0810704192235836,0.106688001925941,1.91493324838215e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0664125142959815,0.00462468586844157,0.057348129993836,0.075476898598127,2.0517242415143e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LARP1,La-related protein 1,37368,0.0901784010219025,0.00628202950977495,0.0778656231827436,0.102491178861061,2.17506069372224e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMSB10,Thymosin beta-10,39858,0.108647892312902,0.00757745861655782,0.0937960734244489,0.123499711201356,2.44288338969379e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WDR46,WD repeat-containing protein 46,37368,0.0506777185513238,0.00353491432189084,0.0437492864804178,0.0576061506222299,2.8341980292491e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMG3,Proteasome assembly chaperone 3,39866,0.069739179654601,0.00486990510272177,0.0601941656532663,0.0792841936559357,3.14809045269918e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARK7,Parkinson disease protein 7,39858,0.0736749814710984,0.00514519395359047,0.0635904013220611,0.0837595616201357,3.20575240056522e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.127942205426284,0.00893593059291084,0.110427781464179,0.14545662938839,3.75787404630976e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MESD,LRP chaperone MESD,39858,0.17121002581184,0.0119750054516062,0.147739015126692,0.194681036496988,4.3748609391209e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0479241314419418,0.0033523789226961,0.0413534687534574,0.0544947941304262,4.55448172509363e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNA4,Ephrin-A4,39720,0.0387463854083027,0.00271199160269913,0.0334308818670124,0.044061888949593,5.08580598506666e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.141020028679215,0.00987131583981927,0.121672249633169,0.160367807725261,5.14387529763199e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL1,Growth-regulated alpha protein,39839,0.132707977477349,0.00930576735090685,0.114468673469571,0.150947281485126,7.33796893246602e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL2,C-C motif chemokine 2,39720,0.0721939537268201,0.00506267418105142,0.0622711123319593,0.0821167951216808,7.45607146352538e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD244,Natural killer cell receptor 2B4,40058,0.0373051787787422,0.00261676998305599,0.0321763096119524,0.0424340479455319,7.767912929053e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,39477,0.084363602566815,0.00591950553089908,0.0727613717262528,0.0959658334073772,8.46284468909838e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,40052,0.043639865788594,0.0030632601423209,0.037635875909645,0.049643855667543,8.94726414768976e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAP3,Cytosol aminopeptidase,39587,0.0679150319187577,0.00476728172545569,0.0585711597368645,0.0772589041006509,9.13465698752729e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP3R1,Calcineurin subunit B type 1,39749,0.0578692676829653,0.00406863614295169,0.0498947408427799,0.0658437945231506,1.25238397361084e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,39477,0.0624037206391094,0.00439087680366461,0.0537976021039268,0.071009839174292,1.48161885866089e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.157083389498891,0.0110563638153173,0.135412916420869,0.178753862576913,1.58060546317546e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGH,Gamma-glutamyl hydrolase,39573,0.047203798219397,0.00332897560848507,0.0406790060267662,0.0537285904120277,2.33101865617534e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,40009,0.0634771232170748,0.0044778667113273,0.0547005044628733,0.0722537419712763,2.42129925691534e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.10749779720787,0.00757998342295743,0.092641029698873,0.122354564716866,2.50811585478829e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.131790682898214,0.00929962949563643,0.113563409086767,0.150017956709662,2.59288250081389e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0585291496052941,0.00413024527103557,0.0504338688740644,0.0666244303365238,2.96742071594499e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,37366,0.122317205672588,0.00865301090455436,0.105357304299661,0.139277107045514,4.78605403047763e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F11,Coagulation factor XI,37249,0.0432316068243134,0.0030636668056859,0.0372268198851691,0.0492363937634578,6.80705429182078e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L1,Bcl-2-like protein 1,37388,0.138384588628792,0.00980766188720005,0.11916157132988,0.157607605927704,6.87230516104798e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0900126587906253,0.00637995706202743,0.0775079429490516,0.102517374632199,6.98908463310104e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,37430,0.0665816346731805,0.00472073914463401,0.0573289859496978,0.0758342833966631,7.43311402096601e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.136460541209121,0.00967608720030012,0.117495410296533,0.155425672121709,7.55657521867656e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0649647301401727,0.00461210406826328,0.0559250061663766,0.0740044541139687,9.61535296447548e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0941909776529868,0.00669124814003479,0.0810761312985186,0.107305824007455,9.90734864012638e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.11301757292909,0.00803628176256605,0.0972664606744607,0.12876868518372,1.17545798537043e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBI,Acyl-CoA-binding protein,39793,0.110256769183883,0.00784271534222478,0.0948850471131227,0.125628491254644,1.26255295452518e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.137131506256875,0.00975528405824084,0.118011149502723,0.156251863011027,1.4315187335803e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATG4A,Cysteine protease ATG4A,39477,0.0809849421898389,0.00577242213664386,0.0696709948020169,0.0922988895776608,1.9113199012965e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.127007536037472,0.00906961970163703,0.109231081422263,0.14478399065268,3.07206925413777e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UMOD,Uromodulin,40012,-0.0722932089739583,0.00516637284726965,-0.0824192997546068,-0.0621671181933098,3.11610680246531e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD274,Programmed cell death 1 ligand 1,39749,0.0460034878181581,0.00328801071536943,0.039558986816034,0.0524479888202821,3.2239774590606e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0551466821429502,0.00394575695495189,0.0474129985112445,0.0628803657746559,4.40865779961116e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP2,Caspase-2,39866,0.0935238657790855,0.00669920654379666,0.0803934209532441,0.106654310604927,4.92469511184328e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.147908221930976,0.0105896891829465,0.127152431132401,0.168664012729551,5.00151689664339e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MIA,Melanoma-derived growth regulatory protein,39913,0.0494455501773039,0.0035432618861804,0.0425007568803903,0.0563903434742174,5.31505696647228e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0546691496810834,0.00391573854212819,0.0469943021385121,0.0623439972236546,5.40045730538131e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF6,SLAM family member 6,39477,0.0516457417283735,0.0037018289093348,0.0443901570660773,0.0589013263906697,5.66330794423704e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0735178797125878,0.00526787616318846,0.0631928424327384,0.0838429169924371,5.84218497525814e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.140098753261769,0.0100411130129054,0.120418171756474,0.159779334767063,6.2333484824533e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0868405664605842,0.00622917483779814,0.0746313837784999,0.0990497491426686,6.45132148523531e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.061217339922227,0.00439261140391537,0.0526078215705529,0.0698268582739011,7.77786638061116e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALB2,Calretinin,39489,0.0398389946992162,0.00286134117029666,0.0342307660054348,0.0454472233929977,8.3649507872796e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYBB1,Beta-crystallin B1,37437,0.0908526512646189,0.0065239113205444,0.0780657850763518,0.103639517452886,8.79381555764388e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.129347462017663,0.00929614450532321,0.11112701878723,0.147567905248097,9.37921113989225e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.126201954461093,0.00907986873350109,0.10840541174343,0.143998497178755,1.1505789764698e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLMH,Bleomycin hydrolase,40052,0.0435460656267543,0.0031363106637626,0.0373988967257796,0.049693234527729,1.39817310975262e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRB1,Chymotrypsinogen B,39858,0.0727067567487477,0.0052429332309108,0.0624306076161625,0.0829829058813329,1.77748128403947e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BST2,Bone marrow stromal antigen 2,40009,0.0723215671325598,0.00521910466218133,0.0620921219946844,0.0825510122704352,2.04267584205382e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEPR,Leptin receptor,39868,-0.0419344426826688,0.00302948814177806,-0.0478722394405538,-0.0359966459247838,2.52320895833546e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0622500130849845,0.0044977286804905,0.0534344648712231,0.0710655612987458,2.92045625523569e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RP2,Protein XRP2,39788,0.0565062472493826,0.00408968442212843,0.0484904657820108,0.0645220287167543,3.58267340952947e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0829565317191915,0.00600483091005321,0.0711870631354872,0.0947260003028957,4.1344093725361e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.0823640482819652,0.00596995007948595,0.0706629461261727,0.0940651504377576,4.72206084764498e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MICALL2,MICAL-like protein 2,37039,0.0920284469363855,0.00666887770858963,0.0789574466275498,0.105099447245221,5.09533717556744e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0677873066748044,0.00491802444624677,0.0581479787601607,0.0774266345894481,5.60828528567011e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA3,Annexin A3,39985,0.0942771813973457,0.00684612570080407,0.0808587750237698,0.107695587770922,6.6730577487018e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADM,Pro-adrenomedullin,40030,0.0354647040741261,0.00258034148641157,0.0304072347607594,0.0405221733874928,9.59634193688272e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUGT1,Protein SGT1 homolog,39477,0.109276406936103,0.0079525904256569,0.0936893297018151,0.12486348417039,1.0222564077935e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BDNF,Brain-derived neurotrophic factor,37437,0.111076182803332,0.00809070176815418,0.0952184073377493,0.126933958268914,1.31279283627996e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0522167277225896,0.00380569952501732,-0.0596758987916235,-0.0447575566535556,1.33028677119937e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.087340926407788,0.00636430735630255,0.074866883989435,0.099814968826141,1.44043235755781e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0408887157997275,0.00298017057190358,0.0350475814787965,0.0467298501206585,1.48528679786431e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXO3,Forkhead box protein O3,39477,0.131321807033566,0.00957948040182875,0.112546025445982,0.150097588621151,1.58835163147274e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMFG,Glia maturation factor gamma,37437,0.0968174297259506,0.00706189334854336,0.0829761187628057,0.110658740689096,1.70063156727537e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0484324012881615,0.00353834596887671,0.0414972431891632,0.0553675593871599,2.06587729109987e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0512039751933153,0.00374103564712491,0.0438715453249505,0.0585364050616802,2.10628957506043e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NBN,Nibrin,39587,0.069118635681099,0.00505161445924992,0.0592174713409692,0.0790198000212289,2.25883969215866e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFA,Protransforming growth factor alpha,39866,0.0614920410208153,0.00449937488691808,0.0526732662424559,0.0703108157991747,2.76864620953168e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA2,Carboxypeptidase A2,39933,0.0863754282213954,0.00632035037605041,0.0739875414843366,0.0987633149584542,2.78333340300743e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.0811939943636513,0.00594758044325534,0.0695367366948708,0.0928512520324317,3.80399968237855e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL11,C-X-C motif chemokine 11,40009,0.104044180610573,0.00763258537968543,0.0890843132663899,0.119004047954757,4.4428936348435e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP3,Caspase-3,40052,0.118820695188211,0.00872256311004153,0.10172447149253,0.135916918883892,5.03594699525019e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,37043,0.0762268466778465,0.00559282647545172,0.0652649067859611,0.0871887865697319,5.15672630938526e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,39477,0.0526771371334371,0.00386722434812972,0.0450973774111029,0.0602568968557713,5.19018371655296e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARSA,Arylsulfatase A,39858,0.0599958515830324,0.00441315242693872,0.0513460728262325,0.0686456303398323,7.34575333198819e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.149877410447336,0.0110253328180009,0.128267758124054,0.171487062770617,7.50155362562723e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XCL1,Lymphotactin,40030,0.0729744700683555,0.00537703028587845,0.0624354907080337,0.0835134494286772,9.9999620883924e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POSTN,Periostin,37437,-0.049470522411983,0.00364436603872444,-0.0566134798478829,-0.0423275649760831,1.06097210523271e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STXBP1,Syntaxin-binding protein 1,37411,0.103993094030345,0.00766627732229959,0.0889671904786375,0.119018997582052,1.20737628596373e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP5,Platelet glycoprotein V,37124,0.0481224538900024,0.00354740172032267,0.0411695465181699,0.0550753612618348,1.21476199717552e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0871806751133541,0.00643913847725922,0.0745599636979261,0.0998013865287822,1.57467162337826e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,37382,0.116992150971827,0.00865919155919635,0.100020135515802,0.133964166427852,2.50529491651889e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIGR,Polymeric immunoglobulin receptor,39677,0.0481633972507485,0.0035667506476687,0.0411725659813179,0.0551542285201792,2.52857542266147e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN2,Nectin-2,39846,0.037318962006207,0.00276532222150736,0.0318989304520526,0.0427389935603614,2.80333075937716e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TST,Thiosulfate sulfurtransferase,39455,0.101093810908442,0.00750270950097642,0.0863885002865286,0.115799121530356,3.76456459934225e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0497575005095997,0.00369613628080311,0.0425130733992256,0.0570019276199738,4.8107339975174e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAP18,Chromatin complexes subunit BAP18,37388,0.0856941860745201,0.00638316576024316,0.0731831811844435,0.0982051909645967,7.87363089793837e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS3BP,Galectin-3-binding protein,37453,0.0396388872131147,0.00295381396315833,0.0338494118453244,0.045428362580905,8.44434607325383e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPPK1,Epiplakin,37043,0.0981856448721581,0.00731861343414811,0.0838411625412278,0.112530127203088,9.03321172869136e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.158659883877174,0.0118376661380646,0.135458058246568,0.181861709507781,9.61436365891533e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGR1,Prostaglandin reductase 1,37437,0.104670886534884,0.0078081768920783,0.0893668598264107,0.119974913243358,1.02177220730238e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0757578567834463,0.0056586959192161,0.0646668127817827,0.0868489007851098,1.18244299944753e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0972529477172711,0.00726578950959178,0.0830120002784712,0.111493895156071,1.33726828230163e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DXO,Decapping and exoribonuclease protein,37388,0.059652142323852,0.00445949850012616,0.0509115252636047,0.0683927593840993,1.50273426201208e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.166615771221695,0.0124652079412788,0.142183963656788,0.191047578786601,1.7133324923336e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPON2,Spondin-2,39775,-0.0439102697108772,0.00328965986070234,-0.0503580030378538,-0.0374625363839006,2.00795243537888e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C4BPB,C4b-binding protein beta chain,39913,0.0518895080504174,0.00388835591112859,0.0442683304646053,0.0595106856362294,2.0839669997023e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0728848403090362,0.00546885941987663,0.062165875846078,0.0836038047719944,2.90440390511873e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPT,Dermatopontin,40052,0.0349677608353406,0.00262833608199235,0.0298162221146356,0.0401192995560456,3.55901082151231e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCA,Calcitonin,39713,0.0795305331176593,0.00597753407113489,0.0678145663382349,0.0912464998970837,3.5597677590371e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0749476117917219,0.00563222896265214,0.0639084430249237,0.0859867805585201,3.82719833202474e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA1,Apolipoprotein A-I,37453,-0.0355782072483615,0.00267768222364715,-0.0408264644067099,-0.0303299500900131,4.896789771586e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNRD2,Protein ZNRD2,37382,0.0884973238142872,0.00666221107862707,0.0754393901001782,0.101555257528396,5.14110657036475e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTF2,Transcription termination factor 2,37039,0.0640934503313361,0.00482556157116471,0.0546353496518533,0.0735515510108189,5.31580471334518e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMTN,Smoothelin,37342,0.125483017536027,0.00944868899768899,0.106963587100557,0.144002447971498,5.35816124116998e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.10466200601401,0.00788257207933972,0.0892121647385038,0.120111847289516,5.63069025580001e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNF,Tumor necrosis factor,39555,0.0494827187209353,0.00372918320608341,0.0421735196370118,0.0567919178048587,5.74550356129203e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0998387163337936,0.00752924828354382,0.0850813896980477,0.11459604296954,6.99374297774784e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12B,Interleukin-12 subunit beta,40058,0.0679857072730177,0.0051319912228966,0.0579270044761404,0.078044410069895,7.5252527719644e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASS1,Argininosuccinate synthase,37021,0.103892426492814,0.00783856784158908,0.0885288335232992,0.119256019462328,7.69828792680109e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL26,C-C motif chemokine 26,39866,0.111028028308675,0.00839314729338982,0.0945774596136306,0.127478597003719,9.72199341251583e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB9,Serpin B9,39749,0.043367177550689,0.00327868806279546,0.0369409489476099,0.0497934061537681,9.94058815292537e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCA,Tubulin-specific chaperone A,37124,0.112163191101696,0.00847973658777911,0.0955429073896492,0.128783474813743,1.08995337885356e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDHB,Succinate dehydrogenase,37382,0.0910317160539889,0.00688275638948861,0.0775415135305912,0.104521918577387,1.09445271758967e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDK,Midkine,39843,0.0655728972478318,0.00496138732044459,0.0558485780997604,0.0752972163959032,1.13574632207731e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFASC,Neurofascin,40058,0.035854798523987,0.00271591453687288,0.0305316060317161,0.0411779910162578,1.3728162048232e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRGN,Neurogranin,37445,0.118802464837832,0.0089949208347224,0.101172420001776,0.136432509673888,1.38840733485968e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0523754552247988,0.00396752784874634,0.044599100641256,0.0601518098083416,1.51938930102416e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTD,Deoxycytidylate deaminase,37124,0.123910124630836,0.00939255199421472,0.105500722722175,0.142319526539497,1.72067398259425e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPXM1,Probable carboxypeptidase X1,39913,0.0877880396350056,0.00665839698170044,0.0747375815508727,0.100838497719138,1.72733844239446e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0471509475241632,0.00357533757755075,0.0401432858721638,0.0541586091761627,1.83393981932569e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTX3,Pentraxin-related protein PTX3,39866,-0.0642399529150531,0.00487582024499392,-0.0737965605952412,-0.054683345234865,1.95537058187036e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREH,Trehalase,37437,0.0974071655916563,0.00739212856283402,0.0829185936085017,0.111895737574811,2.07316044632677e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.113965119754141,0.0086537902489158,0.0970036908662665,0.130926548642016,2.32465335029738e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF23,Fibroblast growth factor 23,40008,0.075334494110487,0.00572710185662677,0.0641093744714985,0.0865596137494755,2.56980313299162e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0624978253879546,0.00475088593093906,0.053186088963314,0.0718095618125952,2.57749590111445e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP6,Platelet glycoprotein VI,39836,0.114370546133565,0.00870917275723354,0.0973005675293876,0.131440524737743,3.43634922921953e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0518392897032666,0.00394958594267252,0.0440981012556285,0.0595804781509048,3.77790196031558e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,39913,0.107717038922827,0.00821082139114223,0.0916238289961881,0.123810248849466,4.0782277008002e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0617658253789061,0.00470626345463591,0.0525415490078197,0.0709901017499925,4.20615401047587e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0750880961547267,0.00572695722930358,0.0638632599852917,0.0863129323241617,4.57163161041649e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ING1,Inhibitor of growth protein 1,39453,0.0579342225377971,0.00441911040259762,0.0492727661487058,0.0665956789268884,4.6479182504896e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP170,Centrosomal protein of 170 kDa,37043,0.0993181199348345,0.00757251639071349,0.084475987809036,0.114160252060633,4.70558421031406e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREML2,Trem-like transcript 2 protein,39858,0.0426343273870917,0.00325286871562039,0.0362587047044757,0.0490099500697076,4.79113501823767e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD46,Membrane cofactor protein,39777,0.0364451485519689,0.00278077156329612,0.0309948362879085,0.0418954608160293,4.83739550101849e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAL,Integrin alpha-L,37056,0.0549954128865648,0.0041952168793575,0.0467727878030241,0.0632180379701055,5.12015192334417e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP25,Synaptosomal-associated protein 25,36991,0.0607340800046922,0.00463662670834782,0.0516462916563305,0.0698218683530539,5.87128674598535e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0559258561511302,0.00427247260865216,0.047551809838172,0.0642999024640884,6.58273322611927e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1R,Complement C1r subcomponent,37453,0.0248140312851435,0.00189632957854144,0.0210972253112023,0.0285308372590847,6.86392477331796e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0973809237507855,0.00744548361285957,0.0827877758695807,0.11197407163199,7.45112875352051e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL14,C-C motif chemokine 14,39843,0.0497793819670671,0.0038153839393295,0.0423012294459813,0.0572575344881529,1.04193935208442e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSTB,Cystatin-B,39619,0.0542905886408597,0.00416315518593812,0.046130804476421,0.0624503728052984,1.13780760211143e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSAP,Prosaposin,37347,0.0357349462130052,0.00274457073447276,0.0303555875734386,0.0411143048525718,1.6022935269786e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLNK,B-cell linker protein,37056,0.0498803285168083,0.00383918066828512,0.0423555344069694,0.0574051226266471,2.32120260715793e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.03962005256911,0.00305525621104123,0.0336317503954692,0.0456083547427508,3.14633628269166e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0299679461955575,0.00231808020988857,0.0254245089841759,0.0345113834069391,4.85268357605606e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOC1,Apolipoprotein C-I,37424,0.0474910858492927,0.00367194188316132,0.0402940797582966,0.0546880919402889,4.88692001943669e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GET3,ATPase GET3,37437,0.0709519844602284,0.00549368647537269,0.060184358968498,0.0817196099519589,6.18024993718321e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL15,C-C motif chemokine 15,40052,0.0546989823973384,0.00425285766519492,0.0463633813735564,0.0630345834211205,1.13053655488621e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3B,Protein FAM3B,39788,0.0452330613997266,0.00351861299496752,0.0383365799295902,0.0521295428698629,1.2346291922601e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.154545565196329,0.0120253603288108,0.13097585895186,0.178115271440798,1.29229987988906e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0621107100671695,0.00483785339416835,0.0526285174145995,0.0715929027197394,1.65085494231514e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0485611805709155,0.00378274073707465,0.0411470087262492,0.0559753524155818,1.67035391792773e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN4,CCN family member 4,40030,0.0503654166267974,0.00393016945374884,0.0426622844974497,0.0580685487561451,2.05315222563512e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSNAX,Translin-associated protein X,37021,0.0493017360400933,0.00384758946602763,0.0417604606866791,0.0568430113935074,2.29869981176646e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.0897121489054598,0.00700487222202867,0.0759825993502836,0.103441698460636,2.46026439949418e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0908588567105968,0.00709841401046216,0.076945965250091,0.104771748171103,2.52148747101141e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0377125540301676,0.00294797114971715,0.031934530576722,0.0434905774836132,2.74273615731025e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0568792677909083,0.00444511746591528,0.0481668375577144,0.0655916980241023,2.87803072695908e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0870777518479968,0.00681219521407133,0.073725849228417,0.100429654467577,3.411317616156e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL25,C-C motif chemokine 25,40058,0.0624509177320797,0.00488961280122487,0.052867276641679,0.0720345588224805,3.54480245225329e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGMN,Legumain,39931,0.0450224385998175,0.00352532631077201,0.0381127990307043,0.0519320781689306,3.60272424839336e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0252588811593558,0.00197822330997627,-0.0291361988469093,-0.0213815634718023,3.72729279627854e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPB6,Heat shock protein beta-6,40030,0.0469206926245631,0.00367738429329793,0.0397130194096992,0.054128365839427,4.17974844904116e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",37043,0.109410737653433,0.00857723346717182,0.0925993600577758,0.126222115249089,4.78179766613148e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0672070212365722,0.00528999162753576,0.0568386376466021,0.0775754048265423,8.41523474362676e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,37382,0.123435288925899,0.0097183254601191,0.104387371024065,0.142483206827732,9.43022348474411e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.136207549082611,0.0107232279383372,0.115190022323471,0.157225075841752,9.57143980090407e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0630935977332112,0.00497322905847936,0.0533460687785916,0.0728411266878307,1.05339603518611e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.024593117061218,0.00194069747829158,-0.0283968841186695,-0.0207893500037665,1.2650144035276e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.055437542507438,0.00437505492284561,-0.0640126501562154,-0.0468624348586606,1.27448562605661e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0661345817669087,0.00521666910556999,0.0559099103199915,0.0763592532138259,1.28804839730787e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,37437,0.034299396291312,0.00270668993113781,0.0289942840262819,0.0396045085563421,1.36053491233673e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0450421593536168,0.0035599315336722,0.0380646935476193,0.0520196251596144,1.61251014568975e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACYP1,Acylphosphatase-1,37073,0.0815282802921251,0.00644523103102965,0.068895627471307,0.0941609331129432,1.83388517870597e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FST,Follistatin,39908,0.0636831890453903,0.00504924224260181,0.0537866742498908,0.0735797038408899,2.6812826698338e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRMD4B,FERM domain-containing protein 4B,37021,0.0870910387406063,0.00690198605023071,0.0735631460821541,0.100618931399059,2.71673844964445e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0809104370404577,0.00642004266476546,0.0683271534175174,0.093493720663398,3.05068183336941e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRK5,G protein-coupled receptor kinase 5,39585,0.0655510298386837,0.00520288905018646,0.0553533673003182,0.0757486923770492,3.20071493604862e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0834971206267308,0.00664477640898819,0.070473358865114,0.0965208823883477,4.8607562444815e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL19,C-C motif chemokine 19,40009,0.142633213921455,0.0113534223928144,0.120380506031539,0.164885921811371,4.97083799455088e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NADK,NAD kinase,39868,0.0657891495338003,0.00523871400554869,0.0555212700829249,0.0760570289846758,5.29336474082161e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABHD14B,Protein ABHD14B,39687,0.07083840455294,0.00564257286147958,0.0597789617444401,0.08189784736144,5.58901586503018e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PQBP1,Polyglutamine-binding protein 1,39477,0.0674104652072574,0.00537105010044842,0.0568832070103785,0.0779377234041363,5.8749869744508e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,39931,0.108662077351856,0.00866138222433183,0.0916857681921653,0.125638386511546,6.19383202251762e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP6,Bone morphogenetic protein 6,39568,0.0513447100769787,0.00410457359711656,0.0432997458266302,0.0593896743273271,9.84758336252357e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBN1,Drebrin,37056,0.0643571086282607,0.00514674068467058,0.0542694968863063,0.074444720370215,1.12437884941712e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0726341757797163,0.00581845644117778,0.0612300011550078,0.0840383504044247,1.35981224938042e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0533412545812818,0.00427220872058301,0.0449677254889391,0.0617147836736245,1.42094798568769e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL24,C-C motif chemokine 24,39908,0.100963464047452,0.00809363399141526,0.0850999414242778,0.116826986670626,1.50471502459604e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1RL,Complement C1r subcomponent-like protein,37432,0.0235495590633505,0.00188800193867299,0.0198490752635515,0.0272500428631496,1.6351173180583e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGRN,Neugrin,37388,0.026079465821138,0.00209303137140251,0.0219771243331891,0.0301818073090869,1.92709570610075e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,37056,0.105648682721662,0.0084814328947129,0.089025074248025,0.1222722911953,2.03954668022305e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.101577208077371,0.00816255667048753,0.0855785970032158,0.117575819151527,2.18997126302714e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0868750004490047,0.0069799156917689,0.0731943656931376,0.100555635204872,2.28600909830216e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DMD,Dystrophin,37043,0.0633118986207896,0.00508665357291708,0.0533420576178721,0.073281739623707,2.30367197792e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0852782586573183,0.00685852710447804,0.0718355455325413,0.0987209717820952,2.49548496056042e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3BP1,SH3 domain-binding protein 1,37382,0.0585641239092693,0.00470807707564929,0.0493362928409967,0.0677919549775419,2.50215691868175e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COLEC12,Collectin-12,39862,0.0302478509740624,0.002438283575388,0.0254688151663019,0.0350268867818228,3.5458187146932e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0450615514933393,0.0036314408682374,0.037943927391594,0.0521791755950846,3.67242621400838e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,37043,0.066762017855625,0.00539018081486909,0.0561972634584816,0.0773267722527684,4.88224973395082e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FADD,FAS-associated death domain protein,39868,0.0933515917516324,0.00754674994845056,0.0785599618526693,0.108143221650596,5.50363647828065e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,37021,0.082326771152,0.00665239994359162,0.0692880672625605,0.0953654750414396,5.55082149451594e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEPH,Hephaestin,37437,0.0319487747105768,0.00258398722033985,0.0268841597587107,0.0370133896624429,6.29774655381188e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB10,Ras-related protein Rab-10,37437,0.0649432198768408,0.00525484390595898,0.0546437258211612,0.0752427139325204,6.73065658768947e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,40052,0.0387985669160878,0.00314162085917169,0.0326409900321112,0.0449561438000643,7.00556279538461e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.0817407712543495,0.0066161175564667,0.0687731808436747,0.0947083616650242,7.1567651739905e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD40LG,CD40 ligand,40058,0.0941099960833603,0.00763430124387815,0.0791467656453591,0.109073226521361,9.24985393158581e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0779710990003265,0.00632515380481359,0.0655737975428918,0.0903684004577611,9.3834520952043e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PVR,Poliovirus receptor,40009,0.0450170502318395,0.00365221779878814,0.0378587033462147,0.0521753971174642,9.40998222572633e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA2,Annexin A2,36879,0.0843477881868068,0.00684224861618063,0.0709369808990928,0.0977585954745209,1.00607213770227e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN9,Septin-9,39788,0.0342128200052439,0.00277733061430241,0.0287692520012112,0.0396563880092766,1.03505262391206e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.105903640721807,0.00859849118153874,0.0890505980059911,0.122756683437623,1.13199525212045e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARD3,Partitioning defective 3 homolog,37169,0.0893245781927366,0.00725902686743413,0.0750968855325657,0.103552270852908,1.30778009508282e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF2,Fibroblast growth factor 2,39866,0.08037880075145,0.00654380282233613,0.0675529472196711,0.0932046542832288,1.59508598876389e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0607364312161866,0.00496699020132519,0.0510011304215892,0.0704717320107839,3.15732681445886e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.0660366696236038,0.00540102615457613,0.0554506583606346,0.076622680886573,3.20965020831431e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NID2,Nidogen-2,39858,0.0872715567613764,0.00713879870952812,0.0732795112907013,0.101263602232052,3.25006376540324e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.144976350688063,0.0118628456454282,0.121725173223024,0.168227528153102,3.40856711378827e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0537717280502934,0.00440006231323318,0.0451476059163564,0.0623958501842304,3.42978736689795e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLF4,Krueppel-like factor 4,36991,0.0473416282470144,0.00387246466244417,0.0397515975086238,0.0549316589854049,3.49753623821714e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPLAH,5-oxoprolinase,37043,0.0831509941214837,0.00681310298434952,0.0697973122721586,0.0965046759708087,4.48670266928059e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP4,Dipeptidyl peptidase 4,39575,0.0358941239825046,0.00294356158691385,0.0301247432721535,0.0416635046928557,4.76151377735028e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLTA,Clathrin light chain A,39585,0.0556929839145368,0.00457189567324525,0.0467320683949761,0.0646538994340975,5.54271734067163e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNC79,Protein unc-79 homolog,36962,0.0675314294860379,0.00554408371164355,0.0566650254112165,0.0783978335608593,6.00186042772436e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFRP1,Secreted frizzled-related protein 1,39689,0.0507411428553694,0.0041715679546628,0.0425648696642303,0.0589174160465085,6.88303262064556e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,39720,0.0471452888908942,0.00388106764523736,0.0395383963062289,0.0547521814755594,8.3570371034039e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB2B,Ras-related protein Rab-2B,37368,0.0748483097168817,0.00615967599247478,0.0627753447716311,0.0869212746621322,8.46963533085196e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G15,Phospholipase A2 group XV,39913,0.0315277073137904,0.00259650441179568,0.0264385586666709,0.03661685596091,8.85719114913595e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0277457554270631,0.00228722679745148,0.0232627909040582,0.032228719950068,1.02228484197646e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.112953407486916,0.00931394326902104,0.0946980786796352,0.131208736294198,1.0664780081529e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAP,Prolyl endopeptidase FAP,40052,0.032469348263223,0.00267811759512558,0.0272202377767769,0.0377184587496691,1.10375952099832e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.0366752121278195,0.00302590872561704,-0.0426059932300289,-0.0307444310256101,1.15215351877786e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWC2,Brorin,39684,0.0458251307661297,0.00378129453714187,0.0384137934733316,0.0532364680589277,1.1823170487962e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH7,Protocadherin-7,37382,0.0399788107724332,0.00329818303098897,0.0335143720316948,0.0464432495131716,1.21475067838317e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.107095634412864,0.00885772701588847,0.0897344894617229,0.124456779364006,1.77870113714329e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0820401995495223,0.00679254153251239,0.068726818145798,0.0953535809532466,1.9222703155911e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRD1,Natural killer cells antigen CD94,40058,0.0541381997803926,0.00448370522320383,0.0453501375429131,0.0629262620178721,2.00626661919294e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDZD2,PDZ domain-containing protein 2,37021,0.0710784067530601,0.00588796894304282,0.0595379876246962,0.0826188258814241,2.23358739780254e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGL1,Fibrinogen-like protein 1,37445,-0.0733847953986058,0.00608123379934843,-0.0853040136453287,-0.0614655771518829,2.32506582445578e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MARCO,Macrophage receptor MARCO,39868,0.0310036325717862,0.00257402155928579,0.025958550315586,0.0360487148279863,2.87616461088763e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STXBP3,Syntaxin-binding protein 3,39477,0.0522845962864627,0.00434096271063969,0.0437763093736089,0.0607928831993165,2.9122640931641e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA6,Integrin alpha-6,39866,0.06265057847212,0.0052092453596164,0.0524404575672718,0.0728606993769681,3.57108987777872e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0516877784130182,0.00429637681761755,0.0432668798504878,0.0601086769755486,3.62719747573892e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA13,Carbonic anhydrase 13,39657,0.124553683378658,0.0103595423429976,0.104248980386383,0.144858386370934,3.75017474716535e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,39477,0.0629759828888663,0.00524231197211848,0.052701051423514,0.0732509143542185,4.24761092662203e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0714467082107338,0.00594574793415915,-0.0831003741616858,-0.0597930422597819,4.3362286305958e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,37368,0.0574135645607293,0.00477909838560734,0.048046531724939,0.0667805973965197,4.45039044170164e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPP1,Tripeptidyl-peptidase 1,39767,0.0547869963133039,0.00456878933391796,0.0458321692188247,0.0637418234077831,5.45763874578594e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASET2,Ribonuclease T2,39974,0.0299777770851105,0.0025010633223149,0.0250756929733733,0.0348798611968477,5.80909173060986e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENAH,Protein enabled homolog,39587,0.0563934911490127,0.00471156726624014,0.047158819307182,0.0656281629908434,7.16174648426699e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLRX,Glutaredoxin-1,39771,0.0658791256385948,0.0055067489803502,0.0550858976371084,0.0766723536400812,7.64773975897527e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX9,Sorting nexin-9,39868,0.0812258213750035,0.00680799787116578,0.0678821455475185,0.0945694972024884,1.12323071280189e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACRBP,Acrosin-binding protein,37368,0.0448895004531507,0.00377122146252314,0.0374979063866054,0.0522810945196961,1.65629927314905e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BGN,Biglycan,39448,-0.139422327207377,0.0117196705742826,-0.162392881532971,-0.116451772881783,1.70734540174133e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASAH1,Acid ceramidase,37340,0.0552077230623827,0.0046430302031494,0.0461073838642099,0.0643080622605555,1.92740923146263e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDF2,Growth/differentiation factor 2,39868,0.0411051811410971,0.00346456844658092,0.0343146269857985,0.0478957352963957,2.47413313871359e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.103284545400128,0.00871141455121113,0.0862101728797538,0.120358917920501,2.74203688042812e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0548231408794354,0.00463228746849341,0.0457438574411883,0.0639024243176824,3.53191417668164e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLN4,Cerebellin-4,40030,0.0360195281814712,0.00304410457432008,0.0300530832158038,0.0419859731471385,3.59675961223138e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCN1,Ficolin-1,37430,0.0653874642749048,0.00552492236414341,0.0545586164411837,0.0762163121086259,3.7036203805325e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0696265929776029,0.00588380667788353,0.0580943318889511,0.0811588540662546,3.80567839881225e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.106042201989625,0.00896191077833699,0.0884768568640849,0.123607547115166,3.81448733526723e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,39788,0.0251714739679074,0.00212933093203609,0.0209979853411166,0.0293449625946981,4.12649729284524e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.032059677053864,0.0027132551927789,0.0267416968760174,0.0373776572317107,4.68838478976673e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_E,,39866,0.0317404420213838,0.00268881800429368,0.0264703587329682,0.0370105253097994,5.01719630526303e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0818764743214945,0.00693518497384325,0.0682835117727618,0.0954694368702273,5.26833040505437e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100P,Protein S100-P,39585,0.0610601228548,0.00517519660986436,0.0509167374994658,0.0712035082101341,5.41391432349597e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD302,CD302 antigen,39788,0.0335158654257422,0.00284934180409098,0.0279311554897239,0.0391005753617605,8.2297558549857e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLO1,Lactoylglutathione lyase,39585,0.0667933004879495,0.00568543091750241,0.0556498558896448,0.0779367450862542,9.79660437623678e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.0365417754498167,0.00311205081190368,0.0304421558584855,0.0426413950411479,1.04934629631189e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTC,Probetacellulin,39477,0.0849854877978744,0.0072730601933613,0.0707302898188863,0.0992406857768626,2.05574194713389e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGR,Tyrosine-protein kinase Fgr,39489,0.0647348504802649,0.00554176331985487,0.0538729943733493,0.0755967065871804,2.14583870325021e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0324776673430827,0.00278112670196705,0.0270266590072273,0.0379286756789381,2.35595705492419e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP1,Interstitial collagenase,39314,0.105150891535815,0.00901278052952394,0.0874858416979485,0.122815941373682,2.5468357789702e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FEN1,Flap endonuclease 1,39477,0.0714621272273373,0.0061282842664968,0.0594506900650036,0.0834735643896711,2.71728321495932e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF22,Kinesin-like protein KIF22,37021,0.138869525386251,0.0119074814739845,0.115530861697242,0.162208189075261,2.8274319528557e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRN1,Secernin-1,39866,0.0643588416695214,0.00552481589158566,0.0535302025220135,0.0751874808170293,3.10167830330981e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0548037033369412,0.00470407785521082,0.045583710740728,0.0640236959331544,3.22482966622692e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCOF1,Treacle protein,37437,0.0347963743655317,0.00299088683738446,0.0289342361642581,0.0406585125668052,3.88330124317604e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0441912228953339,0.00380985663298206,0.0367239038946891,0.0516585418959788,5.54560460688817e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.099167335864714,0.00854846491526196,0.0824123446308005,0.115922327098627,5.73404290201448e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.136648555845632,0.0117854405973193,0.113549092274886,0.159748019416377,5.82736709198533e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MATN2,Matrilin-2,39885,0.033889226221002,0.0029230075639531,0.0281601313956539,0.0396183210463501,5.87735433578438e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS27,Serine protease 27,39818,0.0457441677427122,0.00394573572023035,0.0380105257310607,0.0534778097543637,5.92811982774598e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,37445,0.0288196025622347,0.0024881033433966,0.0239429200091774,0.033696285115292,7.02158816071942e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0471449823255381,0.00407215294948664,0.0391635625445442,0.0551264021065319,7.11231311178368e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFA2,BPI fold-containing family A member 2,36593,-0.123865797591799,0.0106932785268348,-0.144824623504395,-0.102906971679203,7.13298395851816e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGS10,Regulator of G-protein signaling 10,37411,0.0679424079518842,0.0058854492639391,0.0564069273945635,0.0794778885092048,1.09978113139781e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLB,Beta-klotho,39489,-0.0834134283467496,0.0072350834418177,-0.0975941918927123,-0.0692326648007869,1.25304512746028e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0339993110354073,0.00295146465173779,-0.0397841817528134,-0.0282144403180013,1.38823216102062e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFP,Alpha-fetoprotein,39699,0.0764324034470306,0.00663555703008643,0.0634267116680612,0.089438095226,1.40727827807151e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0557781991425376,0.00484243831451618,0.0462870200460858,0.0652693782389893,1.4127560058847e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0415830840078828,0.00360910070687695,0.034509246622404,0.0486569213933616,1.43694033682203e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CORO1A,Coronin-1A,39520,0.101152481577542,0.00878408852109867,0.083935668076189,0.118369295078896,1.4645484755704e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0822201774755314,0.00714161514655195,0.0682226117882896,0.0962177431627732,1.49971110988843e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0433388433197621,0.00376656517151013,0.0359563755836022,0.0507213110559219,1.62933166740507e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0491369630744943,0.00427273594681657,0.0407624006187338,0.0575115255302548,1.74763281842991e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,37411,0.0398113026898421,0.00346368770538912,0.0330224747872794,0.0466001305924048,1.95876333923727e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADA,Adenosine deaminase,40058,0.0391683909109226,0.00341390158465521,0.0324771438049984,0.0458596380168468,2.35633141693028e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",37388,0.120224883703976,0.0104754383092385,0.0996930246178685,0.140756742790084,2.38329531897926e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APLP1,Amyloid-like protein 1,39868,-0.0576120102485329,0.00502878834921527,-0.0674684354129948,-0.0477555850840709,2.86441085523419e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA9,Serpin A9,39715,0.0816312792862485,0.00713059967547029,0.0676553039223267,0.0956072546501703,3.1622065651568e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.031016777452784,0.00271207613193014,0.025701108234201,0.0363324466713671,3.59906033137117e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,39931,0.0511031240338668,0.00447253288585131,0.0423369595775983,0.0598692884901354,4.05297089034942e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0344383558551436,0.00301424865232994,-0.0403462832137103,-0.0285304284965769,4.23971758337478e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0311486187275649,0.00273013039418413,0.025797563154964,0.0364996743001658,4.90665511826733e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FXN,"Frataxin, mitochondrial",40030,0.0821398161728996,0.00720943546036077,0.0680093226705925,0.0962703096752067,5.86947683711335e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.0989206967028568,0.00868582010461162,0.0818964892978181,0.115944904107896,6.20686272548246e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0453867963516755,0.00398531730254399,0.0375755744386893,0.0531980182646617,6.25048377558172e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCS,Copper chaperone for superoxide dismutase,39749,0.0527834622587827,0.00463670854623095,0.04369551350817,0.0618714110093953,6.57422419288424e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPING1,Plasma protease C1 inhibitor,37424,0.0210312927705887,0.00184720767135968,0.0174107657347237,0.0246518198064536,6.75371387427228e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD84,SLAM family member 5,39866,0.034779190324236,0.00306004112725653,0.0287815097148132,0.0407768709336588,8.07224890474244e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,37437,0.0354715831399839,0.00312068309088281,0.0293550442818535,0.0415881219981142,8.36236780002324e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0746319145219048,0.0065679718095102,0.0617586897752648,0.0875051392685448,8.77450659518385e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC3B,Tetranectin,37138,0.0236104225510293,0.00208008979469531,0.0195334465534264,0.0276873985486321,1.00874791126472e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSR,"Glutathione reductase, mitochondrial",37403,0.02511018255385,0.00221372888003781,0.0207712739489759,0.0294490911587241,1.09443530774869e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAST,Gastrin,37388,0.129217633794046,0.0114069789431859,0.106859955065401,0.15157531252269,1.29716750910643e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPL,Periplakin,37056,0.0357318874051204,0.00315459208988786,0.0295488869089402,0.0419148879013007,1.32204697032901e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.10723407254946,0.00948661519147955,0.0886403067741596,0.125827838324759,1.63129252315441e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX7,Syntaxin-7,37056,0.0547977666445477,0.00485308642299939,0.0452857172554689,0.0643098160336265,1.97630014289969e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0416769213852383,0.00369693419056714,0.0344309303717267,0.0489229123987499,2.29228010194947e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARFIP1,Arfaptin-1,37411,0.0765083804879102,0.00680542538253941,0.063169746738133,0.0898470142376875,3.40418547731942e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.121863395299768,0.010853726488425,-0.143136699217081,-0.100590091382455,3.83436043750598e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN2,Dynactin subunit 2,39788,0.104299347876566,0.00930653279625887,0.0860585435958986,0.122540152157233,4.83252006165115e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN6,Dynactin subunit 6,39489,0.0781368949393943,0.00698077660895217,0.064454572785848,0.0918192170929405,5.67712460307107e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0348920449939427,0.00312419686758789,0.0287686191334704,0.041015470854415,7.44704680388847e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX6,Peroxiredoxin-6,40030,-0.064672225878623,0.00580713626203507,-0.0760542129522118,-0.0532902388050343,1.05762370691093e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0399143588490028,0.00358281086217838,0.0328920495591331,0.0469366681388724,1.06793759782473e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO2,Gamma-enolase,40009,0.0723538745099941,0.00650366985898043,0.0596066815863925,0.0851010674335957,1.20376865109519e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.026526580757136,0.0023849825033646,0.0218520150505414,0.0312011464637306,1.24416147588438e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1F,Protein phosphatase 1F,37437,0.0582011056757072,0.00523310084331083,0.0479442280228179,0.0684579833285964,1.30725358618851e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOM,Apolipoprotein M,39908,0.0290206065821016,0.00261462825393338,0.0238959352043922,0.034145277959811,1.60526228837644e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0324206867880124,0.00292102391192161,0.0266954799206461,0.0381458936553788,1.60668131280269e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0833723089873952,0.00755851570464209,0.0685576182062967,0.0981869997684937,3.47052119781448e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.041663963561949,0.00377830701485877,0.0342584818128259,0.0490694453110722,3.72555356043064e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEP1B,Meprin A subunit beta,39868,0.124716918026818,0.0113165874047168,0.102536406713573,0.146897429340063,3.83287979759806e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGES2,Prostaglandin E synthase 2,36961,0.0602347592918965,0.00546367635827714,0.0495259536296733,0.0709435649541197,3.86682130465357e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0687364771923327,0.00624386615460113,0.0564984995293145,0.0809744548553509,4.60032195720125e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKN3,Serine/threonine-protein kinase N3,37169,0.0821719953884393,0.00746947460555552,0.0675318251615505,0.0968121656153282,4.9879708747594e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.06406272911338,0.00582866929241295,0.0526385373002506,0.0754869209265094,5.54417452498213e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0722343521176494,0.00657566179660444,0.0593460549963047,0.0851226492389942,5.94186096822047e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX16,Syntaxin-16,39477,0.062903410566376,0.0057283036529224,0.0516759354066481,0.0741308857261039,5.95824024152356e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0250236304331062,0.00228060925992962,0.0205536362836442,0.0294936245825683,6.54035005160142e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0601990359737096,0.00548775976295079,0.049443026838326,0.0709550451090931,7.03637281121382e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.0436006616743378,0.00397516963063167,0.0358093291982998,0.0513919941503759,7.17031839567485e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL1,Fc receptor-like protein 1,39868,0.0471579127935664,0.00431277241267135,0.0387048788647305,0.0556109467224022,9.88410786098082e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,39587,0.0723508495325033,0.00662484889297237,0.0593661457022775,0.0853355533627291,1.14830607509546e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMA4,Laminin subunit alpha-4,39931,0.0360851333701881,0.00330566798624234,0.0296060241171531,0.0425642426232231,1.20679794609743e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.030009502954272,0.00275179252933622,0.0246159895967731,0.035403016311771,1.42412376865642e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.057856214082285,0.00531050375933561,0.0474476267139872,0.0682648014505828,1.52333124437395e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA14,Carbonic anhydrase 14,40030,-0.0375472223769686,0.00344868440802062,-0.044306643816689,-0.0307878009372481,1.64898599146626e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0957061891430371,0.00880271806217629,0.0784528617411715,0.112959516544903,2.03761643660789e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSE,Cathepsin E,37124,0.0563747948007371,0.00519145188215804,0.0461995491117073,0.0665500404897668,2.35135363124852e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0540496544743409,0.00499045842684053,0.0442683559577335,0.0638309529909483,3.06282144160555e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLIT2,Slit homolog 2 protein,39489,0.0549241004453657,0.00507356598293512,0.0449799111188129,0.0648682897719186,3.2539807799275e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XRCC4,DNA repair protein XRCC4,39489,0.0395435344407004,0.00365409432952173,0.0323815095548378,0.046705559326563,3.39204609059987e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0557157313377521,0.00514985065921976,0.0456220240456814,0.0658094386298229,3.61688114252043e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK4,Dickkopf-related protein 4,39718,0.0481078324292654,0.00445336038945036,0.0393792460659427,0.0568364187925881,4.15838472787342e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.104928185096597,0.00972391529875403,0.0858693111110387,0.123987059082154,4.71461477593756e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0367219620924392,0.00340305279930985,0.0300519786057919,0.0433919455790865,4.7171240977722e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0443953719716901,0.00411761520023816,0.0363248461792233,0.0524658977641569,5.40289398389896e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,37437,0.0264686919600351,0.00245814801570642,0.0216507218492505,0.0312866620708196,6.27950044287452e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0337740836214327,0.00314540514327002,0.0276090895406234,0.0399390777022419,8.68334001547975e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0406846250999465,0.0037924992262666,0.0332513266164639,0.048117923583429,9.28782000653284e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPAG1,Sperm-associated antigen 1,37411,0.0614226924359424,0.00573205287470961,0.0501878688015116,0.0726575160703733,1.09927895915008e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0772365372204476,0.00721115520784222,0.0631026730130768,0.0913704014278183,1.11874123134601e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,37021,0.064949509124431,0.0060824618632364,0.0530278838724877,0.0768711343763744,1.65353273306867e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SWAP70,Switch-associated protein 70,37382,0.0375531680151763,0.00352912228613164,0.0306360883343582,0.0444702476959943,2.44286845943881e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTN,Pleiotrophin,39585,0.0526737707695829,0.00495289601061759,0.0429660945887724,0.0623814469503934,2.51828203437867e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM,Paralemmin-1,37299,0.029679804813294,0.00279647299325245,0.0241987177465192,0.0351608918800688,3.28196730536078e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNAS,Neuroendocrine secretory protein 55,37411,0.094288259966522,0.0088853647950603,0.0768729449682038,0.11170357496484,3.33387295485688e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0371842573264781,0.00350783734429679,0.0303088961316564,0.0440596185212998,3.76003346895943e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PER3,Period circadian protein homolog 3,37056,0.122472816725277,0.0115557469972624,0.0998235526106424,0.145122080839911,3.85941041735182e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL8,Interleukin-8,39750,0.068777940482085,0.00649414702269991,0.0560494123175932,0.0815064686465768,4.01945688705523e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0734129608655105,0.00693527561839871,0.0598198206534491,0.087006101077572,4.25263244710401e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRR3,Small proline-rich protein 3,37388,0.0680521644732535,0.00643871150489653,0.0554322899236563,0.0806720390228507,5.22754853523919e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0593494561737796,0.00561691056357579,0.0483403114691711,0.0703586008783881,5.23169348899411e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBD,Thrombomodulin,39868,0.0282150245283104,0.00267232481694283,0.0229772678871025,0.0334527811695184,5.66463561330374e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRIB,Protein scribble homolog,37043,0.0937472108076595,0.00887641602836846,0.0763494353920573,0.111144986223262,5.71376062496362e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,37169,0.0363516998553448,0.00344259378973825,0.0296042160274579,0.0430991836832318,5.82194190403327e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL20,C-C motif chemokine 20,40058,0.0871180530342664,0.00827630273439418,0.0708964996748538,0.103339606393679,7.92681056125925e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0305048382198728,0.00289690910847018,0.0248268963672712,0.0361827800724743,7.94498386180828e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.0362348682651032,0.00344418470104212,-0.0429854702791458,-0.0294842662510607,8.7845157516394e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBS,Cystathionine beta-synthase,37043,0.0526565188883732,0.00501499797605562,0.0428271228553042,0.0624859149214422,1.09305210940746e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPR,Nucleoprotein TPR,37021,0.0485742288964037,0.00462660733348444,0.0395060785227742,0.0576423792700332,1.10411069687042e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TF,Serotransferrin,37453,0.0225217213430522,0.00214588507028008,0.0183157866053032,0.0267276560808011,1.13800040594641e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR2,TGF-beta receptor type-2,39913,0.0307000233779959,0.00292748328303069,0.0249621561432558,0.0364378906127361,1.20189118337281e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGMB,RGM domain family member B,40009,0.0262599805843676,0.00250532766418577,0.0213495383625635,0.0311704228061717,1.26763105638382e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA4,Annexin A4,39783,0.0746545453042843,0.00712608498350671,0.0606874187366112,0.0886216718719575,1.34545499772224e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0692357264209714,0.00661227842776849,0.0562756607025451,0.0821957921393976,1.47295530976349e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPA1,Inositol monophosphatase 1,39749,0.0630716265124772,0.00602679617514696,0.0512591060091892,0.0748841470157653,1.51123809857294e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO2,Roundabout homolog 2,40009,0.0233540961607033,0.00223494189100698,0.0189736100543297,0.027734582267077,1.77548012927815e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0630855971228643,0.00603601096740591,0.0512550156267487,0.0749161786189799,1.81307893598915e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,39453,0.0680055253117258,0.00651006086841483,0.0552458060096327,0.0807652446138189,1.85036904629227e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR5,Complement factor H-related protein 5,37267,0.0423913987656228,0.00406194959160019,0.0344299775660864,0.0503528199651591,2.11968468253264e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERI1,3'-5' exoribonuclease 1,37169,0.0343411130460968,0.00329075394377019,0.0278912353163072,0.0407909907758864,2.13613270691596e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,39788,0.0348135754346908,0.00334178310969666,0.0282636805396853,0.0413634703296962,2.48399275730995e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0565459725944954,0.00543038418542386,0.0459024195910646,0.0671895255979261,2.70409620677535e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP12,Macrophage metalloelastase,39900,0.0513903940210717,0.00493795371184193,0.0417120047458615,0.0610687832962819,2.76631696405379e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNM1,Dynamin-1,37382,0.117342986477472,0.0112723983254831,0.0952490857595251,0.139436887195419,2.78825109437467e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS7_LGALS7B,Galectin-7,39822,0.0414719279447657,0.00399583161250988,0.0336400979842464,0.0493037579052851,3.72305175651215e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0609397512662747,0.00587351761935692,0.0494276567323352,0.0724518458002143,3.86990756578375e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFRP4,Secreted frizzled-related protein 4,37124,0.0422926172801436,0.00408102686533905,0.0342938046240791,0.0502914299362082,4.54236847839649e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOL1,Apolipoprotein L1,37445,0.0624484053206241,0.00603347935568627,0.050622785783479,0.0742740248577691,5.16652719038776e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELOB,Elongin-B,37021,0.039925417119249,0.00385969736523604,0.0323604102833864,0.0474904239551116,5.54312404578175e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.024780754658109,0.00239729651137231,0.0200820534958193,0.0294794558203988,5.74626053495645e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0477963904887427,0.00462398948176979,0.038733371104474,0.0568594098730115,5.95736739102415e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMOTL2,Angiomotin-like protein 2,37333,0.0490421788254666,0.00476132516080723,0.0397099815102844,0.0583743761406487,8.69711159299466e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VGF,Neurosecretory protein VGF,37411,0.0295733745633154,0.00287472809941274,0.0239389074884664,0.0352078416381643,9.90642231709635e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0336510327391697,0.00327356556622908,0.0272348442293607,0.0400672212489787,1.03697161808429e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.119560594301727,0.0116608383692156,0.0967053510980645,0.14241583750539,1.4087750032866e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0341137896566725,0.00333151901667791,0.0275840123839838,0.0406435669293612,1.5735954135762e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPG,Macrophage-capping protein,39739,0.0583971713488608,0.00570670688305226,0.0472120258580784,0.0695823168396432,1.67953577119828e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPCAL1,Hippocalcin-like protein 1,40058,0.074585036803038,0.00728934773834043,0.0602979152358907,0.0888721583701852,1.69135384472787e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0319088563187597,0.00312418381457404,0.0257854560421946,0.0380322565953249,2.04640978077628e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOE,Apolipoprotein E,37453,0.0727943619127434,0.00712704987019437,0.0588253441671624,0.0867633796583243,2.10663548700599e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BSG,Basigin,40040,0.0195118321185273,0.0019111122171098,0.0157660521729921,0.0232576120640626,2.12800724868952e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNGR2,Interferon gamma receptor 2,39749,0.0522179969820456,0.00511622256488698,0.0421902007548671,0.0622457932092241,2.20833679012966e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0919602820051293,0.00900886124234963,0.074302913970124,0.109617650040135,2.25532172621222e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNB2,Plexin-B2,39984,0.0236462077725111,0.00232116683649722,0.0190967207729765,0.0281956947720456,2.67935740551632e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0416372031520211,0.00409424794918348,0.0336124771716215,0.0496619291324207,3.21786950988529e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSB,Cathepsin B,39847,-0.0513135904669411,0.00504703371879638,-0.061205776555782,-0.0414214043781002,3.29524952804872e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE6,Ribonuclease K6,37386,0.0275157473362393,0.00271753609684246,0.0221893765864281,0.0328421180860506,5.1983369723128e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DENR,Density-regulated protein,37056,0.0575995433488115,0.00568869951312626,0.046449692303084,0.0687493943945389,5.22381640468779e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDF1,Endothelial differentiation-related factor 1,37411,0.0683828454890146,0.00677276124001274,0.0551082334585897,0.0816574575194396,6.93673270152516e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK4,Serine/threonine-protein kinase 4,39868,0.0865238234393279,0.00857582635077139,0.069715203791816,0.10333244308684,7.26305784211748e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,37123,0.052148618299154,0.00517082560791589,0.0420138001076389,0.0622834364906692,7.83137854680026e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOLA1,BolA-like protein 1,36991,0.0543671753958536,0.0054039244919146,0.043775483391701,0.0649588674000062,1.00459338170704e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG4,Regenerating islet-derived protein 4,39885,0.0464292888050142,0.00462075205580727,0.037372614775632,0.0554859628343965,1.10187638674282e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0477835228708928,0.00475489570276747,0.0384639272934685,0.057103118448317,1.1198612312675e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0295604589259124,0.00294337072309064,0.0237914523086548,0.0353294655431701,1.19199728971174e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPMT,Thiopurine S-methyltransferase,39477,0.0717087103052212,0.00715784833762311,0.0576793275634799,0.0857380930469625,1.49359427044673e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA2,Integrin alpha-2,37124,0.0331409803707391,0.00330773959598016,0.026657810762618,0.0396241499788602,1.52158775302574e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ULBP2,UL16-binding protein 2,39749,0.035931889139379,0.00358910142484149,0.0288972503466897,0.0429665279320683,1.59484914143434e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTRK3,NT-3 growth factor receptor,40009,-0.0209721768715557,0.00209625987149896,-0.0250808462196937,-0.0168635075234178,1.70352167672534e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB8,Serpin B8,40058,0.0540777080027755,0.00541189722815813,0.0434703894355856,0.0646850265699654,1.92434268524934e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SF3B4,Splicing factor 3B subunit 4,39788,0.0715630645249235,0.00716406108765837,0.0575215047931131,0.0856046242567339,1.99232585197044e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0578154896437682,0.00579372127778227,0.0464597959393149,0.0691711833482214,2.26731794117257e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0458330732163019,0.00461499553543468,0.0367876819668499,0.0548784644657538,3.56286955463142e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0254674728607499,0.00256745574039493,0.0204352596095758,0.030499686111924,4.10980089046378e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD80,T-lymphocyte activation antigen CD80,37437,0.0326128249971208,0.00329940216247302,0.0261459967586737,0.0390796532355679,5.81181796795821e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AK1,Adenylate kinase isoenzyme 1,39868,0.0608080045039684,0.00615752936312693,0.0487392469522396,0.0728767620556972,6.18981716890479e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX6,Syntaxin-6,39477,0.0660778202955425,0.00670943141642462,0.0529273347193503,0.0792283058717348,8.10835709218749e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0597770721729501,0.00607165121703291,0.0478766357875656,0.0716775085583346,8.56443822006461e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIT,Citron Rho-interacting kinase,37039,0.0438643397553988,0.00445577254213341,0.0351310255728173,0.0525976539379803,8.68572328316591e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0811242608862763,0.00824196394779555,0.064970011548597,0.0972785102239555,8.80445004330523e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAGED1,Melanoma-associated antigen D1,39477,0.0468663902356998,0.00476306936662533,0.0375307742771141,0.0562020061942854,8.8592539916953e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRZB,Secreted frizzled-related protein 3,39695,0.0253974242862408,0.00259128744509676,0.0203185008938512,0.0304763476786305,1.29165864338448e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,39805,0.0324127996882678,0.00331089206703591,0.0259234512368774,0.0389021481396582,1.44253969523175e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPL14,60S ribosomal protein L14,37043,0.038974943551297,0.00398186794341944,0.0311704823821948,0.0467794047203991,1.51143956130523e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0636523698118169,0.00651120462033999,0.0508904087559505,0.0764143308676833,1.69694643566741e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTA,Lymphotoxin-alpha,39866,0.0377957780183839,0.00388267743905023,0.0301857302378455,0.0454058257989224,2.47905267946517e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0348877202068375,0.00359049272509968,0.0278503544656421,0.0419250859480328,3.03879119305297e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0352760242435478,0.00363451068040184,0.0281523833099602,0.0423996651771354,3.27791075398924e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAM2,Neural cell adhesion molecule 2,39858,-0.0254688916452993,0.00262907483811464,-0.030621878328004,-0.0203159049625946,3.92371895396424e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JAM2,Junctional adhesion molecule B,40009,0.0238575234585224,0.00246591799400638,0.0190243241902699,0.0286907227267749,4.42480871746721e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0448192930638488,0.00463278554215418,0.0357390334012266,0.053899552726471,4.44778904261872e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POMC,Pro-opiomelanocortin,37043,0.0675319762423864,0.00698613555625212,0.0538391505521323,0.0812248019326406,4.94806992696664e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0478156442701909,0.00494777162516524,0.038118011884867,0.0575132766555148,5.06922928479238e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGT,Angiotensinogen,37445,0.0213138594175403,0.00220565953885662,0.0169907667213813,0.0256369521136993,5.08434109077295e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMB1,Laminin subunit beta-1,37043,0.0289058439387262,0.00299277981367227,0.0230399955039286,0.0347716923735239,5.34942828988153e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD59,CD59 glycoprotein,39173,0.020058259214862,0.00207816782071284,0.0159850502862649,0.0241314681434592,5.57366290481288e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0499055397153282,0.00517666650651369,0.0397592733625614,0.0600518060680951,6.37127117128712e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP8,Caspase-8,39984,0.0584400506440859,0.0060641114039742,0.0465543922922965,0.0703257089958753,6.39066551472921e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.108278397123974,0.0112364371810426,0.0862549802491309,0.130301813998818,6.60212379969857e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYM,Ketimine reductase mu-crystallin,36991,0.072701411592052,0.00754540365902398,0.057912420420365,0.087490402763739,6.70952578041629e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C7orf50,Uncharacterized protein C7orf50,37388,0.0207437889667607,0.0021558371183349,0.0165183482148242,0.0249692297186971,7.57375529731332e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0918951629327857,0.00957835562240163,0.0731215859128785,0.110668739952693,9.69301828011005e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA2,Carbonic anhydrase 2,39821,0.0640857738453089,0.00668187561860055,0.0509892976328518,0.0771822500577659,9.98466509396395e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C5,Complement C5,37453,0.0143533621644835,0.00149627089669215,0.0114206712069669,0.0172860531220002,1.00482160332841e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA11,Integrin alpha-11,39866,-0.0320542860244911,0.00334413588274716,-0.0386087923546755,-0.0254997796943066,1.05508068350265e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSME2,Proteasome activator complex subunit 2,39666,0.0341137768989839,0.0035595945370086,0.027136971606447,0.0410905821915207,1.07337366919975e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0459804998826006,0.00480277008238808,0.0365670705211199,0.0553939292440812,1.17830839287918e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.079179852582834,0.00827267631680581,0.0629654070018946,0.0953942981637734,1.23677330287734e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR3,Toll-like receptor 3,40058,0.0572610726998441,0.00599122868803157,0.0455182644713022,0.069003880928386,1.37555073634757e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0382351860314333,0.00400278320071291,0.030389730958036,0.0460806411048306,1.4913759428923e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIT,Vitrin,37437,0.0343492275625735,0.00361790460436091,0.0272581345380261,0.0414403205871209,2.58320712060746e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRN,Progranulin,39787,0.0230650870922034,0.00243032235299504,0.0183016552803331,0.0278285189040737,2.61646142388033e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0255894432095621,0.0027027183544303,0.0202921152348788,0.0308867711842455,3.24048063522346e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0207599609846528,0.00219335959366906,0.0164609761810614,0.0250589457882441,3.41485135459763e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0377923761178607,0.00399484276856581,0.0299624842914718,0.0456222679442497,3.57119507312599e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREML1,Trem-like transcript 1 protein,37445,0.049346060670546,0.00521633961051405,0.0391220350339385,0.0595700863071536,3.58114276261236e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD248,Endosialin,37437,-0.0368945753285169,0.00390193046113647,-0.0445423590323444,-0.0292467916246894,3.73554280560028e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDGF,Hepatoma-derived growth factor,40014,0.0869886331233871,0.00923112232577165,0.0688956333648747,0.1050816328819,4.94484947467009e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.030450350809829,0.00323353235075125,0.0241126274023565,0.0367880742173015,5.25749105105063e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0226737415987938,0.00240805986700681,-0.0273935389381271,-0.0179539442594604,5.46059193258557e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA6,Carbonic anhydrase 6,39817,-0.058874510882283,0.00625659888312778,-0.0711374446932134,-0.0466115770713525,5.62348608615445e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0481016989927994,0.00512327214934332,-0.0581433124055123,-0.0380600855800865,6.86392551492749e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDA,Cytidine deaminase,37422,0.0427720821756799,0.00456435193396824,0.0338259523851022,0.0517182119662577,8.3118095976182e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL5,Insulin-like peptide INSL5,37382,0.0892692952487235,0.00953395253761473,0.0705827482749986,0.107955842222448,8.93145580279408e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSHB,Follitropin subunit beta,37043,0.0602728553849127,0.00644121397120691,0.0476480760013472,0.0728976347684783,9.47852812037771e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMM2,Phosphomannomutase 2,37021,0.0553253918395683,0.00592031074295368,0.0437215827833791,0.0669292008957575,1.06480870103439e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.022908861385715,0.00245675152130263,0.0180936284039619,0.0277240943674682,1.25284820472605e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD101,Immunoglobulin superfamily member 2,37382,0.038632584554115,0.00414598917684096,0.0305064457675067,0.0467587233407233,1.36558396577872e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL2A1,Collagen alpha-1(II) chain,37043,0.0735956592458793,0.00792093838514587,0.0580706200109934,0.0891206984807652,1.76047369943279e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0434585944770642,0.0046790571783579,0.0342876424074828,0.0526295465466457,1.77719939627114e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,37043,0.0477849600505962,0.00515012017943007,0.0376907244989132,0.0578791956022791,1.98494651924069e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEL1L,Protein sel-1 homolog 1,37043,0.0285962813007492,0.00308336296000702,0.0225528898991355,0.034639672702363,2.06104150292838e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0558741061184669,0.00602635957167787,0.0440624413579783,0.0676857708789556,2.10589620097339e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A12,Protein S100-A12,39615,0.0680358884906993,0.00734395441946764,0.0536417378285428,0.0824300391528559,2.21411250745156e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRG,Histidine-rich glycoprotein,37380,0.0288413915275343,0.0031125621220436,0.0227407697683288,0.0349420132867397,2.21792193495803e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK6,Kallikrein-6,39889,0.0269269835913612,0.00290822122240229,0.0212268699954527,0.0326270971872697,2.32115061856583e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300E,CMRF35-like molecule 2,39991,0.0349482309787484,0.0037819013316847,0.0275357043686464,0.0423607575888504,2.74249309810409e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,39868,0.059883910833285,0.00648185813948478,0.0471794688798948,0.0725883527866752,2.80216362157459e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0670866550042599,0.00728302124398655,0.0528119333660462,0.0813613766424735,3.69545895708386e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300A,CMRF35-like molecule 8,37124,0.0262048901262471,0.00284581481983021,0.0206270930793799,0.0317826871731143,3.80680732277963e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSF,Cathepsin F,39913,0.0365509033140012,0.00397673527164713,0.0287565021815728,0.0443453044464295,4.35182337676523e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCF2,Neutrophil cytosol factor 2,39843,0.0750596156192813,0.00816644144584405,0.059053390385427,0.0910658408531356,4.35222998538883e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN3,CCN family member 3,40042,0.029239214220528,0.00318318650583003,0.0230001686691012,0.0354782597719549,4.58177999328238e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSNK1D,Casein kinase I isoform delta,37056,0.058304336095866,0.00636623142245009,0.0458265225078638,0.0707821496838681,6.03519213973382e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0380343993276778,0.00416513480210382,0.0298707351155544,0.0461980635398013,7.69386456059264e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCAM1,Vascular cell adhesion protein 1,39908,-0.0239357982277998,0.00262246720074904,-0.0290758339412679,-0.0187957625143317,7.84876632158978e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAA10,N-alpha-acetyltransferase 10,37021,0.0453302749947649,0.00497546914478369,0.0355783554709889,0.0550821945185409,9.34918583692626e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0227680187016653,0.00250005448848493,-0.0276681254990958,-0.0178679119042349,9.63468244330066e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0507319404205426,0.00557755710502734,0.039799928494689,0.0616639523463962,1.04989946256121e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,37382,0.0227924805085971,0.00250992118844066,0.0178730349792534,0.0277119260379408,1.22352795573265e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAEP,Glycodelin,39749,-0.129275143133231,0.0142408515788207,-0.157187212227719,-0.101363074038742,1.23593372710891e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0577991935232637,0.00636793543874529,0.0453180400633229,0.0702803469832045,1.25146786374836e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,39846,0.0611712694515615,0.00674688056916159,0.0479473835360048,0.0743951553671182,1.36773734647234e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0313984716836479,0.00346559769115072,0.0246059002089925,0.0381910431583033,1.45572023094471e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.0424651046899732,0.00470264717857548,0.0332479162199652,0.0516822931599811,1.90809382827762e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2orf69,UPF0565 protein C2orf69,37039,0.0519357847518833,0.00575156574551556,0.0406627158906728,0.0632088536130938,1.95509498609282e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRDT,Bromodomain testis-specific protein,37021,0.0324816862952377,0.00359798345274761,0.0254296387278523,0.039533733862623,1.99315683624335e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIMAP8,GTPase IMAP family member 8,36962,0.0440039374842319,0.00487567452072701,0.034447615423607,0.0535602595448569,2.04096881309425e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMNB2,Lamin-B2,37388,0.0242825342312244,0.00269091859503862,0.0190083337849487,0.0295567346775001,2.05716775794122e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS22,Brain-specific serine protease 4,37056,0.0298330288111158,0.0033122128669046,0.0233410915919828,0.0363249660302488,2.40549078096546e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0482311892239254,0.00536354261365277,0.037718645701166,0.0587437327466848,2.68585333072029e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRDL1,Chordin-like protein 1,39908,0.0271166373730142,0.00301637204498638,0.0212045481648409,0.0330287265811876,2.7475400727942e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP1,"Fatty acid-binding protein, liver",39862,0.0825950606560718,0.00921350881919744,0.0645365833704448,0.100653537941699,3.45334755871156e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXN,Thioredoxin,37289,0.0381006074972524,0.00425088459176355,0.0297688736973959,0.046432341297109,3.57240430591495e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRSF1,G-rich sequence factor 1,36874,0.0712158729774768,0.00795372376576505,0.0556265743965774,0.0868051715583763,3.89655967036372e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGA,Fibrinogen alpha chain,37149,0.0271172002860298,0.00303298892747196,0.0211725419881848,0.0330618585838749,4.36998174621983e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMS,Spermine synthase,36991,0.0564279666740322,0.00631339791706837,0.0440537067565782,0.0688022265914863,4.49363645669356e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEK,Angiopoietin-1 receptor,39913,0.0190045037110661,0.00213039703484901,0.0148289255227621,0.0231800818993702,5.12748046283504e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALCAM,CD166 antigen,40052,0.017004248634165,0.0019089089791219,0.0132627870350861,0.020745710233244,5.74724267757027e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,37169,0.062185000470334,0.00700269095444614,0.0484597261996196,0.0759102747410485,7.52243241920671e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0325182728522019,0.00366366797534559,0.0253374836205246,0.0396990620838793,7.82446896955958e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C7,Complement component C7,37149,-0.0279100434733649,0.00315574312930521,-0.0340953000068031,-0.0217247869399267,1.03681637346386e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0370958428838494,0.0042003571311859,0.0288631429067251,0.0453285428609738,1.16102547185824e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0300670168733337,0.00340573954810595,0.0233917673590461,0.0367422663876214,1.17104384318229e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO1,Roundabout homolog 1,39885,0.0204947576106316,0.00232261654391244,0.0159424291845632,0.0250470860367,1.2165862033202e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFC1,Cryptic protein,39477,0.0405180493152702,0.00459459999907283,0.0315126333170874,0.0495234653134529,1.27929100915301e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRG2,Bone marrow proteoglycan,37437,-0.0439906515328352,0.0049902776778285,-0.053771595781379,-0.0342097072842913,1.33760405640341e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAPK2,Death-associated protein kinase 2,37056,0.0461672150173909,0.00524392989197506,0.0358891124291197,0.056445317605662,1.48391616431571e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,37445,-0.0220228604456507,0.00251749183068203,-0.0269571444337874,-0.0170885764575139,2.42592836769214e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,39913,0.0201673438179864,0.00230736897448621,0.0156449006279934,0.0246897870079794,2.54899983218147e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.030817013029695,0.00353571973345567,0.0238870023521218,0.0377470237072681,3.15981671669972e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD1,Programmed cell death protein 1,39998,0.0350789649190301,0.00402640255813226,0.0271872159050909,0.0429707139329694,3.26425057436803e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APRT,Adenine phosphoribosyltransferase,39738,0.0411953418292051,0.00473267157306046,0.0319193055460066,0.0504713781124036,3.50008641762298e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0239994113663327,0.00275965654350922,0.0185904845410546,0.0294083381916108,3.74714742525666e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18BP,Interleukin-18-binding protein,39931,0.0252122250392056,0.00290584556839864,0.0195167677251443,0.030907682353267,4.47126756640302e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHPS,Deoxyhypusine synthase,37368,0.0350000016150513,0.00403409966423306,0.0270931662731545,0.0429068369569481,4.56184980435523e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM4,Intercellular adhesion molecule 4,39866,-0.044618465097486,0.00515876330879353,-0.0547296411827213,-0.0345072890122507,5.67830379609814e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,39866,0.0513804222058322,0.0059614601572673,0.0396959602975883,0.0630648841140761,7.39224328861216e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,39817,0.0335758157615023,0.00389649655058128,0.0259386825223629,0.0412129490006416,7.51345322672951e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,39617,0.0247991034557604,0.0028782123780253,0.0191578071948308,0.03044039971669,7.57277809237772e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX1,Peroxiredoxin-1,39434,-0.0768907731487517,0.00893082454830492,-0.0943951892634294,-0.0593863570340741,8.02472024923689e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CILP,Cartilage intermediate layer protein 1,37437,0.0455577792677948,0.0052921832727515,0.0351851000532019,0.0559304584823877,8.20887724027782e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300LF,CMRF35-like molecule 1,40030,0.0503343835725739,0.00587332749261991,0.0388226616870389,0.0618461054581089,1.12716240047928e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPO,Myeloperoxidase,39858,0.0381710561613187,0.00446228818771531,0.0294249713133967,0.0469171410092407,1.29369986194525e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0310352365503637,0.00362825565216262,0.0239238554721249,0.0381466176286024,1.29987991577421e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0351386648941496,0.00411873440777745,0.0270659454549058,0.0432113843333934,1.57342355035991e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,39585,0.0443548380558542,0.00520091151222745,0.0341610514918884,0.05454862461982,1.61898959292626e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0513189578022871,0.00602939614617666,0.0395013413557809,0.0631365742487934,1.897783339679e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.022508338671109,0.00264541853996919,0.0173233183327694,0.0276933590094486,1.91672968549678e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0275129947629304,0.00323414540849152,-0.0338519197635738,-0.021174069762287,1.96952056820508e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YAP1,Transcriptional coactivator YAP1,37388,0.0213378381363489,0.00251023366346447,0.0164177801559585,0.0262578961167392,2.08665274827214e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR2,Complement factor H-related protein 2,37364,0.0470278553363458,0.00554546195787575,0.0361587498989093,0.0578969607737822,2.47495091258119e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.045000157935029,0.00531663242327893,0.0345795583854023,0.0554207574846557,2.8453257378077e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC16A1,Monocarboxylate transporter 1,39489,0.0482268245966134,0.00571127138647153,0.0370327326791292,0.0594209165140976,3.32888040841981e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH1,Cadherin-1,39315,0.0334950933821224,0.00396781538691869,0.0257181752237618,0.0412720115404831,3.40233175317743e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRK1,Protein BRICK1,39489,0.0369568061620692,0.00438317533587056,0.0283657825037629,0.0455478298203755,3.70694874117559e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0308245567065613,0.00365858428941854,0.023653731499301,0.0379953819138217,3.90943007462187e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0541269909617077,0.0064270991793412,0.041529876570199,0.0667241053532164,4.01948674721686e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0364480214502957,0.00432794013861051,0.0279652587786191,0.0449307841219723,4.02647805386148e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSC,Dipeptidyl peptidase 1,39856,0.0354484409473746,0.00421094208735644,0.0271949944561559,0.0437018874385932,4.14435724753669e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,37388,0.0295998984367283,0.00351862257817698,0.0227033981835015,0.0364963986899552,4.41833155316798e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0389097676124626,0.00463745345948076,0.0298203588318804,0.0479991763930449,5.25851990023856e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMIGO2,Amphoterin-induced protein 2,39788,0.0185147824199337,0.00220865157422396,0.0141858253344547,0.0228437395054126,5.59368885710263e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XG,Glycoprotein Xg,39985,0.024784351149646,0.00295789409407488,0.0189868787252592,0.0305818235740328,5.77043477710435e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0240168539620726,0.00286989802374874,0.0183918538355251,0.0296418540886201,6.31405327899789e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP3,Stromelysin-1,39858,-0.0392681973556273,0.00469403669500479,-0.0484685092778367,-0.0300678854334179,6.47203215912292e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP9,Caspase-9,37056,0.0521857811694392,0.00623895115326886,0.0399574369090323,0.0644141254298462,6.6382720606219e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QA,Complement C1q subcomponent subunit A,39971,-0.0188685067822061,0.00225868326497648,-0.02329552598156,-0.0144414875828522,7.14495820393806e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP6,Gastrotropin,39564,0.0443430936128766,0.00532342580219075,0.0339091790405827,0.0547770081851704,8.75984975600629e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PZP,Pregnancy zone protein,37453,0.0450787599255306,0.00541644804381304,0.0344625217596571,0.0556949980914042,9.42273192870262e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0697962740357226,0.00840165879136218,0.0533290228046527,0.0862635252667925,1.05559130898079e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGR2,Anterior gradient protein 2 homolog,39364,0.0818444402099964,0.00987032693621731,0.0624985994150105,0.101190281004982,1.20450140337804e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL9,C-X-C motif chemokine 9,39931,0.0531255112825632,0.00641592954792013,0.0405502893686398,0.0657007331964867,1.32492798888155e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPPB,Natriuretic peptides B,39585,-0.103205265376898,0.0124661420302683,-0.127638903756224,-0.0787716269975724,1.3428035174296e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPME1,Protein phosphatase methylesterase 1,39788,0.0486678206667972,0.00588833384400058,0.0371266863325561,0.0602089550010383,1.50440236453115e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0308031081815696,0.00372918046832389,0.0234939144636548,0.0381123018994844,1.59058851987344e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,39489,0.05990958398378,0.00725885523518351,0.0456822277228203,0.0741369402447396,1.66259428288653e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPCAM,Epithelial cell adhesion molecule,39867,-0.0771836041712735,0.00935958423890151,-0.0955283892795204,-0.0588388190630265,1.75683708308289e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHCHD6,MICOS complex subunit MIC25,37368,0.0235893440028854,0.00286152776379551,0.0179807495858462,0.0291979384199246,1.823895057158e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNA1,Ephrin-A1,39826,0.0213795692563396,0.002594679106497,0.0162939982076055,0.0264651403050737,1.85803508014938e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMD,Osteomodulin,39931,-0.0352645093535486,0.00428113522847707,-0.0436555344013636,-0.0268734843057335,1.89755784395167e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN4B,Sodium channel subunit beta-4,37043,0.0336170601387762,0.00408246892655851,0.0256154210427215,0.0416186992348309,1.97191671310404e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0380710574206074,0.00462579665210348,0.0290044959824846,0.0471376188587302,2.01622082272155e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2,Apoptosis regulator Bcl-2,37382,0.0409428962950366,0.00498068852391409,0.031180746788165,0.0507050458019082,2.21308885627183e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANSC1,MANSC domain-containing protein 1,39913,-0.0218454005826894,0.0026580768360787,-0.0270552311814037,-0.0166355699839752,2.21657913321841e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A13,Protein S100-A13,37056,0.0281399733814873,0.00342418449909696,0.0214285717632572,0.0348513749997173,2.26093069426491e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA9,Carbonic anhydrase 9,40030,-0.0349394784822598,0.00425851291808743,-0.0432861638017111,-0.0265927931628084,2.48573835580582e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300C,CMRF35-like molecule 6,40009,0.0268372297796667,0.00327330854091417,0.0204215450394749,0.0332529145198584,2.60859656203468e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0529537589338495,0.00645779753559488,0.0402964757640836,0.0656110421036155,2.62592800458724e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.019380826782437,0.00236869072338031,0.0147381929646116,0.0240234606002624,2.99917577726473e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK7,Kallikrein-7,36818,0.0314547070308738,0.00384478038289164,0.0239189374804062,0.0389904765813414,3.07234085280061e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.026334306004932,0.00322362899709609,0.0200159931706237,0.0326526188392404,3.38664925408193e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN8,Septin-8,37357,0.0256043346076967,0.00313793320237914,0.0194539855310336,0.0317546836843598,3.65641361287491e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0335677305713928,0.00412094394095517,0.0254906804471206,0.0416447806956649,4.05643562855368e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX5,Sorting nexin-5,37043,0.0244395395528095,0.00300107662712802,0.0185574293636385,0.0303216497419804,4.1802616564376e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGCR6,Protein DGCR6,36991,0.0347232643194031,0.00426694589104882,0.0263600503729474,0.0430864782658588,4.38792797962114e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0296272006360429,0.00364277920862487,0.0224873533871381,0.0367670478849476,4.54491542603726e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPOCK1,Testican-1,39749,0.0202961039761147,0.00249744070191828,0.0154011202003549,0.0251910877518745,4.73119556578727e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAM,Integrin alpha-M,39858,-0.0252167360618213,0.00310569386059556,-0.0313038960285885,-0.019129576095054,5.01864445170291e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSM,Oncostatin-M,39785,0.0570774397084809,0.00703475418723485,0.0432893215015006,0.0708655579154612,5.2683455143446e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0396764396064928,0.00488926316090189,0.0300934838111251,0.0492593954018605,5.27236104222889e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.03843136868921,0.00474942496460182,0.0291224957585904,0.0477402416198296,6.30573636555761e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINI2,Serpin I2,37382,0.0456266461102369,0.00563796929530187,0.0345762262914452,0.0566770659290286,6.32850491804812e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA3,Protein disulfide-isomerase A3,37124,0.0201699013183208,0.00249479421206537,0.0152801046626727,0.025059697973969,6.76373772047602e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN5,CCN family member 5,39858,0.030347207306873,0.00378979688147045,0.0229192054191909,0.0377752091945551,1.24949373336152e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK3,Dickkopf-related protein 3,40052,-0.0226210109861522,0.00282661240518862,-0.0281611713003219,-0.0170808506719825,1.2973209376858e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHI3L1,Chitinase-3-like protein 1,39545,0.0591822105369334,0.0074091221648616,0.0446603310938046,0.0737040899800621,1.46907252543855e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN3,Calsyntenin-3,37388,0.0237353982135423,0.00297754721956821,0.0178994056631886,0.029571390763896,1.693138808703e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0330714423053695,0.00415038268750069,0.0249366922378681,0.0412061923728708,1.73647769194943e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.0225245960179727,0.00282878913018954,-0.0280690227131442,-0.0169801693228012,1.79629522138777e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0268858017247395,0.00338195109798136,0.020257177572696,0.033514425876783,1.99273366580082e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0300798760476039,0.00379187664862797,0.0226477978162931,0.0375119542789147,2.28600932493929e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAX,Apoptosis regulator BAX,39456,0.0714486228525832,0.00901629075713016,0.0537766929686081,0.0891205527365583,2.44671363258279e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0629549773028261,0.00797010176953403,0.0473335778345393,0.0785763767711128,3.00029582519159e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH5,Cadherin-5,40052,-0.023667779989067,0.00300066508218124,-0.0295490835501423,-0.0177864764279918,3.27829035605023e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.0257927024636769,0.00327191275730729,-0.0322056514679992,-0.0193797534593546,3.40283201781285e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0801881712597609,0.0101783066826277,0.0602386901618106,0.100137652357711,3.56980994100399e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAM,Signal transducing adapter molecule 1,37368,0.0282502036400852,0.00358631416531793,0.0212210278760621,0.0352793794041084,3.60195406288061e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0397045211019283,0.00504568248723512,0.0298149834269475,0.0495940587769092,3.80775237081105e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSDE1,Cold shock domain-containing protein E1,37021,0.0926294068440612,0.0117966791666114,0.0695079156775029,0.11575089801062,4.40477966548069e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.0330032678750729,0.00420956766765819,-0.0412540205036829,-0.0247525152464628,4.78680953241704e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.0183547732219788,0.00234240074370513,-0.0229458786796408,-0.0137636677643167,4.94583012089867e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.0340528067587335,0.00435349160687772,0.0255199632092531,0.0425856503082138,5.59593799704176e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0309623119038072,0.00395914383306612,0.0232023899909976,0.0387222338166168,5.66322162551632e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX2,Sorting nexin-2,37368,0.0619883622162316,0.00794064922264362,0.0464246897398501,0.0775520346926131,6.3129248811228e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE3,Eosinophil cationic protein,39791,0.0825874960678801,0.0105842289116965,0.061842407400955,0.103332584734805,6.42452059159598e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.0244766137985285,0.00313859946852588,0.0183249588402178,0.0306282687568392,6.64932118262484e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0415943198724417,0.00534231160364982,-0.0520652506155953,-0.031123389129288,7.34765676860279e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0291373586911918,0.00374401695359355,0.0217990854621484,0.0364756319202351,7.64064386590291e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0595851875401821,0.00766881738727338,0.0445543054611263,0.0746160696192379,8.44079545060679e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP2,Retinol-binding protein 2,39788,-0.0582797442291805,0.0075137619671096,-0.0730067176847153,-0.0435527707736457,9.26414153370824e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMOX1,Heme oxygenase 1,39691,-0.0363961795156747,0.00469311284222042,-0.0455946806864267,-0.0271976783449227,9.35282817534417e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD14,Monocyte differentiation antigen CD14,39564,0.0312841063690851,0.00403985916008524,0.0233659824153181,0.0392022303228522,1.02303447359185e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.0428093338838929,0.00552812616302519,0.0319742066043636,0.0536444611634223,1.03429456579683e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.011925039511188,0.00154207597937887,0.00890257059160542,0.0149475084307706,1.11098445351464e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1B,Interleukin-1 beta,39478,0.0424332068050354,0.00549060335008734,0.0316716242388642,0.0531947893712066,1.15569922322749e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0323285494116285,0.00418338970887451,0.0241291055822345,0.0405279932410225,1.15827719214252e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0383411746007849,0.00497341881842201,0.0285932737166777,0.048089075484892,1.3563523715994e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBP1,Z-DNA-binding protein 1,37056,0.0312884216083834,0.00406140065674411,0.023328076321165,0.0392487668956019,1.41424156946564e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LACRT,Extracellular glycoprotein lacritin,37339,0.0365105142492543,0.00475188933355212,0.0271968111554921,0.0458242173430164,1.656345228877e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL2,Fc receptor-like protein 2,39990,0.034969346313747,0.00455371990686739,0.026044055296287,0.0438946373312071,1.69112711286665e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0273011199196463,0.00355646798076564,0.0203304426773457,0.034271797161947,1.72943882114813e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0476444907476792,0.00623437531424162,0.0354251151317656,0.0598638663635927,2.25581697103294e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0519996247798947,0.0068043259783248,0.0386631458623781,0.0653361036974113,2.28004716957282e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0254477888521566,0.00333140681431398,0.0189182314961012,0.031977346208212,2.34062185290765e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHCY,Adenosylhomocysteinase,39868,0.0509227220323479,0.00667146179869278,0.03784665690691,0.0639987871577857,2.4239826597619e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,37357,0.0271740024956296,0.00356271777827662,0.0201910756502074,0.0341569293410518,2.55682204220654e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COPB2,Coatomer subunit beta',37021,0.0320701092028292,0.00421021890377031,0.0238180801514394,0.040322138254219,2.76893901148012e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GC,Vitamin D-binding protein,37453,0.019364725542946,0.00254546379459874,0.0143756165055324,0.0243538345803595,2.97680754894494e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0401989440115159,0.00529261819176299,0.0298254123556604,0.0505724756673713,3.24124061026595e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF1C,Kinesin-like protein KIF1C,37021,0.0273422633846681,0.00360280675962686,0.0202807621357995,0.0344037646335368,3.43618738022292e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PVALB,Parvalbumin alpha,39971,0.085229438905085,0.0112373993920438,0.0632041360966791,0.107254741713491,3.52085379107686e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0576229216434416,0.00766143051083882,-0.0726393254446857,-0.0426065178421975,5.71633727761964e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL21,C-C motif chemokine 21,39931,0.0289798094066337,0.00385457061660738,0.0214248509980832,0.0365347678151841,5.84167825565738e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0446798934389449,0.00595681724286831,0.033004531642923,0.0563552552349668,6.75667642867179e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.0416065880230556,0.00554981138799991,0.0307289577025758,0.0524842183435354,6.95010561733261e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RSPO3,R-spondin-3,40030,0.0198793667210293,0.00265229042423368,0.0146808774895313,0.0250778559525273,6.96353497435207e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0206597202694605,0.00276219038858448,-0.0260736134310861,-0.0152458271078349,7.84875230807019e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHISA5,Protein shisa-5,37437,0.0168370742651704,0.00225745922740897,0.0124124541794488,0.021261694350892,9.28758788209068e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPHS1,Nephrin,37056,0.0251606638263369,0.00337580330823036,0.0185440893422054,0.0317772383104684,9.67460332183975e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAT,Catalase,37252,0.0387364114925211,0.00520301900746185,0.0285384942378959,0.0489343287471464,1.02871004911497e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0262613110097786,0.00353056343111609,0.0193414066847911,0.0331812153347661,1.07470105562127e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CX3CL1,Fractalkine,39749,-0.0242276904279522,0.00326520915862605,-0.0306275003788592,-0.0178278804770451,1.23084797047085e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0420851169732137,0.00567579565405712,0.0309605574912618,0.0532096764551657,1.27861161789144e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFAP1,Actin filament-associated protein 1,37124,0.0619116743396321,0.00835781533188516,0.0455303562891372,0.078292992390127,1.36333468948144e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYGD,Gamma-crystallin D,37388,0.0702257975741174,0.00948615730982253,0.0516329292468653,0.0888186659013696,1.41027359385764e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD2,Sushi domain-containing protein 2,39858,-0.0205156295089604,0.0027757908676307,-0.0259561796095166,-0.0150750794084043,1.53026882687606e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,39477,0.0344728199157651,0.00466481024178887,0.0253297918418589,0.0436158479896712,1.54290511568048e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA7,Thyroxine-binding globulin,37453,0.0134924508527044,0.00182631281364577,0.00991287773795865,0.0170720239674501,1.57964465839059e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.0388944242753725,0.00526996706863725,0.0285652888208435,0.0492235597299015,1.67041145819101e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM3,Myomesin-3,37124,-0.0679738247221675,0.00922528506857423,-0.086055383456573,-0.049892265987762,1.83158230837454e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0435986784482063,0.00592056288154938,0.0319943752003695,0.055202981696043,1.87466178405582e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RCOR1,REST corepressor 1,39585,0.0325715985010698,0.00442742783537716,0.0238938399437305,0.041249357058409,1.97700862892311e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0280531028266994,0.00381678404944069,0.0205722060897957,0.0355339995636032,2.07930022038087e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP3,"Fatty acid-binding protein, heart",37437,0.0353904701194716,0.0048316704633525,0.0259203960113007,0.0448605442276425,2.52951565732649e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0325145762541182,0.004453009828796,-0.0412424755185584,-0.0237866769896781,2.97462419918338e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFR,Epidermal growth factor receptor,40052,0.0115084846750657,0.00157860323477924,0.00841442233489842,0.014602547015233,3.23556659240454e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B2M,Beta-2-microglobulin,37453,0.0220946609166015,0.00303190306751519,0.0161521309042717,0.0280371909289312,3.33440004573691e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17D,Interleukin-17D,39587,0.0242628648800594,0.00333520075005438,0.0177258714099528,0.030799858350166,3.63341043512231e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGKZ,Diacylglycerol kinase zeta,39587,0.0257634510347897,0.00354330567463946,0.0188185719124964,0.0327083301570831,3.73572924621326e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFIC,Nuclear factor 1 C-type,37411,0.0300404634943246,0.004131739459907,0.0219422541529068,0.0381386728357423,3.77345497112955e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GM2A,Ganglioside GM2 activator,37178,0.0258411406011446,0.00356117693587471,0.0188612338068301,0.032821047395459,4.19688063315603e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.0701618581885951,0.00971268255179031,0.0511250003870861,0.0891987159901041,5.33605929522451e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB6,Integrin beta-6,39587,0.021073631700343,0.00292058235358109,0.0153492902873241,0.026797973113362,5.61649377316779e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.0198114738428448,0.00275822225833932,0.0144053582164997,0.0252175894691898,7.20180175999209e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0187635277455017,0.00261519627551671,0.013637743045489,0.0238893124455145,7.5549309390595e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0283169941252896,0.00395034201987357,0.0205743237663374,0.0360596644842418,7.92869526007525e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0186751118654741,0.00260536695871024,0.0135685926264021,0.0237816311045462,7.94599553653664e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLU,Clusterin,37453,0.0224837066854791,0.00313714432063277,0.0163349038170388,0.0286325095539193,8.06501489022485e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CR1,Complement receptor type 1,37420,0.0251212750366363,0.00351133721486341,0.018239054095504,0.0320034959777686,8.83959892850605e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0275269861519589,0.00384921079655653,0.0199825329907081,0.0350714393132097,8.97241373815637e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A11,Protein S100-A11,39703,0.0319794051143344,0.00447481961133146,0.0232087586761247,0.0407500515525441,9.28826850138405e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA4,Carbonic anhydrase 4,40052,-0.0164695057556771,0.00230551909971021,-0.0209883231911091,-0.0119506883202451,9.48473922182766e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGA,Glycoprotein hormones alpha chain,39858,0.062232383338169,0.00871597884536692,0.0451490648012498,0.0793157018750882,9.73206226281639e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRCAM,Neuronal cell adhesion molecule,39868,0.0193866171266561,0.00272550282085309,0.0140446315977841,0.0247286026555282,1.18317370428987e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0297535632598258,0.00418404576783375,0.0215528335548716,0.0379542929647799,1.20967830529648e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAA4,Serum amyloid A-4 protein,37453,0.0231000047599832,0.00324983147852836,0.0167303350620676,0.0294696744578988,1.23553033243942e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.01628273216431,0.00229357258784939,0.0117873298921252,0.0207781344364948,1.3062176069546e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAS2,Growth arrest-specific protein 2,37169,0.0369388544430873,0.00521729119057637,0.0267129637095576,0.047164745176617,1.51295170553591e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.0173859668762635,0.00245758281815607,0.0125691045526776,0.0222028291998494,1.5746133276026e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY75,Lymphocyte antigen 75,39866,0.0268910494225176,0.00380558274913857,0.019432107234206,0.0343499916108292,1.65786524609419e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0248348152349617,0.00352524084134717,0.0179253431859213,0.0317442872840022,1.94886248788846e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CENPF,Centromere protein F,37169,0.0374293781950045,0.00531555669710685,0.027010887068675,0.0478478693213339,1.99545054459853e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSTL3,Follistatin-related protein 3,39803,0.0207818245263968,0.00295194649485233,0.0149960093964862,0.0265676396563074,2.00021823500808e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPQ,Carboxypeptidase Q,37430,0.026146697879251,0.00371990628357773,0.0188556815634387,0.0334377141950634,2.18175006565688e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST5,Cystatin-D,39559,0.0374752030287767,0.00534233869931639,0.0270042191781166,0.0479461868794368,2.39758150379447e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0248661705961984,0.00354593180986832,-0.0318161969435404,-0.0179161442488565,2.43370657468319e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0227945150580978,0.00325605304835691,-0.0291763790328774,-0.0164126510833183,2.66780151104449e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCT,Secretin,37039,0.0304375110957952,0.00435123218312306,0.021909096016874,0.0389659261747164,2.77771399590389e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.0252142427999935,0.0036058263577314,0.0181468231388399,0.032281662461147,2.82442953577484e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0578134724274956,0.00828592741715819,0.0415730546898656,0.0740538901651257,3.1297166797196e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0382692947269159,0.00548722097403682,0.0275143416178037,0.049024247836028,3.19393727470884e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1A,Protein phosphatase 1A,39477,0.0209706420081805,0.00300842824250132,0.0150741226528779,0.0268671613634831,3.28155937091767e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA1,Carbonic anhydrase 1,39531,0.0407596534700849,0.00584817856069967,0.0292972234911135,0.0522220834490562,3.30441318470469e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0390981600646211,0.00561239678561347,0.0280978623648187,0.0500984577644235,3.3806706300072e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0365687598501479,0.00525846366310007,0.0262621710704718,0.0468753486298241,3.70695553311499e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0423960420733961,0.00609657662632432,0.0304467518858004,0.0543453322609918,3.71177935296538e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBS4,Thrombospondin-4,39892,0.0305686230180525,0.00440026480587541,0.0219441039985367,0.0391931420375683,3.87495882716902e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0259045106638249,0.00372830553578512,0.018597031813686,0.0332119895139637,3.87753143427459e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0239408534539098,0.0034570558700329,0.0171650239486453,0.0307166829591743,4.55528188994802e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.0225514841951428,0.00327575404686046,-0.0289719621269893,-0.0161310062632963,6.02001904947596e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOBR,Apolipoprotein B receptor,37043,-0.0288683628216489,0.0041932474017967,-0.0370871277291704,-0.0206495979141274,6.06211526174253e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFD,Vascular endothelial growth factor D,40024,-0.0240250862180737,0.00349679445992753,-0.0308788033595316,-0.0171713690766157,6.6264118559272e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0411597304844173,0.00601385136964925,0.0293725817999048,0.0529468791689298,8.0330375251125e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SBSN,Suprabasin,37420,-0.0228787716895174,0.00334609643011702,-0.0294371206925468,-0.016320422686488,8.40646369488553e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSR,Insulin receptor,37056,0.0112065277733922,0.00164054090728105,0.00799106759512132,0.0144219879516631,8.80239013128751e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0372522164617632,0.00545783340782857,0.0265548629824192,0.0479495699411072,9.1380357389663e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0210693565360512,0.0030876229111819,0.0150176156301346,0.0271210974419677,9.25262831082284e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0471757071900508,0.00691953815133473,0.0336134124134347,0.0607380019666669,9.65014488448602e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0269112371728876,0.0039493593689379,0.0191704928097693,0.0346519815360059,9.82551308780332e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,39868,0.0117210804286708,0.00173085720919033,0.00832860029865774,0.0151135605586838,1.3158217129641e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH15,Cadherin-15,39973,0.0357374834642825,0.00528105700835074,0.0253866117279151,0.04608835520065,1.35909592775147e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RALY,RNA-binding protein Raly,37368,0.032435164796979,0.00479754659667073,0.0230319734675043,0.0418383561264536,1.42886664848838e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPE,Carboxypeptidase E,39906,-0.0256472665563117,0.00379845948272003,-0.0330922471424429,-0.0182022859701804,1.50804117972381e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSH,Pro-cathepsin H,39546,0.0479342487790696,0.00712542305428879,0.0339684195926635,0.0619000779654756,1.78923938122402e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA12,Serpin A12,39405,0.0782632361324395,0.0116340881577149,0.0554604233433182,0.101066048921561,1.79165603097816e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.026871789833036,0.00399875048947354,0.0190342388736678,0.0347093407924041,1.87951784051363e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0249318588662463,0.00371504729662534,0.0176503661648606,0.0322133515676319,1.99719837539658e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,37368,0.0394761202034727,0.00588303498033001,0.0279453716420258,0.0510068687649195,2.02157108890472e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDC1,Syndecan-1,39868,0.0262338426892383,0.00391211783942041,0.0185660917239743,0.0339015936545023,2.07021029891872e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,37410,-0.0319903460485136,0.00477042812818134,-0.041340385179749,-0.0226403069172781,2.08003446659378e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.0272749048783469,0.00409316176170883,0.0192523078253976,0.0352975019312962,2.76055572941826e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0299307590194484,0.00449376477260318,0.0211229800651462,0.0387385379737506,2.83695347675041e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0265893894300869,0.00399770267786635,0.0187538921814689,0.034424886678705,3.00426485658461e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD209,CD209 antigen,39885,-0.0252864110386847,0.0038266656473138,-0.0327866757074197,-0.0177861463699496,4.01965767054904e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0392599396860547,0.00594750097081744,0.0276028377832525,0.0509170415888568,4.23798911703214e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRLB,Fc receptor-like B,39477,0.037614544762762,0.00570233332721413,0.0264379714414224,0.0487911180841017,4.34966604097201e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,39991,0.0164915466933154,0.00250227310339956,0.0115870914106523,0.0213960019759786,4.5154821736632e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS4,Galectin-4,39862,0.0341753152885307,0.005195320484922,0.0239924871380836,0.0443581434389778,4.91287318187666e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECE1,Endothelin-converting enzyme 1,39489,0.0226629734915556,0.0034460179397108,0.0159087783297225,0.0294171686533888,4.96704206041945e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN1,Contactin-1,40052,-0.017249573990832,0.00262337699350631,-0.0223913928981043,-0.0121077550835596,5.00297238879579e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,37388,0.154399560020652,0.0235502917446121,0.108240988201212,0.200558131840092,5.72130066546515e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0760768999848576,0.0116139269764058,0.0533136031111021,0.098840196858613,5.91191642899116e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0261508008331123,0.00399707844225116,-0.0339850745799246,-0.0183165270863,6.23523083278628e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRH,Corticoliberin,39455,0.0560079839891462,0.00856819497700829,0.03921432183421,0.0728016461440825,6.48299095217124e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH1,Protocadherin-1,40018,0.013369604876037,0.00204778938074541,0.009355937689776,0.017383272062298,6.82750823851835e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL3,Insulin-like 3,37388,0.0465766940222794,0.00714168249391711,0.0325789963342019,0.0605743917103569,7.19324746469732e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0168780703932269,0.00258947887507824,0.0118026917980736,0.0219534489883803,7.34008927305758e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYTL1,Cytokine-like protein 1,37437,0.0146571060001314,0.00225496550991716,0.0102373736006937,0.019076838399569,8.31675373002471e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA7,Carbonic anhydrase 7,37169,-0.0215374235161646,0.00331805565457535,-0.0280408125991322,-0.0150340344331969,8.83049441660072e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB37,Ras-related protein Rab-37,39587,0.0530451120225435,0.00820796725056853,0.0369574962114292,0.0691327278336578,1.0592082411208e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.0162427336870386,0.00251337381812113,0.0113165210035212,0.0211689463705561,1.05938787281243e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0244593266858633,0.00378649897430179,0.0170377886962318,0.0318808646754948,1.08651834528636e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,39931,0.0166394414387415,0.00258133354464687,0.0115800276912336,0.0216988551862494,1.18062366647151e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0161780119566813,0.00251610644347759,0.0112464433274652,0.0211095805858973,1.31406935488659e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR15L,Protein GPR15L,37382,0.038903573691892,0.00605007589358328,0.0270454249404688,0.0507617224433152,1.31665292486409e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LUZP2,Leucine zipper protein 2,37368,0.0276703608466918,0.00430814274516825,0.0192264010661621,0.0361143206272216,1.38266190565979e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6,Interleukin-6,39788,0.0447435459623537,0.00696718826159198,0.0310878569696334,0.058399234955074,1.38270720095412e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0191126294726657,0.00298589441348901,0.0132602764222272,0.0249649825231041,1.58790072990629e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.0270358857426555,0.0042238759297714,-0.0353146825650074,-0.0187570889203035,1.58940370765574e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENSA,Alpha-endosulfine,37368,0.033134413796431,0.00517914832118797,0.0229832830869026,0.0432855445059594,1.62981624508487e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE1,Ribonuclease pancreatic,37445,0.0141001156775705,0.00220684079308059,0.00977470772313251,0.0184255236320084,1.72108172748401e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0207649801144877,0.00325771420080286,0.0143798602809141,0.0271500999480613,1.89030480215013e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIMAP7,GTPase IMAP family member 7,37124,-0.020427667600809,0.00321476524978747,-0.0267286074903924,-0.0141267277112256,2.16186080926479e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR2,Folate receptor beta,40009,-0.0180023159306561,0.00283922748344863,-0.0235672017982154,-0.0124374300630968,2.34998368612124e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYZL2,Lysozyme-like protein 2,36962,0.0225229339054178,0.00355202001684522,0.0155609746724012,0.0294848931384344,2.3595535520288e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D17,TBC1 domain family member 17,39489,0.0273886819256694,0.00433443737126498,0.0188931846779901,0.0358841791733488,2.70644062745766e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCP1,Plastin-2,37437,0.0291760309195726,0.00462558497662292,0.0201098843653916,0.0382421774737535,2.92308939645081e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0357315220123216,0.00566573483193058,0.0246266817417376,0.0468363622829055,2.92751771513114e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0188955435145836,0.00300084862506509,-0.0247772068197111,-0.013013880209456,3.13689713112981e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRC1,Macrophage mannose receptor 1,37445,0.0170403240532524,0.00271394072346005,0.0117210002352707,0.0223596478712341,3.51552568242885e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0139631593373178,0.0022346128339775,0.00958331818272188,0.0183430004919137,4.24552811464717e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0334449415581228,0.00535933833408402,0.0229406384233182,0.0439492446929275,4.49540508225013e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,37043,0.0148720930710731,0.00238681961581633,0.0101939266240731,0.0195502595180731,4.77803824088811e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EBI3_IL27,Interleukin-27,40011,-0.0188562377633203,0.00303156215746824,-0.0247980995919581,-0.0129143759346826,5.09475749567421e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0439251081776214,0.00707257820782684,0.0300628548902808,0.057787361464962,5.43458914265671e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0208741830484213,0.00336310579508205,-0.0274658704067821,-0.0142824956900604,5.56414441110548e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD93,Complement component C1q receptor,39238,-0.0188160278788019,0.00303378200785968,-0.0247622406142069,-0.012869815143397,5.71144761861156e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0306114740691671,0.00493978904145092,0.0209294875479233,0.0402934605904109,5.90182455583549e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDM1,Nuclear protein MDM1,37039,0.0190349299521441,0.00308320271050312,0.012991852639558,0.0250780072647303,6.86456924549598e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0197251948194711,0.0032009956762521,0.013451243294017,0.0259991463449252,7.38282366814757e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDN1,Endothelin-1,37043,0.0170041808125453,0.00276970252471999,0.0115755638640942,0.0224327977609965,8.52369299555888e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,37021,0.0276375861669802,0.00450571099974948,0.0188063926074712,0.0364687797264892,8.82068421244461e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,39477,0.0310859104806445,0.00508050119807877,0.0211281281324101,0.0410436928288789,9.66115302006726e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.0204399825334255,0.00334312941957305,0.0138874488710623,0.0269925161957887,9.94140459024246e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0290264401208223,0.00475829153900638,0.0197001887043698,0.0383526915372748,1.089146711591e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIPF,Gastric triacylglycerol lipase,37043,0.0360164599369554,0.0059047571292902,0.0244431359635466,0.0475897839103642,1.09332014980843e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AZU1,Azurocidin,39344,0.0460279748300648,0.00755075075295155,0.0312285033542797,0.0608274463058498,1.11464428134539e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANPEP,Aminopeptidase N,39891,0.0167631752750339,0.00275017805829249,0.0113728262807806,0.0221535242692872,1.11729534102875e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD276,CD276 antigen,39862,-0.02098868202141,0.00346682790952684,-0.0277836647240827,-0.0141936993187374,1.44317267522773e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR4,Complement factor H-related protein 4,37409,0.0428792797676918,0.00709050080937665,0.0289818981813136,0.0567766613540701,1.51049895173429e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.030392529718459,0.00503229216826936,0.020529237068651,0.0402558223682669,1.58097175931403e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.029003152671135,0.00480876718561212,0.0195779689873352,0.0384283363549347,1.66880791369785e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0154584698451219,0.00256334273961438,-0.0204826216147661,-0.0104343180754777,1.67731726130665e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK4,Kallikrein-4,40030,-0.0357031920491487,0.00592563835229748,-0.0473174432196518,-0.0240889408786456,1.72556944133939e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD7,T-cell antigen CD7,37037,0.0254171414226975,0.00421921231873555,0.0171474852779758,0.0336867975674192,1.74537801304807e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.0212522313966632,0.00353057692139127,0.0143323006307363,0.0281721621625901,1.78867964012145e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,39444,0.0167524162250349,0.00278414604083034,0.0112954899850074,0.0222093424650623,1.8157290004956e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN2,Calsyntenin-2,40058,-0.0233302308005245,0.00387958669074927,-0.0309342207143931,-0.0157262408866559,1.85361431709388e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYT1,Synaptotagmin-1,37388,0.0219306884150764,0.00364896072890269,0.0147787253864272,0.0290826514437257,1.90153928623743e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0262844531104255,0.00437451663211472,0.0177104005114806,0.0348585057093703,1.92018457198685e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP4,Guanylate-binding protein 4,39489,0.0289301253593447,0.00481821850438973,0.0194864170907409,0.0383738336279486,1.96389215875205e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0159030696289367,0.00264855652457799,-0.0210942404171096,-0.0107118988407638,1.9694825623512e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFHD1,EF-hand domain-containing protein D1,37411,0.0204151255227814,0.00340117390491765,0.0137488246691428,0.02708142637642,1.99416389624968e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.0152948339364492,0.00254894685120057,-0.0202907697648024,-0.0102988981080961,2.01777772171867e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0254338258240706,0.00424023570320234,-0.0337446878023472,-0.017122963845794,2.0378100428461e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP9,Fatty acid-binding protein 9,39866,0.0326643559628599,0.00544952048789925,0.0219832958065774,0.0433454161191424,2.09152994700967e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTB,Lymphotoxin-beta,37368,0.0201668154339507,0.00336820202273867,0.0135651394693829,0.0267684913985185,2.18614320325223e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0245678773660187,0.00410940094944649,0.0165134515051036,0.0326223032269338,2.30923852159081e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL34,Interleukin-34,39456,0.02104841063085,0.00352604915457374,0.0141373542878855,0.0279594669738145,2.4328552656406e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.0192388640655532,0.00323178553062824,0.0129045644255218,0.0255731637055845,2.68749639868562e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL1A1,Collagen alpha-1(I) chain,40052,-0.0144882555421166,0.00243807179733848,-0.0192668762649,-0.00970963481933319,2.86455046488247e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKD1,Polycystin-1,37437,0.0152806593903801,0.00258238362369354,0.0102191874879408,0.0203421312928195,3.35217324750761e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.0233309160580236,0.00395535324710073,0.0155784236937062,0.031083408422341,3.74065741634704e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.0276652889289125,0.00469819744388916,0.0184568219388898,0.0368737559189353,3.99246266803621e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LBP,Lipopolysaccharide-binding protein,39931,-0.0335361904853341,0.00570472346860502,-0.0447174484837999,-0.0223549324868682,4.21765971201807e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0176479875120208,0.00301628029382034,-0.0235598968879086,-0.0117360781361329,4.98603819219558e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MET,Hepatocyte growth factor receptor,39879,-0.0112168496067304,0.00192242836472941,-0.0149848092016,-0.00744889001186071,5.4917453879851e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0195945633630266,0.00335983022649142,0.0130092961191034,0.0261798306069498,5.60099120350702e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL3,Fc receptor-like protein 3,39587,0.0299187616478808,0.00513591905815879,0.0198523602938896,0.039985163001872,5.80903182741289e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPH1,Neurexophilin-1,39489,0.0215330408037085,0.00370106417374429,0.0142789550231697,0.0287871265842473,6.06963205893202e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLVRB,Flavin reductase,39858,0.0369338005970097,0.006355715677642,0.0244765978688314,0.0493910033251881,6.32378219209987e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.022123635505865,0.00381092725864396,0.0146542180789229,0.0295930529328072,6.5686667299388e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFB,Vascular endothelial growth factor B,37056,0.0162241060635409,0.00279660610646275,0.0107427580948739,0.0217054540322079,6.72900327117186e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.0144992875382684,0.00250164953759673,0.00959605444457878,0.019402520631958,6.92385160367736e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMBS,Porphobilinogen deaminase,40030,0.0245312583442812,0.00423294509802587,0.0162346859521505,0.0328278307364119,6.9461453113382e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.0195937177525817,0.00338178569492027,0.0129654177905379,0.0262220177146254,7.00481697971418e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITM2A,Integral membrane protein 2A,39866,-0.0337372730506914,0.00582387505847439,-0.0451520681653012,-0.0223224779360816,7.04694612667574e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PADI4,Protein-arginine deiminase type-4,39456,0.0401388188683975,0.00692990796338406,0.0265561992601648,0.0537214384766303,7.08445292796385e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST7,Cystatin-F,39882,0.0526831006729377,0.00909669121682683,0.0348535858879571,0.0705126154579183,7.10855695456804e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0172517737607775,0.00298123099598785,0.0114085610086413,0.0230949865129137,7.30716651882897e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0245240444402162,0.00424279586315607,0.0162081645484303,0.0328399243320021,7.60428492879339e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNC,Tenascin,39931,-0.0267775829238954,0.00463567456152307,-0.0358635050644806,-0.0176916607833101,7.77195975975396e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MATN3,Matrilin-3,39720,-0.0178133980373274,0.00308562253310311,-0.0238612182022095,-0.0117655778724453,7.93130282410324e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0440352769427302,0.00764457207183251,0.0290519156819384,0.0590186382035219,8.58236856450951e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRLF1,Cytokine receptor-like factor 1,39931,0.0147916030782858,0.00257142872559502,0.00975160277611957,0.019831603380452,8.96440349314222e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMPD3,AMP deaminase 3,37388,0.0400810502430202,0.00697963641070193,0.0264009628780444,0.053761137607996,9.52547304549205e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0207282858286413,0.00361030803461773,0.0136520820807906,0.0278044895764921,9.56198476228026e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPM3,Tropomyosin alpha-3 chain,37021,-0.0250496360775716,0.00437364129336603,-0.033621973012569,-0.0164772991425741,1.04205969496648e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGA4,Pepsin A-4,37445,0.0350495186252223,0.00613179666632832,0.0230311971592188,0.0470678400912258,1.11334937550344e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA12,Carbonic anhydrase 12,39788,-0.0178935234073065,0.00313549351513398,-0.0240390906969691,-0.0117479561176439,1.17192203804087e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,37411,0.015727695582602,0.00275737720733105,0.0103232362562332,0.0211321549089709,1.19571169075965e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A14,Protein S100-A14,37411,0.0286805885509144,0.00503526524073968,0.0188114686790646,0.0385497084227641,1.25240976572862e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OBP2B,Odorant-binding protein 2b,39701,-0.035322628705861,0.00620364193855113,-0.0474817669054212,-0.0231634905063008,1.264057478341e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0201470962417753,0.00354106422885517,0.0132066103532191,0.0270875821303314,1.30074253984082e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN10,Ataxin-10,39489,0.0410181306554808,0.00721224182210727,0.0268821366841506,0.0551541246268111,1.31378295830411e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CABP2,Calcium-binding protein 2,37039,0.0368398998797018,0.00648470863488943,0.0241298709553186,0.0495499288040851,1.36709090630516e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG4,Desmoglein-4,39725,0.02732588151304,0.00483068639372711,0.0178577361813349,0.0367940268447451,1.56947720277708e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHB6,Ephrin type-B receptor 6,39713,0.0168132600699799,0.00297856224905191,0.0109752780618382,0.0226512420781217,1.68247555870428e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.0114922932121165,0.00203816134436751,0.00749749697715623,0.0154870894470769,1.74389174318006e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,37124,0.0293243998311175,0.00520123538392567,0.0191299784786232,0.0395188211836118,1.75578544513733e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0234183311511596,0.00415569801700418,0.0152731630378314,0.0315634992644878,1.77818885811864e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MST1,Hepatocyte growth factor-like protein,37271,0.0350533839376041,0.00622367040528715,0.0228549899432413,0.0472517779319669,1.81428337994385e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST1,Cystatin-SN,35640,0.0559295713220933,0.00993821680123844,0.0364506663916659,0.0754084762525206,1.86768836955036e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.0173645108759578,0.003089968016796,0.0113081735630377,0.023420848188878,1.95228962636565e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0157013103029724,0.00279554998366198,-0.0211805882709499,-0.010222032334995,1.98072357083999e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRP2,Neuropilin-2,39858,-0.0157321945312723,0.00281169916142655,-0.0212431248876684,-0.0102212641748763,2.23899879543052e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG3,Desmoglein-3,39964,0.0183689942758913,0.00328401070425763,0.0119323332955463,0.0248056552562362,2.26204334395277e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.0135875518058972,0.00243144274149256,0.00882192403257176,0.0183531795792226,2.33087239344128e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0373185704698648,0.00668998289845654,0.02420620398889,0.0504309369508396,2.477265583636e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0177863621415653,0.00319359861047413,0.011526908865036,0.0240458154180946,2.60503999400711e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLGN,Calmegin,37039,0.0239507658580512,0.00430288702699171,0.0155171072851474,0.0323844244309549,2.65425883350962e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR1,Cadherin-related family member 1,39489,0.0234064792422585,0.00420966694473922,0.0151555320305696,0.0316574264539474,2.73919873831854e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN2,Prefoldin subunit 2,39489,0.0305666141955933,0.00550250206162103,0.0197817101548161,0.0413515182363705,2.82078447746404e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.019384040598974,0.00349774161687966,0.0125284670298899,0.0262396141680582,3.03985369384872e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.0262477476708977,0.00475979498134911,0.0169185495074535,0.035576945834342,3.55379220266881e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA1,Annexin A1,37072,0.0237738801588088,0.00431104311769609,0.0153242356481245,0.0322235246694932,3.56045105668972e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0216279738749526,0.00393969994718178,0.0139061619784763,0.0293497857714289,4.09959150278988e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LXN,Latexin,39682,-0.0360696483620991,0.00658469028241965,-0.0489756413156416,-0.0231636554085566,4.37205700977261e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PREB,Prolactin regulatory element-binding protein,39587,0.0154391035659282,0.00281911494538621,0.00991363827297126,0.0209645688588852,4.40280204736215e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CR2,Complement receptor type 2,39931,0.0243966719954679,0.00446611239252401,0.0156430917061209,0.033150252284815,4.76131186366818e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTX1,Neuronal pentraxin-1,39858,0.0219913922574055,0.00402726482859091,0.0140979531933673,0.0298848313214437,4.81527422605464e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC16,Mucin-16,39788,0.0996418373360592,0.018311933425358,0.0637504478223575,0.135533226849761,5.36558916951715e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN8,Tetraspanin-8,37382,0.0523614417123326,0.00966084239347545,0.0334261906211207,0.0712966928035445,6.06323813678956e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.0145449147604244,0.00268767538625157,0.00927707100337133,0.0198127585174775,6.33461462559211e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSHB,Thyrotropin subunit beta,39868,0.0398470744958544,0.00737724828107732,0.0253876678649428,0.0543064811267659,6.70867347021655e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0198192941940706,0.0036788158641169,0.0126088151004015,0.0270297732877398,7.24905548212978e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0280329314363355,0.00520413989429299,0.0178328172435212,0.0382330456291497,7.28113171042297e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.0299934916304495,0.0055938091595916,0.0190296256776499,0.040957357583249,8.34898049121885e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB2A2,Mammaglobin-A,37021,-0.0165807171622795,0.00309606724223938,-0.0226490089570687,-0.0105124253674903,8.67968823452917e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OLFM4,Olfactomedin-4,36654,0.064837153290241,0.0121334591665525,0.0410555733237981,0.088618733256684,9.26478139700388e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0264384050507189,0.00496212471036378,0.0167126406184059,0.0361641694830319,1.00870012939292e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0131544348588542,0.00248225595805673,0.00828921318106306,0.0180196565366454,1.17716641459551e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS53,Serine protease 53,37388,0.0194108470350376,0.00367659306839498,0.0122047246209834,0.0266169694490918,1.31487586738325e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0200097602925867,0.00379234102233833,0.0125767718888036,0.0274427486963699,1.33533423892014e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0273490768566855,0.00518761595288489,0.0171813495890311,0.0375168041243399,1.37029331111543e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.016411927425865,0.00311389888979577,0.0103086856018653,0.0225151692498647,1.37790661130446e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0202673403875832,0.00385812356841165,0.0127054181934964,0.02782926258167,1.51783398416315e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0138232741829762,0.00263596829084556,0.00865677633291892,0.0189897720330335,1.59412141776912e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRL,Prolactin,40009,-0.039146363818998,0.00747119729963598,-0.0537899105262845,-0.0245028171117115,1.62915040493951e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,37021,0.0227538576265012,0.00434571993425401,0.0142362465553633,0.0312714686976391,1.66689923396154e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALB1,Calbindin,39788,0.0215791714333513,0.00412514951324929,0.0134938783873827,0.0296644644793199,1.70615732920026e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.0110630963678526,0.00211666574185211,-0.0152117612218827,-0.00691443151382248,1.748046845764e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMB,Granzyme B,39866,0.0328250429402758,0.00631435057505416,0.0204489158131697,0.045201170067382,2.03393130540331e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOB,Apolipoprotein B-100,37445,0.0116131941819036,0.00223412845994937,0.00723430240040283,0.0159920859634044,2.04269672758146e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSLN,Mesothelin,39766,0.0268490372877,0.00516856167912786,0.0167186563966094,0.0369794181787906,2.07600620372711e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLMP,CXADR-like membrane protein,40030,0.0104749174628728,0.00201748434845688,0.00652064813989731,0.0144291867858483,2.10490098981101e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SATB1,DNA-binding protein SATB1,37411,0.0153276737145328,0.00295739017178192,0.00953118897784023,0.0211241584512254,2.2167593736824e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0313343928915745,0.00605095898800184,0.0194745132750909,0.0431942725080581,2.26535985549474e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UROS,Uroporphyrinogen-III synthase,37039,0.0349930374405909,0.00675725337006739,0.0217488208352588,0.048237254045923,2.26864512934383e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,39456,0.0260998410692001,0.00504799478896771,0.0162057712828234,0.0359939108555768,2.36559136223285e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLIN3,Perilipin-3,39868,0.0218409173477371,0.00423115402758957,0.0135478554536615,0.0301339792418127,2.47342564716267e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSAB1,Tryptase alpha/beta-1,40038,0.026530313168477,0.00515148201517674,0.0164334084187306,0.0366272179182235,2.63493783338331e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.036040042183607,0.00701726857458584,0.0222861957774188,0.0497938885897953,2.84752397076176e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEPACAM2,HEPACAM family member 2,37388,-0.0211611021295778,0.00412946240628364,-0.0292548484458938,-0.0130673558132619,3.02565767591184e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINI1,Neuroserpin,37088,0.0155646161768555,0.00303806765622144,0.00961000357066144,0.0215192287830495,3.04628653909459e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,37388,0.0223722547908095,0.00437785916610132,0.0137916508252509,0.0309528587563681,3.25999667284424e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR1,Folate receptor alpha,39809,0.0137858374351329,0.0026979501262623,0.00849785518765878,0.019073819682607,3.2631845266699e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0352841742041505,0.00693161878474289,0.0216982013860544,0.0488701470222466,3.62245489126099e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNPEP,Aspartyl aminopeptidase,37388,0.0296108941562502,0.00582522363689914,0.0181934558279279,0.0410283324845725,3.76043658390639e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0150156616931332,0.00295791859116326,0.00921814125445325,0.0208131821318132,3.89017558008512e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6L2,Seizure 6-like protein 2,39788,-0.0119889475059,0.00236387951369493,-0.016622151352742,-0.0073557436590579,3.98652822202608e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRUNE2,Protein prune homolog 2,37169,0.0142360914656243,0.00281016909456489,0.00872816004027707,0.0197440228909714,4.11876468576257e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNPY2,Protein canopy homolog 2,39585,0.0300785483573874,0.0059414429677408,0.0184333201406154,0.0417237765741593,4.18471072495221e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0192506062626981,0.00383280611073511,0.0117383062856573,0.0267629062397389,5.15417563098055e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP1,Caspase-1,39489,0.0330744324894913,0.00659308068767059,0.0201519943416569,0.0459968706373256,5.31884074910453e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HYAL1,Hyaluronidase-1,39747,0.011266761540621,0.00224712731846597,0.00686239199642766,0.0156711310848143,5.39259170186743e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.018098220582726,0.00361480985318939,0.0110131932704748,0.0251832478949772,5.59566087583835e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0251314572816589,0.00502926571873931,0.0152740964729298,0.0349888180903879,5.89445227518325e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAL,Galanin peptides,39931,-0.0316960934588872,0.00634490777847038,-0.0441321127046891,-0.0192600742130853,5.9294325451497e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA2,Ephrin type-A receptor 2,39248,0.0144215558580348,0.00289068226050593,0.00875581862744316,0.0200872930886264,6.13611008444685e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.0205774904073458,0.00413707691014937,0.012468819663453,0.0286861611512386,6.62882534589845e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C8B,Complement component C8 beta chain,37453,0.0148343501799172,0.00298875390626218,0.00897639252364333,0.0206923078361911,7.01125005287184e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.012832518711331,0.00258847808321316,-0.0179059357544288,-0.00775910166823317,7.22795395739869e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,39477,0.0226612054965008,0.00458140996546904,0.0136816419641815,0.0316407690288201,7.64085612354874e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0179169517509836,0.00363009922523936,0.0108019572695145,0.0250319462324528,8.08309562848654e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH3,Cadherin-3,40009,0.0168077207211208,0.0034138803201568,0.0101165152936135,0.0234989261486281,8.59159666316978e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIF,Leukemia inhibitory factor,39489,0.0249001374191972,0.00506362050075352,0.0149754412377203,0.0348248336006741,8.85660279654067e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEPD,Xaa-Pro dipeptidase,37445,0.0124434140840645,0.00253391777123822,0.00747693525243753,0.0174098929156914,9.17880144347051e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD1,Bromodomain-containing protein 1,37169,-0.0148808792721144,0.00303417228941711,-0.020827856959372,-0.00893390158485687,9.4806893776226e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PI3,Elafin,39594,0.0255976014889843,0.00522321719532599,0.0153600957861454,0.0358351071918233,9.64295293842106e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INHBB,Inhibin beta B chain,37124,0.0239039750705645,0.00487968517210372,0.0143397921332412,0.0334681580078878,9.76252497767177e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0184408566825363,0.00376963113978653,0.0110523796485547,0.0258293337165179,1.00815585031902e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGFAC,Hepatocyte growth factor activator,37318,0.0136157284785768,0.00279193747467634,0.00814353102821122,0.0190879259289425,1.09051391055224e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK8,Kallikrein-8,39315,0.0166843474364767,0.00342911971254264,0.0099632727998931,0.0234054220730602,1.15299086324387e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX18,Sorting nexin-18,37382,0.0216610930675165,0.00445921393806713,0.0129210337489049,0.030401152386128,1.20146071205427e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP7,Dipeptidyl peptidase 2,39754,0.0286985200362653,0.00592545408578668,0.0170846300281234,0.0403124100444072,1.28928076130898e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHAD,Chondroadherin,37124,0.0240293866080759,0.00497103014715607,0.01428616751965,0.0337726056965018,1.35394725054903e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDF15,Growth/differentiation factor 15,40052,0.0201309820507055,0.00417822497610339,0.0119416610975428,0.0283203030038681,1.46266205282144e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL15,Interleukin-15,39866,0.0154104196148413,0.00319885853831911,0.0091406568797358,0.0216801823499467,1.46718242436484e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCN,Decorin,39585,-0.010314157722157,0.00214246319964479,-0.0145133855934607,-0.00611492985085316,1.49195890266175e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0669624966123829,0.0139478533263122,0.0396247040928109,0.0943002891319549,1.59402191204766e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROCR,Endothelial protein C receptor,37021,-0.0172965387089282,0.00360293862838347,-0.0243582984205598,-0.0102347789972966,1.59870615042932e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLC,Galectin-10,39841,-0.0314832209435516,0.00656195081662267,-0.044344644544132,-0.0186217973429712,1.61830311699199e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC1,Sialoadhesin,39931,0.0197506823181778,0.00411839652621016,0.0116786251268059,0.0278227395095497,1.63543415526659e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTF4,Neurotrophin-4,39477,0.0187851351314545,0.00392073636386446,0.0111004918582802,0.0264697784046289,1.67288788497979e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0305134416548805,0.00637109652433855,0.018026092467177,0.0430007908425841,1.69121577786933e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOSB,Protein fosB,39489,0.0184359622974975,0.00385207150816151,0.0108859021415009,0.025986022453494,1.71705737408351e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.0115125048215519,0.00240658482497123,-0.0162294110784955,-0.0067955985646083,1.73569025435369e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMH,Granzyme H,39585,0.0353185010690978,0.00742583336011311,0.0207638676832761,0.0498731344549194,1.99054432024075e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACAN,Aggrecan core protein,39730,0.0131962957859288,0.00277557993984197,0.00775615910383851,0.018636432468019,2.00756068019307e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN2,Ataxin-2,36991,0.0521840514484587,0.0109780199894727,0.0306671322690923,0.0737009706278251,2.02043491755242e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSBP1,Heat shock factor-binding protein 1,37043,0.0452637792698579,0.0095324410845028,0.0265801947442324,0.0639473637954834,2.07197126052243e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.0125043164872914,0.00264176285076291,0.00732646129979613,0.0176821716747868,2.22776781867837e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.0128918565601405,0.00272616950182848,-0.0182351487837243,-0.00754856433655666,2.28025594711951e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.018406048306241,0.0038930552935093,0.0107756599309627,0.0260364366815192,2.29111405960257e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFD,Complement factor D,37453,0.00850546201963564,0.00179996591902673,0.00497752881834324,0.012033395220928,2.32024800790611e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA5,Protein disulfide-isomerase A5,36962,0.0285950389132543,0.00605565896250767,0.0167259473467393,0.0404641304797694,2.35915802275892e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0157081741228341,0.00333013362454266,-0.0222352360269377,-0.00918111221873051,2.4183658573433e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICOSLG,ICOS ligand,39788,0.00874517624008715,0.00185612004844939,0.00510718094512634,0.012383171535048,2.47933681948415e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPC1,Glypican-1,40030,0.0134499844035281,0.00285680359946503,0.00785064934857663,0.0190493194584795,2.52168429110013e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0273354004682245,0.00581081126282171,0.0159462103930939,0.038724590543355,2.57386735137286e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF7,SLAM family member 7,39866,-0.0267304791884066,0.00568722836946314,-0.0378774467925543,-0.0155835115842588,2.62213856904469e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.0144206433917385,0.00307046102299328,-0.0204387469968054,-0.00840253978667172,2.66755349493871e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPO,Erythropoietin,39866,0.0357211076457524,0.00760702586569174,0.0208113369489966,0.0506308783425082,2.67763004609966e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,39835,0.020491722213915,0.00436451191796766,0.0119372788546984,0.0290461655731316,2.68720143766758e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNG,Interferon gamma,39587,0.0528495271615888,0.011269212992844,0.0307618696956146,0.074937184627563,2.75869604047598e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.0223077620954606,0.00475852508338962,0.0129810529320169,0.0316344712589042,2.78634715374907e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.013662161630111,0.0029227037707502,0.00793366223944059,0.0193906610207814,2.97616717650876e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM2,Myomesin-2,37021,-0.0237406856213027,0.0050791722295727,-0.0336958631912652,-0.0137855080513402,2.9813838941371e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMOD1,Leiomodin-1,37411,-0.0162206966877928,0.00347291120184639,-0.0230276026434117,-0.00941379073217386,3.03156379635463e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0174528701103105,0.00373776337804245,-0.0247788863312737,-0.0101268538893473,3.0516894440785e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,37043,0.0181420474069314,0.00390464277317248,0.0104889475715133,0.0257951472423495,3.41252350299579e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.00958092724107988,0.00206643443671618,-0.0136311387370436,-0.00553071574511618,3.57840620713864e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMS1,PMS1 protein homolog 1,37039,0.0227390812731704,0.00490516105586554,0.0131249656036739,0.0323531969426668,3.5906577192969e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARF2,Scavenger receptor class F member 2,40009,-0.0128506163352773,0.00277331357751023,-0.0182863109471974,-0.00741492172335727,3.62048790541648e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0409219651071955,0.00883796930708633,0.0235995452653063,0.0582443849490847,3.68096665733908e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0158918556229463,0.00343542101480445,0.00915843043392957,0.022625280811963,3.75893945990134e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.0182215498050465,0.00395074277956594,0.0104780939570972,0.0259650056529957,4.01624243876175e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD55,Complement decay-accelerating factor,39315,0.0115337881144889,0.00250390016759457,0.00662614378600352,0.0164414324429743,4.13111006162921e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0171582708067324,0.00373143618861615,0.00984465587704477,0.0244718857364201,4.29905483368545e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MBL2,Mannose-binding protein C,37257,-0.0487125077775392,0.0105957183867928,-0.069480115815653,-0.0279448997394253,4.31756003444132e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA4,Carboxypeptidase A4,36868,0.0197615433477924,0.00429895047466132,0.0113356004174562,0.0281874862781286,4.33006178643131e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.012115997895583,0.00263791782169069,0.00694567896506921,0.0172863168260967,4.4081354577275e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F3,Tissue factor,39931,-0.0122783621467366,0.00267656067689739,-0.0175244210734555,-0.00703230322001771,4.52265365862591e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN4,Contactin-4,39858,-0.0107479939034904,0.00235311274617488,-0.0153600948859932,-0.00613589292098765,4.9710704343558e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB6A,Ras-related protein Rab-6A,39866,0.0208262127823904,0.00456040879418272,0.0118878115457923,0.0297646140189886,4.99054727461133e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSPN,Persephin,39866,0.0423761082815509,0.00928714371364572,0.0241733066028053,0.0605789099602965,5.08319519753803e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK11,Kallikrein-11,39779,0.0130827942916517,0.00286933466295085,0.007458898352268,0.0187066902310353,5.16521867540037e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC13A1,Solute carrier family 13 member 1,37368,0.0268735668706607,0.0058979246052971,0.0153136346442784,0.038433499097043,5.24825979388206e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TK1,"Thymidine kinase, cytosolic",37169,0.0206709079533669,0.00454363615020632,0.0117653810989625,0.0295764348077713,5.42696274420405e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF3,Trefoil factor 3,39839,0.0217151646200056,0.0047787783963839,0.0123487589630932,0.0310815702769181,5.55791977272168e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.00995751973366646,0.0021919799609653,0.00566123901017446,0.0142538004571585,5.5943050010825e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L15,Bcl-2-like protein 15,37056,0.0253440537550393,0.0055797782531054,0.0144076883789527,0.0362804191311259,5.61833546567131e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAP,Cartilage-associated protein,37039,0.0220690154033748,0.00487221704183235,0.0125194700013834,0.0316185608053662,5.96246441729347e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRELP,Prolargin,39862,0.00989771928190104,0.00218629153805245,0.00561258786731823,0.0141828506964839,6.02091965706197e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0174770786565907,0.00386174001790966,0.00990806822148776,0.0250460890916936,6.07225395301821e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,39699,0.0126232605456769,0.00279275974302845,0.00714945144934112,0.0180970696420126,6.22888863371353e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGBL1,Integrin beta-like protein 1,37437,0.0159167247474991,0.00352272490369776,0.00901218393625147,0.0228212655587467,6.28645265241472e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN1,Calsyntenin-1,39489,0.0224119983958246,0.00496545755270466,0.0126797015925235,0.0321442951991258,6.42071611560697e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0183064425809499,0.00406727139216677,0.0103345906523031,0.0262782945095968,6.82411313542105e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.031201245244065,0.0069434111582874,-0.0448103311143083,-0.0175921593738217,7.05943399643889e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM5,Intercellular adhesion molecule 5,39868,0.0194825231754054,0.00434825096132333,0.0109599512912117,0.0280050950595991,7.49693832469911e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARTN,Artemin,39587,0.019579346248094,0.00441576683664449,0.0109244432482708,0.0282342492479172,9.31433912383295e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MILR1,Allergin-1,39587,-0.0216199601410695,0.00487834373394352,-0.0311815138595988,-0.0120584064225402,9.4071249575849e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,39489,0.0370550793380345,0.00836671278212229,0.0206563222850749,0.0534538363909942,9.53713136291013e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTX2,Neuronal pentraxin-2,37437,-0.0146979422331009,0.00332413054880782,-0.0212132381087642,-0.00818264635743758,9.87383251576709e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.01335926995679,0.00302879824706888,0.007422825392535,0.019295714521045,1.03688898183348e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0268037496228033,0.00608593276513742,0.014875321403134,0.0387321778424727,1.0700816920105e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTPN,Myotrophin,39585,0.014083209713529,0.00319919331152464,0.00781279082294075,0.0203536286041173,1.07908445233929e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0250725940771001,0.00570103052944988,0.0138985742393784,0.0362466139148219,1.10023309169095e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTN2,Alpha-actinin-2,37021,-0.0255326404546216,0.00582390781873424,-0.0369474997793407,-0.0141177811299025,1.17365405607632e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC2,Mucin-2,37437,0.0389896530521061,0.00889615664209661,0.0215531860335967,0.0564261200706154,1.18069249952174e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3D,Protein FAM3D,37382,0.036047936834046,0.00823160677627855,0.0199139875525401,0.052181886115552,1.20005514563173e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD6,Programmed cell death protein 6,39868,-0.0300677066479052,0.00686687744324988,-0.0435267864366749,-0.0166086268591354,1.20169970142751e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,39866,0.0201708821007681,0.00461157513644833,0.0111321948333294,0.0292095693682069,1.22779185998803e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF16,Fibroblast growth factor 16,37056,0.020828796548248,0.0047655602163192,0.0114882985242623,0.0301692945722336,1.24800296829628e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIL1,Nucleotide exchange factor SIL1,37043,0.014328705408234,0.00329327182505067,0.00787389263113474,0.0207835181853334,1.36597967604828e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPA,Apolipoprotein(a),37186,-0.0753934619767732,0.0173395562807244,-0.109378992286993,-0.0414079316665533,1.38365330323531e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN1,Tetraspanin-1,39585,0.0173057375547238,0.00398071915312755,0.0095035280145938,0.0251079470948538,1.38632958317717e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,37388,0.0122975791074135,0.00283044580937477,0.00674990532103895,0.0178452528937881,1.40450889421399e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.0250941595491145,0.00578452176727672,0.0137564968852521,0.0364318222129769,1.4457078776756e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0429009345558218,0.00989267598838076,0.0235112896185955,0.0622905794930481,1.45754921053641e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEFL,Neurofilament light polypeptide,39438,0.0185856021284157,0.00428668443286425,0.0101837006400018,0.0269875036168297,1.46236361491273e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP9,Matrix metalloproteinase-9,39843,0.0257583119353169,0.00597384863637831,0.0140495686080154,0.0374670552626184,1.62867504823965e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTG,Protogenin,40030,0.0105748150863878,0.00245315679282596,0.00576662777244888,0.0153830024003266,1.63703610425085e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.0184174024935348,0.00428346673689157,0.0100218076892273,0.0268129972978423,1.72297512757023e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPARCL1,SPARC-like protein 1,39871,-0.0115363594923782,0.00268365899489326,-0.016796331122369,-0.00627638786238744,1.72785112522038e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLASP1,CLIP-associating protein 1,36962,0.0310100261718048,0.00722226853096588,0.0168543798511116,0.0451656724924979,1.77009319530635e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0145068904809323,0.00338008493638752,0.0078819240056128,0.0211318569562519,1.7823317852088e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.0137695556548019,0.00322314030368225,0.00745220065958466,0.0200869106500191,1.94970147051882e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNU13,NHP2-like protein 1,37021,0.0260663084257668,0.00610406206951534,0.0141023467695168,0.0380302700820169,1.9656044986649e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNLY,Granulysin,39858,0.0214534511182093,0.00502503673843024,0.011604379110886,0.0313025231255326,1.97206536098226e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,39931,0.0118262243230351,0.00277649194961125,0.00638430010179705,0.0172681485442731,2.06130406658431e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,39868,0.0132552383113474,0.00312421763724036,0.00713177174235631,0.0193787048803385,2.22050464041424e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.0172856589496814,0.00408223412337605,0.00928448006786438,0.0252868378314985,2.30717599018817e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFLAM,Pikachurin,37382,0.0126897416130748,0.00302286433052078,0.00676492752525409,0.0186145557008956,2.71100992709002e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB1A1,Uteroglobin,39903,0.0226006101908828,0.00539309126121217,0.0120301513189069,0.0331710690628586,2.79633529153401e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDK2,Protein sidekick-2,37124,0.0153385877915491,0.00366495354652778,0.00815527884035462,0.0225218967427435,2.867431729435e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSPN,Claspin,39453,0.0142054514954849,0.00339739680633581,0.00754655375506675,0.0208643492359031,2.91461646573577e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP8,Neutrophil collagenase,39985,0.0294992245195806,0.00706250884694119,0.0156567071795759,0.0433417418595854,2.97094269861848e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RETN,Resistin,39790,0.0167546244732707,0.00401937040546506,0.00887665847855915,0.0246325904679822,3.08271406184461e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF3,Granulocyte colony-stimulating factor,39587,0.0196914005845543,0.00472653878259209,0.0104273845706738,0.0289554165984348,3.1146116708005e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0356935102996609,0.00859160371765958,0.0188539670130482,0.0525330535862737,3.2810994850486e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0348428387427286,0.00838910582354928,-0.0512854861568852,-0.018400191328572,3.29407990894449e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUP50,Nuclear pore complex protein Nup50,37021,-0.0135291029094521,0.00326026224096763,-0.0199192169017487,-0.0071389889171556,3.35008070932189e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.0140689745551717,0.00339392585615329,0.00741687987711127,0.0207210692332322,3.41047078088373e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.013459380084984,0.00326403029332213,0.00706188071007267,0.0198568794598954,3.74963641050156e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.0092811011069806,0.00226326174755029,0.00484510808178204,0.0137170941321792,4.13838751452198e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH6,Cadherin-6,39868,-0.0153654416725411,0.00374878188126735,-0.0227130541598251,-0.00801782918525708,4.17376964206993e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFAP,Glial fibrillary acidic protein,39453,0.017597797926538,0.00431041448780541,0.00914938553043943,0.0260462103226366,4.47522691355384e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0264906927831954,0.00649266207619319,-0.0392163104525341,-0.0137650751138568,4.5275083734288e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB44,Ras-related protein Rab-44,37368,0.0169064491488414,0.00416674542752987,0.00873962811088286,0.0250732701867999,4.98859696900228e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD160,CD160 antigen,40058,0.0179096601028892,0.00441903001552344,0.00924836127246325,0.0265709589333152,5.08339476703415e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0269957239337066,0.00666375154027233,0.0139347709147729,0.0400566769526404,5.12558610957767e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECM1,Extracellular matrix protein 1,37106,0.0144334190940287,0.00357015377601012,0.00743591769304881,0.0214309204950085,5.31153978298943e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPS10,40S ribosomal protein S10,37021,-0.0170790471074976,0.00423295535737992,-0.0253756396079623,-0.00878245460703296,5.49621607028983e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP2,Guanylate-binding protein 2,39587,0.0235029863321141,0.00584330370185351,0.0120501110764812,0.034955861587747,5.79243374356279e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17RA,Interleukin-17 receptor A,39858,0.0174759019656607,0.00434580202455074,0.00895812999754128,0.0259936739337802,5.81361562137624e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MERTK,Tyrosine-protein kinase Mer,40058,0.0100441159136172,0.00249798779633464,0.00514805983280126,0.0149401719944331,5.82431482812456e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.0171331773394847,0.00426482625658591,0.00877411787657629,0.0254922368023931,5.9187030147226e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEO1,Neogenin,37411,0.00855612732846443,0.00213070095092155,0.0043799534646582,0.0127323011922707,5.96043322785197e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0215293538191908,0.00536965486846889,-0.0320538773613898,-0.0110048302769918,6.11374965453585e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0100247843760876,0.00250151756620726,0.00512180994632136,0.0149277588058538,6.16483848860274e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPON1,Spondin-1,39885,0.012582736734527,0.00314018432784386,0.00642797545195301,0.0187374980171009,6.17712943173016e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAFB2,Scaffold attachment factor B2,37411,0.0107953209863042,0.00270258496048458,0.00549825446375444,0.016092387508854,6.51891741425364e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAM,Basal cell adhesion molecule,39858,-0.00926406812508613,0.00232201899055531,-0.0138152253465745,-0.00471291090359772,6.64625322205574e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPEP1,Dipeptidase 1,39713,-0.0185894817180568,0.00466854956808334,-0.0277398388715002,-0.0094391245646135,6.86848935656896e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHNAK2,Protein AHNAK2,37043,0.0114123065776624,0.00289595718965279,0.00573623048594291,0.0170883826693818,8.16389007227537e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0226765168512621,0.00575810947234198,0.0113906222854718,0.0339624114170524,8.24533919525908e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOC,Brother of CDO,39585,-0.00909377891305031,0.00231024115850533,-0.0136218515837208,-0.00456570624237986,8.31072976010464e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRAL,GDNF family receptor alpha-like,36942,-0.0240372221139821,0.00613652321162228,-0.0360648076087617,-0.0120096366192024,9.00853435673978e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYMP,Thymidine phosphorylase,39764,0.0261048245223874,0.00667869278107167,0.0130145866714869,0.0391950623732878,9.31892607039795e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST6,Cystatin-M,39524,0.0180579794273174,0.00462340330971618,0.00899610894027373,0.0271198499143611,9.43175338456195e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0187096566500303,0.0047913782137611,-0.0281007579490021,-0.00931855535105857,9.46676786744569e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCAN,Versican core protein,40009,-0.0113602822384836,0.00291448714925042,-0.0170726770510144,-0.00564788742595278,9.7435853040403e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA4,Apolipoprotein A-IV,37453,0.0135799379589322,0.0034903845786192,0.00673878418483852,0.0204210917330258,0.000100443965452803
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCP2,Non-specific lipid-transfer protein,39477,0.0298524272644706,0.00768907110991346,0.0147818478890402,0.044923006639901,0.000103835229705285
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD3,Bromodomain-containing protein 3,37021,0.0177534525638826,0.00457488189681588,0.00878668404612346,0.0267202210816417,0.000104691555676367
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,37437,-0.0150007865146136,0.00386757203833419,-0.0225812277097486,-0.0074203453194786,0.000105552480877989
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.0123511250871199,0.00318721783470314,-0.0185980720431381,-0.00610417813110178,0.000106969959434154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.0208935295059751,0.00539254397092576,0.0103241433229606,0.0314629156889896,0.000107270528951368
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP4,Bone morphogenetic protein 4,39720,-0.0175402164579026,0.00452903477417004,-0.0264171246152758,-0.00866330830052929,0.000108007336683337
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERC2,ERC protein 2,37039,0.0286091013136061,0.0073945427576732,0.0141157975085666,0.0431024051186456,0.000109832166226943
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.010315624147132,0.00267417129847173,0.00507424840212737,0.0155569998921365,0.000115082683036365
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALPP,"Alkaline phosphatase, placental type",39788,0.0401033430352513,0.0103968465670945,0.0197255237637461,0.0604811623067565,0.000115116475245266
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX3,Syntaxin-3,37388,0.0144118419305594,0.00374878234148327,0.00706422854125221,0.0217594553198666,0.000121397981094704
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PODXL,Podocalyxin,39788,0.00568620096727487,0.00148076654457386,0.00278389853991011,0.00858850339463962,0.000123491050934929
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QL2,Complement C1q-like protein 2,37056,0.0158868095070759,0.00414198613738906,0.00776851667779337,0.0240051023363585,0.000125864757684924
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0224345636447689,0.00585340283491513,0.0109618940883353,0.0339072332012026,0.000127296022864814
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00724036636932583,0.00188929178850977,-0.010943378274805,-0.00353735446384667,0.000127513216635615
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0167099031870603,0.00436295291384407,0.00815851547592588,0.0252612908981946,0.000128659129607204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.0115910793045381,0.00303275711211748,-0.0175352832442883,-0.00564687536478784,0.000133004101427986
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0120032111736185,0.00314180287427352,-0.0181611448071946,-0.00584527754004243,0.000133796889550851
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY6D,Lymphocyte antigen 6D,39761,0.0135722141866689,0.00356691660344694,0.00658105764391294,0.020563370729425,0.000142319798336746
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.0163649307229133,0.00431749232116342,0.00790264577343301,0.0248272156723936,0.000151081410966805
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0135714773046579,0.00359133610960266,0.00653245852983664,0.0206104960794791,0.000158168255446305
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSB,Lupus La protein,39489,0.0225965145693041,0.00598741354863446,0.0108611840139806,0.0343318451246276,0.000161242691471451
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYO6,Unconventional myosin-VI,37411,0.014201889868438,0.00376346248836426,0.00682550339124404,0.021578276345632,0.000161579203735167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,39928,0.0299121212777463,0.00793735887971248,0.0143548978735098,0.0454693446819827,0.00016480320494993
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,0.0154994847482169,0.00412462895107815,0.00741521200410368,0.02358375749233,0.000172022756745402
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.016143435523554,0.00429657001451206,0.00772215829511038,0.0245647127519977,0.000172391434125638
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.037784626553407,0.0100785203669953,0.0180307266340962,0.0575385264727178,0.000178152575117436
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.0109383685331659,0.00292583970491608,0.00520372271153032,0.0166730143548014,0.000185736772878532
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLPS,Colipase,39836,0.0254984068859407,0.00682868110853386,0.0121141919132143,0.038882621858667,0.000189104698794598
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK14,Kallikrein-14,40030,-0.0165859687101957,0.00444827894355671,-0.0253045954395669,-0.0078673419808246,0.00019318359616434
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO4,Roundabout homolog 4,37043,-0.0065316862199402,0.0017604578795314,-0.00998218366382174,-0.00308118877605866,0.000207930123755937
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA7A,Semaphorin-7A,40002,0.00984644964870814,0.00265521318872577,0.00464223179880562,0.0150506674986107,0.000209315993061072
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR101,Probable G-protein coupled receptor 101,36991,-0.0229192975964396,0.00618175488530408,-0.0350355371716356,-0.0108030580212436,0.000210117466834121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIM,Vimentin,39585,0.0427282460225103,0.0115621088720218,0.0200665126333476,0.0653899794116731,0.000220163763368027
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD86,T-lymphocyte activation antigen CD86,37382,0.0106771418566943,0.00289153070832742,0.00500974166837252,0.016344542045016,0.000222884226399787
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,37056,0.0396648153406956,0.0108156983255609,0.0184660466225962,0.060863584058795,0.000246052459548974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPS,Calcyphosin,37388,0.0314515532412692,0.00858054707155779,0.014633680981016,0.0482694255015225,0.000247850164986473
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMNB1,Lamin-B1,37348,0.0209573058502761,0.00571994788113535,0.00974620800325078,0.0321684036973013,0.000249357398069005
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TERF1,Telomeric repeat-binding factor 1,37056,-0.0105420555973102,0.00288358155477054,-0.0161938754446605,-0.00489023574995998,0.000257287175650913
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0182130498789921,0.00498657784217086,0.00843935730833719,0.027986742449647,0.000260794081773411
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DRAXIN,Draxin,39749,0.0151103806726042,0.00414370892328327,0.00698871118296901,0.0232320501622394,0.000266599031126026
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.0101009310469399,0.00277332663966867,-0.0155366512606904,-0.00466521083318927,0.00027120761109922
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NINJ1,Ninjurin-1,39477,0.0202695721899449,0.00556578315651222,0.00936063720318092,0.0311785071767088,0.000271594444288138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF8,SLAM family member 8,39477,0.0186818425017692,0.00513116232062457,0.00862476435334509,0.0287389206501934,0.000272607054804427
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00668291844755792,0.00183699558651071,0.00308240709799692,0.0102834297971189,0.000275822148219808
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD3,Extracellular superoxide dismutase,37445,-0.0218309600190071,0.00600797163978701,-0.0336065844329897,-0.0100553356050246,0.000280453274383814
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0253896886100679,0.00699282304593821,0.0116837554400291,0.0390956217801068,0.000283394726777095
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.0130727623294434,0.00362171109237124,-0.020171316070491,-0.00597420858839575,0.00030786087615065
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMP,Cartilage oligomeric matrix protein,39729,0.0119126991878956,0.00330132107671053,0.00544210987754293,0.0183832884982482,0.000308962001041033
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNGR1,Interferon gamma receptor 1,39931,0.00717104869029501,0.00199086707673561,0.00326894921989321,0.0110731481606968,0.00031676403868304
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.0128971541780275,0.00358879830046519,0.00586310950911576,0.0199311988469393,0.000326993720927442
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.013004766283101,0.00362751105657903,-0.0201146879539959,-0.00589484461220612,0.000338213184500768
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELAVL4,ELAV-like protein 4,36991,0.0298652306693306,0.00833612110474109,0.0135264333040381,0.0462040280346232,0.00034138399904366
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.0146419392868045,0.0040946803733494,-0.0226675128185693,-0.00661636575503966,0.000350350703107649
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.0184706567887465,0.0051782456071183,0.00832129539879467,0.0286200181786984,0.000362210652434219
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.0172557227229704,0.00483869757244767,-0.0267395699649678,-0.00777187548097295,0.000363260060866396
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTXR,Neuronal pentraxin receptor,39868,0.0119312238573665,0.00335164613662837,0.00536199742957494,0.0185004502851581,0.000372198185985441
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LHB,Lutropin subunit beta,39477,0.0310314018574977,0.00872662897095427,0.0139272090744273,0.0481355946405681,0.00037773854468712
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0131260706300149,0.00369692077459334,-0.0203720353482178,-0.00588010591181194,0.000385779469268224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.0245168161531655,0.00692985663110824,0.0109342971561934,0.0380993351501377,0.000404767861663057
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL3,Myosin light chain 3,37043,-0.0254266644215211,0.00718825780711151,-0.0395156497234596,-0.0113376791195825,0.000405706044244976
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0119868850105026,0.00339458343511075,0.00533350147768554,0.0186402685433197,0.000414878459714153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.01998706948562,0.00568319895518173,-0.0311261394377762,-0.00884799953346377,0.000438139029490699
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL28,C-C motif chemokine 28,39815,0.0206520903569887,0.00587313776533591,0.0091407403369303,0.0321634403770471,0.000438715306118747
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD200,OX-2 membrane glycoprotein,39866,-0.00889738872158678,0.00253602666163004,-0.0138680009783817,-0.0039267764647919,0.000452052569077787
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDI2,Protein DDI1 homolog 2,37124,0.0259582975788256,0.00741380379454595,0.0114272421415156,0.0404893530161357,0.000464434837490552
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00943824195478904,0.00269936286370934,0.00414749074191873,0.0147289931676593,0.000472719735695398
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,37056,0.0223952791770289,0.00640709905604548,0.0098373650271798,0.0349531933268781,0.000474932219317314
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0161374074785952,0.00461835046827167,-0.0251893743964077,-0.00708544056078274,0.000476771636305266
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAG,S-arrestin,36991,-0.0183164558122758,0.00524298121287934,-0.0285926989895193,-0.00804021263503233,0.000478268301894739
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLL4,Delta-like protein 4,37043,0.0296730308567755,0.00849755418804953,0.0130178246481985,0.0463282370653526,0.000481078811988993
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.0309758875300664,0.00887075401732956,0.0135892096561005,0.0483625654040323,0.000481145893869076
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RCC1,Regulator of chromosome condensation,37368,0.0174359883568066,0.00499697773466483,0.00764191199686354,0.0272300647167497,0.000485818121686582
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0254651002340466,0.00730020489900583,0.0111566986319952,0.0397735018360981,0.00048774867035926
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0205504463903149,0.00591092223123046,0.00896503881710315,0.0321358539635266,0.000509277344185909
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,40058,0.019568214458569,0.00564163697008209,0.00851060599720806,0.0306258229199299,0.000524664359778771
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0189028963121664,0.00545417501591035,0.00821271328098208,0.0295930793433506,0.000530362823684632
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,37043,0.012386058779643,0.0035787607121243,0.00537168778387935,0.0194004297754066,0.000539895351903616
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWF,von Willebrand factor,40052,-0.0248958590263128,0.00720196403392999,-0.0390117085328156,-0.0107800095198101,0.000548002429773104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD48,CD48 antigen,39908,0.00986004664300152,0.0028542023839861,0.00426580997038877,0.0154542833156143,0.000552591677453652
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,39489,0.0134713902033511,0.00390611681379839,0.00581540124830624,0.0211273791583959,0.000564581688753729
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0204074283570723,0.00593630481622466,0.00877227091727193,0.0320425857968726,0.000588109811656449
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.0175869305450064,0.00515535565238422,0.00748243346633335,0.0276914276236795,0.000647962278676435
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00944601962811074,0.00277585924202704,0.00400533551373774,0.0148867037424837,0.000668336956449903
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNXB,Tenascin-X,39858,-0.00859555013648798,0.0025366228817153,-0.01356733098465,-0.003623769288326,0.000704249336316311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0199185960096764,0.00587858370390871,0.00839657195001535,0.0314406200693375,0.000705260539558501
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NME1,Nucleoside diphosphate kinase A,37056,-0.00729328451791113,0.00215466960052845,-0.0115164369349469,-0.00307013210087537,0.000714184297104726
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.0121720822022829,0.00359612275036987,0.00512368161155799,0.0192204827930079,0.000714432214291731
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKCQ,Protein kinase C theta type,39587,0.0144317369913305,0.00427510830351459,0.0060525247164419,0.0228109492662191,0.0007379035777353
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.0163127666645122,0.00483293374697774,0.00684021652043581,0.0257853168085885,0.00073905498122763
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EXTL1,Exostosin-like 1,37021,0.0158310868243316,0.00470894630808939,0.00660155206047644,0.0250606215881869,0.000776237921454461
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.0131427923021857,0.00391515403151116,0.00546909040042386,0.0208164942039476,0.000790439731977051
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTF3,Neurotrophin-3,39866,0.0111301221628728,0.00331875703104183,0.00462535838203085,0.0176348859437148,0.000799231708520467
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP290,Centrosomal protein of 290 kDa,37169,0.017165633934952,0.00511854399488213,0.00713328770498298,0.0271979801649209,0.000799853646940187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN1,Nectin-1,37056,0.0106106526225076,0.00316676195334463,0.00440379919395212,0.0168175060510631,0.000808536400091257
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDS,Iduronate 2-sulfatase,40058,0.00296707937821599,0.000887505592970515,0.00122756841599378,0.0047065903404382,0.000830157220501196
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.0610869539894741,0.018414689711071,0.0249941621557749,0.0971797458231734,0.000910969915487533
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,40030,0.0191162555273202,0.00577816399998569,0.00779105408734823,0.0304414569672921,0.000940484717438601
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANSC4,MANSC domain-containing protein 4,37021,0.0202797662553725,0.00614461071065513,0.00823632926248845,0.0323232032482566,0.000967986223192943
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",39842,0.0212678151585617,0.00644541625550752,0.00863479929776692,0.0339008310193564,0.000970066697313673
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.00692231972968957,0.00210885155521549,0.00278897068146721,0.0110556687779119,0.00103149451285752
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLIC5,Chloride intracellular channel protein 5,37039,-0.0103304196828841,0.00316247733010835,-0.0165288752498965,-0.00413196411587177,0.00109141272470172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBA,Lysosomal acid glucosylceramidase,37039,0.0169312572539578,0.00519632585422997,0.00674645857966704,0.0271160559282485,0.00112360435766865
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD58,Lymphocyte function-associated antigen 3,39835,-0.00557559354295888,0.00171692751136032,-0.0089407714652251,-0.00221041562069266,0.00116694558517315
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA4,Ephrin type-A receptor 4,37124,0.00901230351728719,0.00277755173263567,0.00356830212132127,0.0144563049132531,0.0011786846688544
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0234829818143603,0.00723760770580842,0.00929727071097581,0.0376686929177448,0.00117909492446876
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,39788,0.00831281584440221,0.00256462016883645,0.00328616031348276,0.0133394713753217,0.00119212054984673
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00905509728699226,0.00280542007939204,0.00355647393138386,0.0145537206426007,0.00125080824055029
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,36962,-0.0129891907543162,0.00402726447429211,-0.0208826291239288,-0.00509575238470372,0.00126143453115585
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.0136271301870404,0.00422512395315794,-0.02190837313523,-0.00534588723885083,0.00126165639460115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR158,Probable G-protein coupled receptor 158,37411,0.011339642057017,0.00351884694311583,0.00444270204850995,0.018236582065524,0.00127357678925869
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,39868,-0.00852217204157775,0.0026448252323921,-0.0137060294970663,-0.00333831458608923,0.00127462058037024
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.011525554996695,0.00357760961939889,0.00451344014267315,0.0185376698507168,0.00127795128214485
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CADPS,Calcium-dependent secretion activator 1,37039,-0.0137502567793077,0.00427446608110371,-0.022128210298271,-0.00537230326034445,0.00129925665761028
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMOD4,Tropomodulin-4,36962,-0.0129369793144579,0.00402379680913227,-0.0208236210603571,-0.00505033756855862,0.00130707315052759
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.0221639212695921,0.00690975139888878,0.00862080852777005,0.0357070340114141,0.0013410354007852
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.0109267130536007,0.00340816205553221,-0.0176067106824439,-0.00424671542475762,0.00134896215424714
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA2,GDNF family receptor alpha-2,39788,0.00657014999959262,0.00205013732748702,0.00255188083771806,0.0105884191614672,0.00135452552568204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPA2,Replication protein A 32 kDa subunit,37056,0.0100994333025683,0.003152165469351,0.00392118898264031,0.0162776776224962,0.00135870294328336
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FMR1,Synaptic functional regulator FMR1,39477,0.0112334677986613,0.00351163051190681,0.00435067199532391,0.0181162636019986,0.00138213002953349
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.0172608963844274,0.00539652861208133,0.00668370030474799,0.0278380924641068,0.00138411123552678
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP1,Methionine aminopeptidase 1,39489,0.00959969881089923,0.00300683043970263,0.00370631114908208,0.0154930864727164,0.00141262393652969
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDK1,Cyclin-dependent kinase 1,36962,0.0113982653287957,0.00357075341060051,0.00439958864401875,0.0183969420135727,0.00141567237736311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD109,CD109 antigen,39858,-0.0106128295613217,0.00332786212323982,-0.0171354393228718,-0.00409021979977169,0.00142999743556445
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.00839937059960661,0.00265226765497094,0.00320092599586356,0.0135978152033497,0.00154433425236535
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD99,CD99 antigen,39858,-0.00597975415076109,0.00188834044403843,-0.00968090142107642,-0.00227860688044576,0.00154483800835374
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMBN,Ameloblastin,39587,-0.00889399691416601,0.00281292325965289,-0.0144073265030857,-0.00338066732524635,0.00157076544203431
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDHB15,Protocadherin beta-15,37368,-0.0123446482544423,0.00392109833137133,-0.0200300009839302,-0.00465929552495454,0.00164601401509813
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH4,Myosin-4,37021,-0.0147682508528604,0.00471303446957426,-0.024005798413226,-0.00553070329249488,0.00173119515406081
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARG1,Arginase-1,39754,0.0159510394802376,0.00509691842455196,0.00596107936811575,0.0259409995923594,0.00175393594410443
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100G,Protein S100-G,37411,-0.0138630082510199,0.00443186168879652,-0.0225494571610611,-0.00517655934097877,0.00176353465673469
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIFR,Leukemia inhibitory factor receptor,39866,-0.00751773368097096,0.00240503230807586,-0.0122315970047997,-0.00280387035714226,0.00177618311940302
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EP300,Histone acetyltransferase p300,37056,0.00911817806313025,0.00292091911809285,0.00339317659166827,0.0148431795345922,0.00180209940023006
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCLRE1C,Protein artemis,36962,-0.00954002854962453,0.00306122501192036,-0.0155400295729884,-0.00354002752626062,0.00183464026326264
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM171B,Protein FAM171B,37368,0.00851874673429157,0.00273473655067372,0.00315866309497108,0.0138788303736121,0.00184320256626836
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QSOX1,Sulfhydryl oxidase 1,37186,0.0129050756568094,0.00414384265671623,0.00478314404964561,0.0210270072639733,0.00184786926900874
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.00735394379821128,0.00236956625551017,0.00270959393741134,0.0119982936590112,0.00191579227942984
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THY1,Thy-1 membrane glycoprotein,40009,0.00825960557522303,0.00266270839986592,0.00304069711148584,0.0134785140389602,0.00192577632399003
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1R1,Interleukin-1 receptor type 1,39826,-0.00687511196033337,0.00221679595567566,-0.0112200320334577,-0.00253019188720908,0.00192960878338448
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G1B,Phospholipase A2,40031,-0.012450505696973,0.00402727684542175,-0.0203439683139996,-0.00455704307994637,0.00199456704717392
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.0108597517823745,0.00351291549947753,0.00397443740339853,0.0177450661613505,0.0019963289610114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM3,Intercellular adhesion molecule 3,40052,-0.00770328482654623,0.00249613395646328,-0.0125957073812143,-0.0028108622718782,0.00203152138407668
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH12,Protocadherin-12,37411,0.00769630377942832,0.00249632814717733,0.00280350061096075,0.0125891069478959,0.00205302553735715
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSC2,Desmocollin-2,39673,-0.0101044449183012,0.00328394531295676,-0.0165409777316965,-0.003667912104906,0.00209507170291579
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0120439160087529,0.00391669716786688,-0.019720642457772,-0.00436718955973382,0.00210907590377024
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0211875771233555,0.00690856274043608,0.00764679415210078,0.0347283600946102,0.00216685522452407
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.0366000375431423,0.011944711580826,0.0131884028447233,0.0600116722415613,0.00218680283976053
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEDD9,Enhancer of filamentation 1,37056,0.0101015361385826,0.00329669923340691,0.00364000564110502,0.0165630666360601,0.00218739678273133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHB4,Ephrin type-B receptor 4,40052,-0.00707906241324247,0.00231554166953312,-0.0116175240855274,-0.00254060074095756,0.00223783075188612
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF1,Trefoil factor 1,39789,0.0226728742820386,0.007420096117925,0.00812948589090557,0.0372162626731716,0.00224979273353087
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF2,Trefoil factor 2,39908,0.0171493599697367,0.00562621817285349,0.00612197235094386,0.0281767475885295,0.00230656435915935
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX2,Peroxiredoxin-2,37249,0.0182184772730985,0.00600426421432341,0.00645011941302463,0.0299868351331724,0.00241591849944973
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH7B,Myosin-7B,36962,-0.0131388120696787,0.0043399240791434,-0.0216450632647998,-0.00463256087455769,0.00247123082816907
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.00890257102591692,0.00295681728981801,-0.0146979329139602,-0.00310720913787363,0.00261002915751984
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.0094073222441305,0.00313242340222449,-0.0155468721124905,-0.00326777237577051,0.00267650207400029
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPP1,Osteopontin,40012,-0.0132919841303801,0.0044366098548742,-0.0219877394459335,-0.0045962288148267,0.00273981625026336
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CENPJ,Centromere protein J,37169,0.0213284122147421,0.00716442029014886,0.00728614844605032,0.0353706759834339,0.00291616779784156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPH3,Neurexophilin-3,37056,0.00872982114576295,0.00293330471755661,0.00298054389935199,0.0144790983921739,0.00292464772884821
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00872765131469015,0.00293436580362295,0.00297629433958918,0.0144790082897911,0.00294199841022239
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PADI2,Protein-arginine deiminase type-2,39587,0.0166402403472347,0.00561835490627238,0.0056282647309408,0.0276522159635285,0.00306339516108831
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.013240723963614,0.00447147487208835,0.00447663321432086,0.0220048147129072,0.00307022039585893
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNN,Tenascin-N,37437,0.0125413564223353,0.00423998515942775,0.00423098550985686,0.0208517273348137,0.00310299071095668
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0169542878970916,0.00575866603094491,0.00566730247643957,0.0282412733177436,0.00324418882278512
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0849765652953499,0.0289943910252522,0.0281475588858556,0.141805571704844,0.00338575748861023
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00651915910574071,0.00223131885309919,0.0021457741536663,0.0108925440578151,0.00348650351547649
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH23,Cadherin-23,37388,-0.00772708085070483,0.00264900444570531,-0.0129191295642872,-0.00253503213712242,0.00354024704366699
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RALB,Ras-related protein Ral-B,37056,0.00841918448638461,0.00288706988468661,0.00276052751239885,0.0140778414603704,0.00354954834294528
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSTL1,Follistatin-related protein 1,37043,-0.00657294840265188,0.00226323910093905,-0.0110088970404924,-0.00213699976481134,0.00368778521625901
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.0150868597165016,0.00519872836936098,-0.0252763673204491,-0.00489735211255406,0.00371370753838676
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0101114056990575,0.00350182715075918,-0.0169749869145455,-0.0032478244835695,0.00388873736176975
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.0198312846497936,0.00687725744848598,0.00635186005076108,0.0333107092488261,0.00393671130311943
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHGA,Chromogranin-A,37437,-0.022247732463323,0.00773224507002315,-0.0374029328005683,-0.00709253212607758,0.00401761412823712
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.0103461711560257,0.00360489698902017,-0.0174117692545053,-0.0032805730575462,0.00411083661919643
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RYR1,Ryanodine receptor 1,37021,-0.00957147160277226,0.00333880439582418,-0.0161155282185877,-0.00302741498695687,0.00415386504219156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP152,Centrosomal protein of 152 kDa,36962,0.0117864258507239,0.00411731815976509,0.00371648225758433,0.0198563694438635,0.00420785298181786
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,37169,0.0147778857651329,0.00520098458412245,0.00458395598025289,0.0249718155500129,0.0044989379178104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTP1,Glutathione S-transferase P,39393,-0.0194305318287653,0.00684808192529362,-0.0328527724023408,-0.00600829125518982,0.0045545990796332
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BEX3,Protein BEX3,36962,-0.0130458397185548,0.00461700898115158,-0.0220951773216119,-0.00399650211549775,0.0047262923564375
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN2B,Sodium channel subunit beta-2,37039,-0.00803427143023431,0.00284357738702408,-0.0136076831088015,-0.0024608597516671,0.00472911677292192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,37124,0.00790765842171929,0.00279876915125532,0.00242207088525886,0.0133932459581797,0.00472913124721457
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",36991,0.0181611150539044,0.00642926930099796,0.00555974722394838,0.0307624828838604,0.00473880116761264
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.017100406611663,0.00606138611944767,0.0052200898175456,0.0289807234057805,0.00479050412536977
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.00919229711296114,0.00325898531661987,-0.0155799083335361,-0.00280468589238619,0.00479930413468082
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,39858,0.00935076638109801,0.00331808550865109,0.00284731878414187,0.0158542139780541,0.00483648686486619
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNR,Tenascin-R,39749,-0.0116305248160146,0.00413546434528099,-0.0197360349327653,-0.0035250146992638,0.00492356474745133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.0112991216392196,0.00402661793869637,-0.0191912927990645,-0.00340695047937473,0.00502176446708028
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUK1,Guanylate kinase,37021,-0.0113375008211266,0.00408695657813196,-0.0193479357142652,-0.00332706592798795,0.00554378825196166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDRG1,Protein NDRG1,39489,0.018949266621869,0.00683359651533864,0.00555541745180523,0.0323431157919327,0.00556153367048998
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,-0.00719258139549129,0.00260966090407602,-0.0123075167674803,-0.0020776460235023,0.0058555118659719
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASPN,Asporin,37437,0.00733087908660604,0.00266156193275648,0.00211421769840333,0.0125475404748087,0.00588867196044419
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,37169,0.0185656385648493,0.00678136761879379,0.00527415803201342,0.0318571190976851,0.00619446851751645
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.0174646555492947,0.00639569382115138,0.00492909565983802,0.0300002154387514,0.00632836559938058
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP7,Retinoid-binding protein 7,37382,0.016166137885051,0.00594783223991439,0.00450838669481879,0.0278238890752832,0.00657638696055721
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMMD9,COMM domain-containing protein 9,37368,0.0105099717143489,0.00387346672895041,0.00291797692560614,0.0181019665030918,0.00666963090815015
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00786703935347105,0.00290540941103155,0.00217243690784921,0.0135616417990929,0.00678342349571959
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP164,Centrosomal protein of 164 kDa,39587,0.0161574606758621,0.00596966525449224,0.00445691677705729,0.0278580045746669,0.00680506730974115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM26,Tripartite motif-containing protein 26,36962,0.0149122126914187,0.00551054300294725,0.00411154840564208,0.0257128769771953,0.00681617485525219
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00793135358925105,0.00293186489787105,0.00218489838942379,0.0136778087890783,0.00683458147215544
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.039783139364097,0.0147184562670267,0.0109349650807247,0.0686313136474694,0.00688011790346232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,36962,0.0113621440253351,0.00420782785263838,0.00311480143416385,0.0196094866165063,0.00693785276560793
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,39866,0.016511470083952,0.00612082950332351,0.00451464425743792,0.0285082959104661,0.00699172085849315
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGMA,Repulsive guidance molecule A,40009,-0.0082340884637196,0.00305302315717478,-0.0142180138517822,-0.00225016307565704,0.00700340163590133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA6,Corticosteroid-binding globulin,37453,0.00468178881170674,0.00173609879798411,0.00127903516765789,0.00808454245575559,0.0070110424327819
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCB,Calcitonin gene-related peptide 2,37388,0.0103884303403695,0.00388251658422658,0.0027786978352854,0.0179981628454536,0.00746642579198575
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.00773237535904239,0.00289029451324751,0.00206739811307726,0.0133973526050075,0.00747397463671818
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,0.00917310414293601,0.00343465088995169,0.00244118839863069,0.0159050198872413,0.00757578571900914
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00708539931116568,0.00265336617183883,0.00188480161436157,0.0122859970079698,0.0075851591152093
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.0119858112389553,0.00449337486141291,0.00317879651058597,0.0207928259673246,0.00765096470416444
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM19,Probable RNA-binding protein 19,37021,-0.0125059020580772,0.00468975550015405,-0.0216978228383791,-0.00331398127777528,0.00767067574847211
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,37169,0.0121169268226175,0.00455153616754373,0.00319591593423181,0.0210379377110032,0.00777338021749132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC12A2,Solute carrier family 12 member 2,37021,-0.00731043878474433,0.00274768762278597,-0.0126959065254048,-0.00192497104408383,0.00781011301974035
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK15,Kallikrein-15,37351,0.0132025648152504,0.00497238559963001,0.00345668903997559,0.0229484405905252,0.0079359861150757
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00826872787928155,0.003115484585599,-0.0143750776670556,-0.00216237809150751,0.00796039962761046
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL19,Interleukin-19,39419,0.0179548023839975,0.00676611449728607,0.0046932179693168,0.0312163867986782,0.00797106912559505
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,37169,-0.0115831376146725,0.00436732609839227,-0.0201430967675214,-0.00302317846182367,0.00800577279913863
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.0186771429970562,0.00704527996836187,-0.0324858917350455,-0.00486839425906696,0.0080346572509801
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNLZ,DNL-type zinc finger protein,36991,-0.0234214420452239,0.00886244776985846,-0.0407918396741465,-0.00605104441630132,0.00823276085057708
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",37021,0.0146817426235613,0.00555916032793558,0.00378578838080752,0.025577696866315,0.00827593484623444
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM1,Myomesin-1,36991,0.0123496005524636,0.00467665281080816,0.00318336104327963,0.0215158400616476,0.00828347601570858
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSMB,Beta-microseminoprotein,39780,0.0173932514166484,0.00661448623491223,0.00442885839622047,0.0303576444370764,0.00855752442387276
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.0137380151931089,0.0052363209520729,0.00347482612704604,0.0240012042591718,0.00871059626998572
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO1,Alpha-enolase,39830,0.0203999935718619,0.00779433757017455,0.00512309193431982,0.0356768952094041,0.0088716152096383
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA10,Annexin A10,39489,0.0201369194774382,0.00773072684378288,0.00498469486362372,0.0352891440912526,0.00920176464629494
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD33,Myeloid cell surface antigen CD33,39913,0.0201210834237591,0.00773583966916384,0.00495883767219798,0.0352833291753202,0.00930319338541972
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX5,Syntaxin-5,37056,0.0104473933129001,0.00401952283264639,0.00256912856091323,0.0183256580648871,0.00935554996186218
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.0149636228059296,0.00576245704529107,0.00366920699715914,0.0262580386147001,0.00942170790539739
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,37056,0.00516136122190672,0.0019884937693898,0.00126391343390272,0.00905880900991072,0.00945267858386864
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.0156677204282822,0.00607818932781948,-0.0275809715108083,-0.00375446934575598,0.00995696408750705
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0158961566429953,0.00618951332790385,-0.0280276027656869,-0.00376471052030381,0.0102325466902588
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00365634158727945,0.00142722747985051,0.000858975726772447,0.00645370744778645,0.0104223720639314
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0171757633613265,0.00675138304225178,0.00394305259851298,0.0304084741241399,0.0109692707428729
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3GL3,Endophilin-A3,37083,0.0207040346214101,0.00814511923308426,0.00473960092456498,0.0366684683182553,0.0110366541845813
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNL1,Thioredoxin-like protein 1,36971,0.024459288914919,0.00965344388765249,0.00553853889512015,0.0433800389347179,0.0112968826980646
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.0102867004696249,0.00406093821290734,-0.0182461393669233,-0.00232726157232649,0.0113178760621095
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00664056060127313,0.00262282490236724,-0.0117812974099129,-0.00149982379263334,0.0113582432611348
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN2,Contactin-2,40030,0.0110519263161815,0.00436803023504296,0.00249058705549733,0.0196132655768657,0.0114096370386911
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TUBB3,Tubulin beta-3 chain,36991,-0.00701972898132158,0.00277755726752046,-0.0124637412256617,-0.00157571673698147,0.0115058636957657
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.0126422001434251,0.00500820129269233,-0.0224582746771021,-0.00282612560974816,0.011604571364381
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL5,Fc receptor-like protein 5,39858,-0.0138387623981407,0.00551251279350555,-0.0246432874734116,-0.00303423732286981,0.012068301423692
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMG4,Proteasome assembly chaperone 4,37056,0.0136483672236256,0.00547252176460823,0.00292222456499346,0.0243745098822577,0.0126440603876769
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.0124718008527809,0.00500721071863246,0.00265766784426125,0.0222859338613005,0.0127590123036634
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA1,Alpha-1-antitrypsin,37247,-0.00198071245678861,0.00079800479361501,-0.00354480185227403,-0.00041662306130319,0.013073930848147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGN,Mimecan,39858,0.00966133480556955,0.00389522532136344,0.0020266931756972,0.0172959764354419,0.0131373259476647
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHGB,Secretogranin-1,39952,0.00964406843985119,0.00388950112651281,0.00202064623188608,0.0172674906478163,0.0131663543238386
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESPL1,Separin,36962,-0.0131423990552893,0.00530793453258908,-0.0235459507391639,-0.00273884737141475,0.0132992252351968
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSC1,Hamartin,37056,0.0186577833894554,0.00754355100020985,0.00387242342904404,0.0334431433498667,0.0133980835950985
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA3G,Semaphorin-3G,37124,0.010682548015138,0.00432343726464808,0.00220861097642774,0.0191564850538482,0.01349185584982
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEG1,Protein LEG1 homolog,36703,-0.0169950091222622,0.00690275123312864,-0.0305244015391943,-0.00346561670533005,0.0138270738625774
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",37021,0.0154194944388363,0.0062636891336192,0.0031426637369427,0.02769632514073,0.0138397045164411
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.009077584123138,0.00369977463119831,0.00182602584598931,0.0163291424002867,0.0141582011855233
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00725204921738813,0.00298118974130537,-0.0130951811103467,-0.0014089173244296,0.0150016405807204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,39866,0.00830922245982124,0.00341612527668226,0.00161361691752401,0.0150048280021185,0.0150119658932071
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.00854306062311421,0.00353609287908689,0.00161231858010392,0.0154738026661245,0.015707139708457
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RLN1,Prorelaxin H1,37411,-0.0191944525837044,0.00795726927622413,-0.0347907003651037,-0.00359820480230508,0.0158701763401061
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SULT1A1,Sulfotransferase 1A1,40009,-0.0306406394633797,0.0127223272391118,-0.0555764008520388,-0.00570487807472052,0.0160331017264902
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-0.0116332626267435,0.00484063279601141,-0.0211209029069258,-0.00214562234656109,0.016263638291861
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00599425146450196,0.00250069158362658,-0.0108956069684101,-0.00109289596059386,0.0165417140698825
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.0138438143812976,0.00577617310590095,0.00252251509373173,0.0251651136688634,0.0165544283218342
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM25,Transmembrane protein 25,37411,-0.0104637178207533,0.00441505416845523,-0.0191172239909256,-0.00181021165058107,0.0178015764211108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.00672804238139789,0.00284167417903829,-0.0122977237723129,-0.00115836099048283,0.0179166786104722
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB39B,Ras-related protein Rab-39B,37021,0.0206984479324983,0.00875251244553034,0.00354352353925884,0.0378533723257378,0.0180514160605875
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL11,Interleukin-11,39587,0.0145020088674893,0.00613476539316688,0.00247786869688217,0.0265261490380963,0.0180954838606878
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRR4,Proline-rich protein 4,37031,-0.016269464239631,0.00689600009849393,-0.0297856244326791,-0.00275330404658292,0.0183258830493766
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00870481945011211,0.00372621504656528,0.00140143795884416,0.0160082009413801,0.0194987113849983
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PXDNL,Peroxidasin-like protein,37368,0.0137039847694293,0.00587314605063763,0.0021926185101795,0.025215351028679,0.0196454566204907
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCND2,G1/S-specific cyclin-D2,37169,0.00845929989025083,0.00362988547872186,0.00134472435195598,0.0155738754285457,0.019796761035314
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00697038733562842,0.00300540305383806,-0.012860977321151,-0.00107979735010583,0.0203924027865135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.014155150154935,0.00612022881041928,0.00215950168651318,0.0261507986233568,0.0207439185567343
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRTN,Neurturin,39587,0.0113029672098797,0.00489437434362443,0.0017099934963758,0.0208959409233836,0.0209354293474588
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.00688979492132646,0.00298883508269572,0.00103167815924285,0.0127479116834101,0.0211717024457263
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACHE,Acetylcholinesterase,37124,0.0074278950792568,0.00322640345400663,0.0011041443094038,0.0137516458491098,0.021338100575909
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH17,Cadherin-17,39868,-0.0150750271507818,0.00654914664443028,-0.0279113545738652,-0.0022386997276985,0.0213574932199904
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEX33,Testis-expressed protein 33,37169,-0.00901179002141098,0.00391795402092774,-0.0166909799024294,-0.0013326001403926,0.0214564474835993
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPN1,Epsin-1,37169,0.00976333417727874,0.00424949124493977,0.00143433133719678,0.0180923370173607,0.021603986885402
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS5,Transmembrane protease serine 5,39667,-0.00859255033729831,0.003750282844583,-0.015943104712681,-0.00124199596191562,0.021966448976662
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,37368,0.0084237486294367,0.00371910258175686,0.00113430756919325,0.0157131896896801,0.0235287595367533
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,36430,0.0115675897868231,0.00510997854265196,0.00155203184322528,0.021583147730421,0.0236079618794647
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,0.00771016642461135,0.00340735523410152,0.00103175016577236,0.0143885826834503,0.0236612688126582
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.0153572702210537,0.00680529054243815,0.00201890075787488,0.0286956396842324,0.0240426841996152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00721299432283792,0.00319870379790303,-0.0134824537667279,-0.000943534878947986,0.0241513525495496
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX1B,Syntaxin-1B,37039,0.00943766335813626,0.00419283011550054,0.0012197163317552,0.0176556103845173,0.0244079500230077
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCUN1D2,DCN1-like protein 2,36962,-0.0178182409605919,0.00793312321409428,-0.0333671624602167,-0.0022693194609671,0.0247169983457661
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.0191497491373166,0.00852984344463192,0.00243125598583809,0.0358682422887952,0.0247828576051369
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0142729538326718,0.00636041311355069,-0.0267393635352311,-0.00180654413011244,0.024846918634176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0143698150107398,0.00646938994635086,-0.0270498193055875,-0.00168981071589212,0.0263513424896848
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GKN1,Gastrokine-1,39123,0.0061289688991811,0.0027714467013629,0.000696933364509817,0.0115610044338524,0.0270181270128755
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,36962,-0.0080915143273791,0.0036644362620987,-0.0152738094010925,-0.000909219253665653,0.0272531764612064
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KEL,Kell blood group glycoprotein,39489,0.00771122643035183,0.00350096649868862,0.000849332092922136,0.0145731207677815,0.027637546400743
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGM2,Phosphoglucomutase-2,37039,0.013116610805237,0.00597329344318656,0.00140895565659139,0.0248242659538827,0.0281181947324523
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL36A,Interleukin-36 alpha,37056,-0.0127523690551352,0.0058090773757092,-0.0241381607115252,-0.00136657739874513,0.0281631210222657
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0155004140718702,0.00706867220406371,-0.029355011591835,-0.00164581655190531,0.0283368898873819
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSAP,Gamma-secretase-activating protein,39477,0.0190085316476281,0.00867959147941804,0.00199653234796873,0.0360205309472874,0.0285370832972825
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.0112516648589021,0.00513807492959581,0.00118103799689434,0.0213222917209099,0.0285516864602898
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.0053561870731731,0.0024468792788954,0.000560303686538124,0.0101520704598081,0.02861473982542
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLL1,Delta-like protein 1,39913,0.00612692214293251,0.00280092714485541,0.00063710493901591,0.0116167393468491,0.0287231756604879
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC39A14,Zinc transporter ZIP14,39489,0.0070276894663209,0.00322179849883769,0.00071296440859902,0.0133424145240428,0.0291765355682681
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROK1,Prokineticin-1,39866,0.0138688161413654,0.006385333066205,0.00135356333160361,0.0263840689511272,0.0298717981054305
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL36G,Interleukin-36 gamma,37021,0.0143394558871225,0.00665722898712332,0.00129128707236079,0.0273876247018842,0.0312608070459784
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COPE,Coatomer subunit epsilon,39489,0.0100528979820753,0.00466801017809867,0.000903598033001949,0.0192021979311487,0.0312889646822878
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00720459632558543,0.00335022005167033,0.000638165024311585,0.0137710276268593,0.031531729777505
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA5,Annexin A5,39415,0.0064179930767436,0.00298495517536676,0.000567480933024758,0.0122685052204624,0.031561587791313
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPTC,Opticin,39788,-0.00932304018323556,0.00434503261621253,-0.0178393041110121,-0.000806776255459005,0.0319137591008184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REST,RE1-silencing transcription factor,36962,-0.0075095015949505,0.00352122840345978,-0.0144111092657317,-0.000607893924169318,0.032973060698428
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPT2,Angiopoietin-2,40030,-0.00800386134533743,0.00375552274832204,-0.0153646859320486,-0.000643036758626221,0.0330857058714464
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17C,Interleukin-17C,39587,-0.0139574922978869,0.00654954901652139,-0.0267946083702688,-0.00112037622550502,0.0330995328931421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.0075543665082793,0.00356266394437553,0.000571545177303259,0.0145371878392553,0.0339882540046868
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00986774859661768,0.00465695976983717,-0.0189953897454985,-0.000740107447736827,0.0341154564052175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAMDC2,MAM domain-containing protein 2,37437,-0.00690271446638096,0.00326137893034974,-0.0132950171698665,-0.000510411762895466,0.0343202941865527
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00697029777469557,0.00330052997544027,-0.0134393365265585,-0.000501259022832652,0.0347161984565574
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MELTF,Melanotransferrin,37437,0.00604594261025647,0.00286649669768486,0.000427609082794141,0.0116642761377188,0.0349477556504281
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.00662526737583863,0.00314452562554929,0.000461997149762017,0.0127885376019152,0.0351427499192055
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.00418646766033676,0.00198974770361552,-0.00808637315942317,-0.000286562161250343,0.0353956798883576
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,37382,0.0103316184229606,0.00493975792688083,0.000649692886274122,0.020013543959647,0.0364997972780178
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.0062070602133735,0.00297127245428675,0.000383366202971466,0.0120307542237755,0.0367215745996288
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MN1,Transcriptional activator MN1,37039,-0.0121761243830884,0.00583851588257803,-0.0236196155129414,-0.000732633253235504,0.0370446897317643
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOC,Myocilin,39858,-0.00944556345707545,0.00453277130560943,-0.0183297952160699,-0.000561331698080961,0.0371906885733084
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN15,Tetraspanin-15,37021,-0.0101020529094151,0.00487111309528425,-0.0196494345761722,-0.000554671242657923,0.0381108321784037
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00652929834901741,0.00314901946504716,0.000357220197524979,0.0127013765005098,0.0381509360537793
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP10,Bone morphogenetic protein 10,37124,-0.00575321352687034,0.00279021910960773,-0.0112220429817015,-0.000284384072039191,0.039234619157516
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00809782080286972,0.00396417564139192,0.000328036545741568,0.0158676050599979,0.0410933885116776
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00774135223645882,0.00379901008653426,0.000295292466851659,0.015187412006066,0.0415964784737611
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG1B,Lithostathine-1-beta,40052,0.0108904520234137,0.00535617485108616,0.000392349315284852,0.0213885547315426,0.0420433683382294
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00780848232788107,0.00384344544072308,0.000275329264063832,0.0153416353916983,0.042210560827209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WNT9A,Protein Wnt-9a,39587,0.00561243805896738,0.00277304944592508,0.000177261144954218,0.0110476149729805,0.0429949667703889
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JCHAIN,Immunoglobulin J chain,39587,-0.012046604116479,0.00596922906991336,-0.0237462930935092,-0.000346915139448825,0.0435959973898226
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASA1,Ras GTPase-activating protein 1,39489,0.0064709717510112,0.00322134646817417,0.000157132673389834,0.0127848108286326,0.0445777883687594
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEF,Thyrotroph embryonic factor,37021,0.00839900911918294,0.00418439521335609,0.000197594501005002,0.0166004237373609,0.0447464640584056
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN3,Neuronal-specific septin-3,37411,-0.0150783329151452,0.00752947174639389,-0.0298360975380772,-0.000320568292213138,0.0452427968777409
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00738941190424517,0.00370325985424692,0.000131022589921195,0.0146478012185691,0.046021832349782
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PODXL2,Podocalyxin-like protein 2,39913,0.00538426340545663,0.00270834587332523,7.59054937391852e-05,0.0106926213171741,0.0468257143462477
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBQ1,Hemoglobin subunit theta-1,40030,-0.0117520777845657,0.00591218796466549,-0.02333996619531,-0.000164189373821318,0.0468538218641489
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,40030,-0.0109445362653509,0.00552654532802471,-0.0217765651082793,-0.000112507422422446,0.0476802776924522
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1,Integrin beta-1,39862,0.00423668390474015,0.00214220074798233,3.79704386947724e-05,0.00843539737078552,0.0479768713249181
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00953035154095724,0.00482102183213312,8.11487499763237e-05,0.0189795543319382,0.0480808965838206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA10,Ephrin type-A receptor 10,39489,0.0125020816720278,0.00632902229531703,9.71979732064358e-05,0.0249069653708492,0.0482451577130119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL31,Interleukin-31,37056,-0.0111624958772535,0.00567174602237702,-0.0222791180811124,-4.58736733944896e-05,0.0490788055088583
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACE,Angiotensin-converting enzyme,37445,-0.0049798422238701,0.00253051248711311,-0.0099396466986118,-2.00377491283944e-05,0.0490977288491982
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_A,,37411,0.0062521694739634,0.00318554840805019,8.49459418502882e-06,0.0124958443537418,0.0497053542846107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTNNA1,Catenin alpha-1,36991,-0.00679897768265245,0.0034662663363351,-0.0135928597018693,-5.09566343565027e-06,0.0498453106227968
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JUN,Transcription factor AP-1,39587,0.0100123144839497,0.00511778425019396,-1.85426464304559e-05,0.0200431716143299,0.0504384531298677
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00765783843885069,0.00391794604801774,-0.0153370126929655,2.13358152640715e-05,0.0506568381718973
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,37021,0.00762232389070142,0.00391973861241512,-6.03637896322215e-05,0.0153050115710351,0.0518444081022194
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCG3,Secretogranin-3,39885,-0.00621124762736431,0.00319677630480069,-0.0124769291847737,5.4433930045051e-05,0.0520370018475
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.00914159317764381,0.00471286345401161,-0.0183788055475066,9.56191922189421e-05,0.0524361578983602
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMIGO1,Amphoterin-induced protein 1,37039,0.00955560729604195,0.00492754796126759,-0.000102386708042518,0.0192136013001264,0.0524956796895852
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBX2,Chromobox protein homolog 2,37021,-0.00773506599196241,0.0039908587221742,-0.0155571490874238,8.70171034990236e-05,0.0526206854299202
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_DRA,,39799,-0.00676693829120214,0.00349799348765261,-0.0136230055270013,8.91289445969822e-05,0.0530669026266396
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOP56,Nucleolar protein 56,37021,0.0210042362380727,0.0108870698814678,-0.000334420729604195,0.0423428932057497,0.0537172413165302
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00938128541918453,0.00488257707598186,-0.000188565649739916,0.018951136488109,0.0547019975280347
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00483612391702166,0.00251833020683515,-0.00977205112241857,9.98032883752376e-05,0.0548321973523997
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOX9,Transcription factor SOX-9,37039,0.00511167810306683,0.0026658893263984,-0.000113464976674034,0.0103368211828077,0.0552038740306492
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPE4,NXPE family member 4,37021,-0.00660068963933505,0.00344767875094241,-0.0133581399911822,0.000156760712512074,0.0555739335871608
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAT1,Diamine acetyltransferase 1,37021,-0.00938198522955782,0.00490057914131136,-0.0189871203465281,0.000223149887412443,0.0555824783790399
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,39489,0.0101890386570953,0.00532562175253013,-0.0002491799778637,0.0206272572920544,0.0557392845014499
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELENOP,Selenoprotein P,37453,0.0041802525556236,0.00219215286840776,-0.000116367066455604,0.00847687217770281,0.0565524565085912
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6L,Seizure 6-like protein,39913,0.00506013490321973,0.0026543831737249,-0.000142456117281077,0.0102627259237205,0.0566250168695389
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLI2,Zinc finger protein GLI2,37056,-0.00647238253576006,0.00339606909300995,-0.0131286779580596,0.000183912886539444,0.056691978089395
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.00872853689584815,0.00458416952734498,-0.000256435377748008,0.0177135091694443,0.0569200383099931
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNL1,Interferon lambda-1,39489,0.00843320529798813,0.00442944400653522,-0.000248504954820901,0.0171149155507972,0.0569419431237266
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCUN1D1,DCN1-like protein 1,36991,-0.0140769354347051,0.00739902363188561,-0.0285790217532009,0.000425150883790696,0.0571225016360555
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGN,Secretagogin,39587,-0.00808031887437597,0.00424932929587116,-0.0164090042942834,0.000248366545531504,0.0572480587609847
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPT,Microtubule-associated protein tau,39489,0.00986976475298364,0.00519505453797353,-0.000312542141444478,0.0200520716474118,0.057472702008869
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.00618146149698865,0.00325445822670376,-0.012560199621328,0.000197276627350713,0.0575320700440991
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FZD8,Frizzled-8,36991,0.00795284153150887,0.004200838042906,-0.00028080103258689,0.0161864840956046,0.0583591000954471
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00934877800853619,0.004947943653886,-0.000349191553080377,0.0190467475701528,0.0588566049456209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00735108850556703,0.00389281396434241,-0.000278826864544089,0.0149810038756781,0.0589971053797846
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSN,Gelsolin,37383,-0.0034619601560377,0.00184000841253475,-0.00706837664460581,0.00014445633253041,0.0599265548195328
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAV,Integrin alpha-V,40030,-0.00306710576587137,0.00163038568780987,-0.00626266171397871,0.000128450182235972,0.0599606498096311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.0113674724174025,0.00604325780583388,-0.0232122577168369,0.000477312882031913,0.0599916751382403
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARB1,Scavenger receptor class B member 1,39489,0.0105415835410909,0.00562253977933702,-0.000478594426409662,0.0215617615085914,0.060827961498828
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MKI67,Proliferation marker protein Ki-67,37056,0.00725606171038166,0.00387917493192746,-0.00034712115619616,0.0148592445769595,0.0614342102466141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB2,Integrin beta-2,39731,-0.00529536570649567,0.00283369703645637,-0.0108494118979502,0.000258680484958807,0.0616811995409064
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.00877400647009725,0.00469640782422067,-0.000430952865375266,0.0179789658055698,0.0617504997777744
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.0121331318497318,0.00651307998425802,-0.0248987686188775,0.000632504919413948,0.062500482229134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00470268936315386,0.00252860805360834,-0.00965876114822621,0.00025338242191849,0.0629371124658045
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.00791381764885716,0.00426505833492651,-0.0162733319853131,0.000445696687598814,0.0635470775463704
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.005608709641785,0.0030233964974369,-0.000317147493191334,0.0115345667767613,0.0636003264745676
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00607773594469332,0.00328173332618904,-0.0125099332640238,0.000354461374637194,0.0640457286830488
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.0104988540934046,0.00569374019694431,-0.000660876692606279,0.0216585848794154,0.0652159667634959
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.0215078447064714,0.011703853155702,-0.00143170747870455,0.0444473968916473,0.0661292669465672
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP29,Dual specificity phosphatase 29,37039,-0.0120252094987059,0.00655650704815239,-0.0248759633130845,0.000825544315672808,0.0666634981137439
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAN,Neurocan core protein,40009,0.00663151860659103,0.00362014085117194,-0.000463957461705974,0.013726994674888,0.0669936786544911
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.00951953111160624,0.00519917368329855,-0.0197099115308714,0.000670849307658917,0.0671277706726315
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHODH,Dihydroorotate dehydrogenase,37021,0.00837538576381055,0.00457943909850093,-0.000600314869251262,0.0173510863968724,0.0674355842889341
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD5,Sushi domain-containing protein 5,37064,-0.00610176048731229,0.00334412214544686,-0.0126562398923881,0.000452718917763549,0.0680806020292604
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA11,Serpin A11,40052,-0.0073513327708567,0.00403289300942888,-0.0152558030693373,0.000553137527623903,0.0683455303550062
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TJP3,Tight junction protein ZO-3,36991,-0.00780307589083035,0.00428837505576106,-0.016208291000122,0.000602139218461324,0.0688445270420995
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C9orf40,Uncharacterized protein C9orf40,37382,0.0142332312816004,0.00782677297738047,-0.00110724375406527,0.0295737063172662,0.0690050861074628
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUCL3,Mucin-like protein 3,36962,-0.00806246760132619,0.00443748538306287,-0.0167599389521294,0.000635003749477022,0.069255249069785
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERVV_1,,37021,-0.00860557018685372,0.00474628271526008,-0.0179082843087635,0.000697143935056028,0.0698364078351636
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.0151274877110687,0.0083531112730673,-0.00124461038414317,0.0314995858062807,0.0701635514236597
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00535485232001979,0.00296310264763692,-0.0111625335093882,0.00045282886934857,0.0707574919358086
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HCG22,Protein PBMUCL2,37021,-0.00965859819926663,0.00534581601194052,-0.0201363975826701,0.000819201184136795,0.0708227809739281
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0151736609728433,0.00840670278144325,-0.031650798424472,0.00130347647878549,0.0711056352705462
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUMF1,Formylglycine-generating enzyme,37056,0.0120894456331542,0.00674938942091488,-0.00113935763183895,0.0253182488981474,0.0732855579544567
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00406762797320772,0.00227854320662462,-0.000398316711776546,0.00853357265819198,0.0742498910904178
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.0147418285109972,0.00826325440078526,-0.0309378071365363,0.00145415011454194,0.0744425136576769
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAGLN3,Transgelin-3,36962,-0.0104833189446635,0.00590038387965875,-0.0220480713487947,0.00108143345946761,0.0756378271537153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.00641507943040417,0.0036184658344074,-0.0135072724658427,0.000677113605034338,0.0762729220952941
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.0137088333819196,0.00773615960404112,-0.00145403944200101,0.0288717062058402,0.0764062238075095
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POF1B,Protein POF1B,37056,0.00790472308143538,0.00446642039252342,-0.000849460887910521,0.0166589070507813,0.0767816021435334
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0450293959501002,0.0254942557306633,-0.0949981371822002,0.00493934528199987,0.0773759586692636
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,37043,0.0102217286615272,0.00578848743140701,-0.00112370670403052,0.021567164027085,0.0774404456375941
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,39788,-0.0112841055509782,0.00639478659155457,-0.0238178872704252,0.00124967616846872,0.0776537253715053
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.0117211319671143,0.00666402557636709,-0.0247826220967938,0.00134035816256516,0.0786234064910482
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NLGN2,Neuroligin-2,36991,-0.00809480690830812,0.00465177325712592,-0.0172122824922749,0.00102266867565868,0.0818552164803658
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP6,Guanylate-binding protein 6,37021,-0.00787950788597925,0.00455618015541299,-0.0168096209905887,0.00105060521863022,0.0837590178591577
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA4C,Semaphorin-4C,39788,0.00482487116067554,0.00279075386567419,-0.000645006416045865,0.010294748737397,0.0838504250481905
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD27,CD27 antigen,39913,0.00662386472816928,0.00383526633812586,-0.000893257294557404,0.014140986750896,0.0841700542852512
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.0102394941766016,0.00593861046181327,-0.0218791706817556,0.00140018232855236,0.0846908479882904
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSP90B1,Endoplasmin,39405,0.0114617094161354,0.00665541805170987,-0.00158290996521597,0.0245063287974867,0.0850600313595036
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,39794,0.0044136474985067,0.00256380620208052,-0.000611412657571112,0.00943870765458451,0.0851756437602162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIP1,Huntingtin-interacting protein 1,37021,0.00569223655589179,0.00330930682419491,-0.000794004819530235,0.0121784779313138,0.0854433821353765
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00623666906057661,0.0036343847615996,-0.0133600631933118,0.000886725072158603,0.0861823124027053
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.00955059019845113,0.00556699315473373,-0.0204618967817292,0.00136071638482697,0.086263582034784
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNG,Uracil-DNA glycosylase,37368,0.00585369509941058,0.00342317678060237,-0.000855731390570062,0.0125631215893912,0.0872854451989354
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAP1A,Ras-related protein Rap-1A,37056,-0.0114587196910163,0.00671258007403127,-0.0246153766361176,0.00169793725408503,0.0878360112044484
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRG3,Proteoglycan 3,37437,-0.00839551461752906,0.00492990092220261,-0.0180581204250462,0.00126709118998805,0.088595005042338
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00535223659733521,0.00314777358803318,-0.000817399635209834,0.0115218728298802,0.0890896759540809
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.0146960099341701,0.00866713328800545,-0.00229157131032058,0.0316835911786608,0.0899850637576783
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF12,Fibroblast growth factor 12,37056,0.00781240727498986,0.00462614821885637,-0.00125484323396862,0.0168796577839484,0.0912909976460059
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00678302987421324,0.00401801692058947,-0.0146583430385686,0.00109228329014213,0.0914054870550023
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA3,Carbonic anhydrase 3,40017,0.0100076934147442,0.00594048395885188,-0.00163565514460552,0.0216510419740939,0.0920735761211685
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTN4,Alpha-actinin-4,39587,0.00520308742627932,0.00309574688911099,-0.000864576476378218,0.0112707513289369,0.0928369388401285
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.00808474527887782,0.0048154839858258,-0.0175230938910964,0.00135360333334074,0.0931898528967527
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTTG1,Securin,37169,0.00688460753006588,0.00411805866313962,-0.00118678744968777,0.0149560025098195,0.0945854994888298
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRDL2,Chordin-like protein 2,39868,0.00926375907615013,0.00555322327628288,-0.00162055854536432,0.0201480766976646,0.0953001625810623
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAPPA,Pappalysin-1,39587,0.00780047167865674,0.00467887648845472,-0.00137012623871451,0.016971069596028,0.0955009775040765
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP112,Centrosomal protein of 112 kDa,37021,0.00766280869474275,0.00460331466424344,-0.00135968804717439,0.0166853054366599,0.0960107035873
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.0075924203295354,0.00456933336435556,-0.0013634730646015,0.0165483137236723,0.0966161171068004
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00764679623476877,0.00460712047608476,-0.00138315989835735,0.0166767523678949,0.0969829880798682
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.00590772478878643,0.00356449980075837,-0.00107869482069998,0.0128941443982728,0.097466800661504
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00793122381629575,0.00482565368936755,-0.0173895050474561,0.00152705741486465,0.100292243630396
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00765003481727275,0.00466752751553394,-0.0167983887477193,0.00149831911317377,0.101239070518329
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM132A,Transmembrane protein 132A,37043,0.0101448415020002,0.00619128150672139,-0.00199007025117377,0.0222797532551741,0.101326931361686
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAD1,Glutamate decarboxylase 1,36962,-0.00418247141794344,0.00255883069118519,-0.00919777957266642,0.000832836736779533,0.102172793468384
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL33,Interleukin-33,39587,0.0063024848416255,0.00385931378254209,-0.00126177017215701,0.013866739855408,0.102476730086917
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAYN,Layilin,39713,0.00518192479488521,0.00318030429849808,-0.00105147163017102,0.0114153212199414,0.103252429943257
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0156273003681612,0.00960898881676009,-0.034460918449011,0.00320631771268859,0.103905326359491
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYB5A,Cytochrome b5,36962,0.0114977403026646,0.00707099899980271,-0.00236141773694873,0.0253568983422779,0.103964802403131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,39732,0.00629533816945054,0.00387427273551232,-0.0012982363921536,0.0138889127310547,0.104201941153353
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTN,Neuroplastin,39477,0.0134576306398456,0.00828269213350796,-0.00277644594182998,0.0296917072215212,0.104227613501135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK12,Kallikrein-12,39477,-0.0219120632123582,0.0135880606980368,-0.0485446621805103,0.00472053575579389,0.106852339915371
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00766217915521812,0.0047638280874363,-0.0169992822065933,0.00167492389615703,0.107769806257056
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-0.00469928691441312,0.0029402176574909,-0.0104621135230953,0.00106353969426903,0.110004933483667
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMA1,Laminin subunit alpha-1,37021,-0.00851197867761828,0.00534955929543388,-0.0189971148966687,0.00197315754143214,0.111598686963083
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.00975342753325339,0.00616524963847843,-0.0218373168246711,0.00233046175816433,0.113673236003784
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,39913,-0.00635388256571157,0.00402648847647827,-0.014245799979609,0.00153803484818584,0.114580535165676
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.00714930810818351,0.00453079544250228,-0.016029667175488,0.00173105095912096,0.11460413760349
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1B,Protein phosphatase 1B,37056,0.00992742586265568,0.00629391407933642,-0.00240864573284371,0.0222634974581551,0.114749196957068
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.00891466276569261,0.00566943963977765,-0.00219743892827159,0.0200267644596568,0.115879733639318
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB116,Beta-defensin 116,36991,-0.0119533519059093,0.0076379962116504,-0.0269238244807441,0.00301712066892545,0.117610450084798
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.0107023119888636,0.00684230629334684,-0.0241132323238234,0.00270860834609624,0.117809237119127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.00758987152382615,0.00485370063655244,-0.0171031247714689,0.00192338172381662,0.117901019762172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBH,Dopamine beta-hydroxylase,37430,-0.0168047123851561,0.0107507437463296,-0.0378761701279621,0.00426674535764989,0.118047476030612
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,37388,0.0106928557484256,0.00687522080358378,-0.00278257702659864,0.0241682885234498,0.119904095200056
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00810155991055262,0.00521950080372803,-0.00212866166475432,0.0183317814858596,0.120645368727706
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHIT1,Chitotriosidase-1,39906,0.0230741234872148,0.0148704463307045,-0.00607195132096591,0.0522201982953956,0.120759348072672
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GH2,Growth hormone variant,39477,0.0249807697688994,0.0162138166480116,-0.00679831086120339,0.0567598503990021,0.123407938158149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00816480401857818,0.00532082889845717,-0.0185936286595542,0.00226402062239787,0.124931151908213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTKN2,Rhotekin-2,37021,-0.00781922161441887,0.00512727310427617,-0.0178686768988002,0.00223023366996241,0.127276795852906
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPHS2,Podocin,37056,-0.0153222362951026,0.0100741838600537,-0.0350676366608079,0.00442316407060274,0.128298677796761
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPESP1,Sperm equatorial segment protein 1,37437,0.00437492037487835,0.0028788016622866,-0.00126753088320339,0.0100173716329601,0.128609197949964
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXDC2,Plexin domain-containing protein 2,37388,0.00401765175139405,0.00264503301245974,-0.00116661295302704,0.00920191645581515,0.128800463291267
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0138880952441608,0.00914678256794381,-0.0040395985890091,0.0318157890773306,0.128948170534099
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP13,Collagenase 3,39489,-0.00479805982623527,0.00316614356943168,-0.0110037012223214,0.00140758156985083,0.129684497397625
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL5A1,Collagen alpha-1(V) chain,37124,0.00588029573191701,0.00390434425124342,-0.00177221900052009,0.0135328104643541,0.132067759667367
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00818496952568256,0.00544321494752748,-0.0188536708228364,0.00248373177147131,0.132682219235271
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00645259125948501,0.00429136056840963,-0.00195847545459787,0.0148636579735679,0.132702024847458
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLN1,Cerebellin-1,36991,-0.0142495483658627,0.00948945831885052,-0.0328488866708097,0.00434978993908433,0.133219648232223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRXN3,Neurexin-3,37039,0.00519626115633262,0.00346162059112606,-0.00158851520227446,0.0119810375149397,0.133351975602625
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.0144551498042038,0.00963200552923987,-0.00442358103310637,0.0333338806415139,0.133445823913848
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAND5,DAN domain family member 5,37056,-0.00792643901136444,0.00530111037579078,-0.0183166153479144,0.00246373732518549,0.134875399154806
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSLNL,Mesothelin-like protein,37039,-0.00533913566925165,0.00357987649502792,-0.0123556935995064,0.00167742226100308,0.135872536765003
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.0068954228951937,0.00462459990212462,-0.00216879291297056,0.0159596387033579,0.135973476660178
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1A,Interleukin-1 alpha,39587,0.0078384392740739,0.00526460227429097,-0.0024801811835364,0.0181570597316842,0.136535108260592
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00757754596580365,0.00509349491005763,-0.0175607959895166,0.0024057040579093,0.136856356562394
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP350,Centrosome-associated protein 350,36962,-0.00530655072069088,0.00357163406202889,-0.0123069534822675,0.00169385204088574,0.13736965994291
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGLON5,IgLON family member 5,36962,0.013492806525494,0.00909933397530147,-0.00434188806609684,0.0313275011170849,0.138142434186761
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL9,Interleukin-9,37169,-0.00836729457494256,0.00565106212111391,-0.0194433763323258,0.0027087871824407,0.13872120316583
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPLX2,Complexin-2,36962,-0.00438059588652993,0.00295977839046122,-0.0101817615318339,0.00142056975877407,0.138886122227064
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPEP,Glutamyl aminopeptidase,37021,0.00608801001333027,0.00413294805178238,-0.00201256816816319,0.0141885881948237,0.140763367953752
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20,Interleukin-20,39587,0.0070576127377798,0.00481421391547658,-0.0023782465365543,0.0164934720121139,0.142669686555166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRR1B,Cornifin-B,37169,0.0126754940848799,0.00865007968740259,-0.00427866210242919,0.029629650272189,0.142845927692317
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00692839347942612,0.00472928132473753,-0.0161977848759117,0.00234099791705943,0.142944952781792
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6,Seizure protein 6 homolog,37039,-0.00448252098497304,0.00306763331578387,-0.0104950822839094,0.00153004031396334,0.143975891400007
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA6C,Semaphorin-6C,37056,0.00377303500723274,0.00258444232515896,-0.00129247195007881,0.0088385419645443,0.144340550111856
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTN3,Myeloblastin,39421,0.00662076250610867,0.00456055795662816,-0.00231793108888253,0.0155594561010999,0.146592969049438
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF5,Fibroblast growth factor 5,39587,-0.00473873888105419,0.00326516608137594,-0.011138464400551,0.00166098663844266,0.146716001885849
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN5,Contactin-5,39897,-0.0051351218250459,0.00354942130777544,-0.0120919875882858,0.00182174393819397,0.147986772285866
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.0121228003050275,0.00838885994311379,-0.0285649657935306,0.00431936518347548,0.148451638931708
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.00468081591599313,0.00324120399936447,-0.00167194392276124,0.0110335757547475,0.148717846944604
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.00619163237057975,0.00429349004516347,-0.0146068728591002,0.00222360811794066,0.149298699680165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC44A4,Choline transporter-like protein 4,37039,-0.0096261608668663,0.00668998393045984,-0.0227385293705676,0.00348620763683499,0.15020502056717
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00934479600645604,0.00650139183929991,-0.0220875240114839,0.00339793199857178,0.150641555791604
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00369468424917864,0.00258937107794225,-0.00138048306358817,0.00876985156194546,0.15364249715429
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RLN2,Prorelaxin H2,37095,0.0199851012680106,0.0140096214541336,-0.00747375678209116,0.0474439593181124,0.153739908236614
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00798958757624009,0.00560148839942668,-0.00298932968663621,0.0189685048391164,0.153796079092612
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTN,Titin,37021,-0.00961720887966296,0.00674843416707857,-0.022844139847137,0.00360972208781104,0.154151352831139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCP11,T-complex protein 11 homolog,37169,-0.00835089513803229,0.00587628253547792,-0.019868408907569,0.00316661863150444,0.1553056767588
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHD,SH2 domain-containing adapter protein D,37002,0.011658956283347,0.008205908492244,-0.00442462436145123,0.0277425369281452,0.155398582881373
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.016826934229347,0.0118724995159459,-0.00644316482190696,0.040097033280601,0.156414183612548
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,37039,0.0109050974278386,0.00770900107621143,-0.00420454468153577,0.026014739537213,0.157211545581869
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RELB,Transcription factor RelB,37056,0.00684249343659035,0.0048559595336191,-0.00267518724930309,0.0163601741224838,0.158831547411358
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0235853252654678,0.0168035043880698,-0.0565201938660846,0.00934954333514893,0.160462262090088
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.0036999057738094,0.00264300800634269,-0.00148038991862227,0.00888020146624108,0.161567137247789
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD4,Sushi domain-containing protein 4,37368,0.0057373458785016,0.00412045184083482,-0.00233873972953465,0.0138134314865379,0.163822113755013
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.00805070066391663,0.00578563282072106,-0.0193905409925299,0.00328913966469664,0.164093363515326
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBLN2,Fibulin-2,37437,-0.00414608959224609,0.00298698797291059,-0.0100005860191508,0.00170840683465867,0.165144500757145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENG,Endoglin,40052,-0.00231484910575394,0.00167032719991396,-0.00558869041758529,0.000958992206077412,0.165807014468058
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKAP12,A-kinase anchor protein 12,37124,-0.00287551403620929,0.00208098131251515,-0.00695423740873898,0.00120320933632041,0.167054315857146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAP1,Antigen peptide transporter 1,37169,-0.00800473112191935,0.00580497582532488,-0.0193824837395561,0.0033730214957174,0.167935484204258
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,39866,0.006245225677225,0.00453614505660787,-0.00264561863372643,0.0151360699881764,0.16860281274588
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00377438138382645,0.00274264108623533,-0.00160119514519479,0.00914995791284769,0.168787733221011
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00437156331478364,0.0031794008367587,-0.0106031889548307,0.0018600623252634,0.16916590718573
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD82,CD82 antigen,37169,-0.00571140335010786,0.00415851431928485,-0.0138620914159062,0.00243928471569045,0.169643709392299
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NME3,Nucleoside diphosphate kinase 3,39885,0.00322245809489443,0.0023502973312058,-0.00138412467426894,0.0078290408640578,0.170367570494583
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00652021933546107,0.00476829786665666,-0.0158660831541081,0.00282564448318599,0.171520073510356
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00987192809813528,0.00723460737952708,-0.0240517585620083,0.00430790236573779,0.17242032052434
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00340443180458982,0.0024970752607146,-0.0014898357064108,0.00829869931559043,0.17279011105732
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.0115187028369022,0.00845074512133626,-0.0280821632747213,0.00504475760091685,0.172892993426031
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00657215680186838,0.00483179544973561,-0.00289816227961342,0.0160424758833502,0.173793302856896
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB5,Integrin beta-5,39913,0.00504627406163717,0.00374079543882107,-0.00228568499845214,0.0123782331217265,0.17736105829867
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00859465795654574,0.00637543877284198,-0.00390120203822453,0.021090517951316,0.177649343037222
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,37382,0.019309072092049,0.0143795329379563,-0.00887481246634535,0.0474929566504433,0.1793539838067
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,39931,0.0036045794885513,0.00268717204922471,-0.00166227772792913,0.00887143670503173,0.179808739069629
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,36991,0.013904079288456,0.0103785398163036,-0.00643785875149901,0.034246017328411,0.180367664631347
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHPK,Sedoheptulokinase,37169,-0.00551823172385671,0.0041326371711644,-0.0136182005793389,0.00258173713162551,0.18180724533722
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRMD7,FERM domain-containing protein 7,37039,0.00440018832317307,0.00331679798748893,-0.00210073573230524,0.0109011123786514,0.184651637924093
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCN1,Transcobalamin-1,37235,0.00445757059643065,0.00337787295801755,-0.00216306040128374,0.011078201594145,0.186978389495188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDNRB,Endothelin receptor type B,37056,0.0060760765420555,0.00460472287204051,-0.00294918028714391,0.0151013333712549,0.187014403367156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLHL41,Kelch-like protein 41,37411,0.00659167635179217,0.00504301701596324,-0.00329263699949578,0.0164759897030801,0.191204377135596
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10,Interleukin-10,39587,0.0101551974576377,0.00780500346206059,-0.00514260932800108,0.0254530042432764,0.193238577397201
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00429435213821434,0.00330483833158422,-0.00218313099169074,0.0107718352681194,0.193821049121095
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,37437,-0.00277513752943961,0.00214704113814197,-0.00698333816019787,0.00143306310131866,0.19619204181928
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00514097210197818,0.00398014137854428,-0.012942049203925,0.0026601049999686,0.196498852838924
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00611967080437645,0.00473855467892651,-0.00316789636631951,0.0154072379750724,0.196565073088809
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.00951138447421031,0.00737566157831734,-0.00494491221929167,0.0239676811677123,0.197224944222941
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.0043874597065409,0.00340986550627904,-0.0110707960988478,0.00229587668576603,0.198223040125375
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,37021,-0.00479048813480563,0.00373715087132323,-0.0121153038425992,0.0025343275729879,0.199915852404708
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,0.0105133662552257,0.00823586112890756,-0.00562892155743308,0.0266556540678845,0.2017849286263
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL12,Stromal cell-derived factor 1,39587,0.00500502248419611,0.00393084735292405,-0.00269943832753503,0.0127094832959273,0.202941746936921
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCARE,Photoreceptor cilium actin regulator,36991,-0.0106970244405638,0.00841651746677748,-0.0271933986754476,0.00579934979432009,0.203766771893328
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,0.0033568313120154,0.00264128210826048,-0.00182008162017514,0.00853374424420594,0.203779303166415
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH17,Protocadherin-17,39868,0.00436192235505988,0.00344798537396198,-0.00239612897790561,0.0111199736880254,0.20586678202518
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.00369105753566079,0.0029218891045388,-0.00941796018055683,0.00203584510923525,0.206523362062538
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.0069977316901439,0.00554261322727285,-0.0178612536155987,0.00386579023531089,0.206779557055079
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.00799206414443916,0.00635929431755395,-0.0204562810068449,0.00447215271796658,0.208865253540417
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AOC3,Membrane primary amine oxidase,39931,-0.00370366809537186,0.00296218205101076,-0.00950954491535295,0.00210220872460924,0.21120178810203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM3,Paralemmin-3,37021,0.00933172837416205,0.00746502952881894,-0.00529972950232306,0.0239631862506472,0.211300172125551
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB6B,Ras-related protein Rab-6B,39489,0.00579650809964288,0.00464056940393015,-0.00329900793206021,0.014892024131346,0.211649347190805
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYTH3,Cytohesin-3,36962,0.00890272630524316,0.00713563032220541,-0.00508310912627944,0.0228885617367658,0.212183758724706
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH22,Cadherin-22,37169,-0.00356509901973856,0.00286020109008531,-0.00917109315630576,0.00204089511682865,0.212620996529973
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKLR,Pyruvate kinase PKLR,39881,0.00783702549370405,0.00630649490580124,-0.00452370452166638,0.0201977555090745,0.213999848909049
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN4,Nectin-4,39913,0.00359647903364561,0.00289904684156227,-0.00208565277581643,0.00927861084310765,0.214781687838885
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRC,Chymotrypsin-C,39856,0.00752939487455704,0.00609042895896365,-0.00440784588501172,0.0194666356341258,0.216377574933253
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBN2,Fibrillin-2,37039,0.0073201259253055,0.00593020044217181,-0.00430306694135125,0.0189433187919623,0.217083026934121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CORO6,Coronin-6,36991,-0.00460223441373435,0.00374091197134551,-0.0119344218775715,0.00272995305010284,0.218627796002152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCC,Netrin receptor DCC,37039,0.00273933290785716,0.00223138111807112,-0.00163417408356223,0.00711283989927656,0.219604033272122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMI,N-myc-interactor,37311,0.00863847241618274,0.00712073088648287,-0.00531816012132368,0.0225951049536892,0.225096048446119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.0073762082900985,0.00610391851621312,-0.0193398885818762,0.00458747200167921,0.226900466262062
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOH,Beta-2-glycoprotein 1,39858,0.00422086938873936,0.00350317007179454,-0.00264534395197793,0.0110870827294567,0.228270778467181
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDAC8,Histone deacetylase 8,37056,0.00745897897136266,0.00623856711734806,-0.00476861257863953,0.0196865705213649,0.231864906158752
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B4,Protein ATP1B4,36962,-0.00489274398613131,0.00413240118704005,-0.0129922503127298,0.00320676234046718,0.236436364100538
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP73,Tumor protein p73,37039,-0.00403975118971323,0.00341557172889489,-0.0107342717783472,0.00265476939892075,0.236931467147543
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.00495081164454907,0.00420794505870988,-0.0032967606705223,0.0131983839596204,0.239396967107753
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BSND,Barttin,36962,-0.00389949451833137,0.00332710964148387,-0.0104206294156397,0.00262164037897702,0.241203643499836
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF75D,Zinc finger protein 75D,37169,0.0068460905073473,0.00584161314649079,-0.00460347125977466,0.0182956522744693,0.241237286076616
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSLP,Thymic stromal lymphopoietin,39585,0.0069369486612052,0.00592441427511714,-0.00467490331802439,0.0185488006404348,0.241653190583835
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLINT1,Clathrin interactor 1,36962,-0.00564686147994042,0.00482704680290672,-0.0151078732136376,0.00381415025375676,0.242087556151645
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00562652956217898,0.0048229534824284,-0.00382645926338069,0.0150795183877386,0.243387618289405
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WIF1,Wnt inhibitory factor 1,40030,-0.00384182834991538,0.00330450487840471,-0.0103186579115886,0.00263500121175785,0.245007640001343
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00556400433827119,0.00479040067747473,-0.0149531896661217,0.00382518098957927,0.245463689300379
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB118,Beta-defensin 118,36991,0.00662211542572024,0.0057337852565727,-0.00461610367716225,0.0178603345286027,0.248140479529147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00596702517700085,0.00517107834128739,-0.0161023387259241,0.00416828837192244,0.248552577479695
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM171A2,Protein FAM171A2,37411,0.0178877131479216,0.0155031756957737,-0.0124985112157948,0.048273937511638,0.24859858131524
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00807566927235815,0.00700742869081442,-0.00565889096163811,0.0218102295063544,0.249159565267754
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.00691873693815042,0.00600521685944482,-0.00485148810636143,0.0186889619826623,0.249292220238488
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13,Interleukin-13,39587,0.00551805138570688,0.00480636074039748,-0.00390241566547218,0.0149385184368859,0.250956029920061
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00491602275866035,0.00428447521692881,-0.0133135941838408,0.00348154866652011,0.251235665832464
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00618542070710549,0.0053984996235567,-0.00439563855506565,0.0167664799692766,0.251912607432116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",39064,0.0032786358566608,0.00286156125733546,-0.0023300242077167,0.00888729592103831,0.251916346222662
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK1,Kallikrein-1,39720,-0.0141869285389272,0.0123854755182862,-0.0384624605547682,0.0100886034769137,0.25204056105629
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUCA2A,Guanylin,39796,-0.00364483576231897,0.00318295291048728,-0.00988342346687403,0.0025937519422361,0.252180197855751
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00572472628246776,0.00501250621371004,-0.0155492384613394,0.00409978589640391,0.253437964585232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.00227216617156762,0.00199215776524703,-0.0061767953914518,0.00163246304831656,0.254071989688065
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.00714955776518483,0.0062812991961048,-0.0194609041895502,0.00516178865918058,0.255045534138967
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.00804551611357245,0.00713992811491036,-0.0220397752187968,0.00594874299165186,0.259832848954758
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB5,Serpin B5,39585,0.00540189943915585,0.00479937220049596,-0.00400487007381624,0.0148086689521279,0.260376215057289
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.00926668486455276,0.00823706349245156,-0.0254113293097578,0.00687795958065231,0.26061023772259
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00690091732486445,0.00616008929000399,-0.00517285768354338,0.0189746923332723,0.262622338991034
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.0060412413884904,0.0053931187167196,-0.00452927129628002,0.0166117540732608,0.262655935283234
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00553987570812809,0.00494601214154522,-0.0152340595055567,0.00415430808930053,0.262704819051772
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00512051988115647,0.00457542500496958,-0.0140883528908969,0.00384731312858391,0.263102870688135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHP1,Calcineurin B homologous protein 1,36991,0.00801574342920441,0.00716303841310096,-0.00602381186047347,0.0220552987188823,0.263142536726392
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNNI3,"Troponin I, cardiac muscle",39585,0.00928396274372976,0.00830118806349799,-0.0069863658607263,0.0255542913481858,0.263417700947546
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00509201714033815,0.00455727798767883,-0.0140242819961886,0.00384024771551235,0.263870578022398
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACRV1,Acrosomal protein SP-10,37056,0.00801778036487783,0.00720383841905926,-0.00610174293647831,0.022137303666234,0.26573417597884
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00699004530324646,0.0062853241194565,-0.0193092805773812,0.00532918997088828,0.266106236001852
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTO1,Protein LTO1 homolog,39587,0.00439314454871434,0.00397858014443792,-0.00340487253438397,0.0121911616318127,0.269523680846209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASN,Vasorin,39642,0.0029461369290701,0.00269796827345229,-0.00234188088689638,0.00823415474503658,0.274857008255569
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,H2AP,Huntingtin-interacting protein M,36962,-0.00538948723661297,0.0049431506987253,-0.0150780626061146,0.00429908813288862,0.275603736275299
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00319792927882865,0.00293673975764235,-0.00895393920380766,0.00255808064615035,0.276200328244393
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00373501551398084,0.00343500021777051,-0.00299758491284936,0.010467615940811,0.276905562510166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCNE1,G1/S-specific cyclin-E1,37056,0.0102537985199032,0.00944471470159795,-0.00825784229522879,0.0287654393350352,0.277646953724144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISM2,Isthmin-2,37437,-0.00476666292813997,0.00439071077561775,-0.0133724560483508,0.00383913019207082,0.277664457363733
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF9,Fibroblast growth factor 9,36931,0.00433208761724186,0.00399797781891771,-0.00350394890783684,0.0121681241423206,0.278575619296392
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00366328544352143,0.00338161707155258,-0.00296468401672162,0.0102912549037645,0.278697577925675
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00272239354612346,0.00251598712248124,-0.0076537283061867,0.00220894121393978,0.279254883138223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA3,GDNF family receptor alpha-3,39709,-0.00293214647224359,0.00272531839331151,-0.00827377052313415,0.00240947757864696,0.281992230351643
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR4,Toll-like receptor 4,37056,0.00292735047455292,0.00272205663821675,-0.0024078805363519,0.00826258148545775,0.282206997610331
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00518257549114836,0.00484937374989537,-0.00432219705864656,0.0146873480409433,0.285219891743157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRNN,Cornulin,39397,0.00680923184180843,0.0063786461299948,-0.00569291457298137,0.0193113782565982,0.285760782531403
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0179862587885632,0.016921907992298,-0.0151806808763409,0.0511531984534673,0.2878445669066
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00426886691808316,0.00404949466345752,-0.00366814262229358,0.0122058764584599,0.291819564050177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00561549251051148,0.00535820717315721,-0.0161175785698996,0.00488659354887664,0.294649808409275
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTA2,"Actin, aortic smooth muscle",39585,0.00445688097727581,0.00426151854143919,-0.00389569536394501,0.0128094573184966,0.295649422360433
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FZD10,Frizzled-10,37039,0.00616208418534935,0.00590938993383663,-0.00542032008497044,0.0177444884556691,0.297077903716415
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00592590827637862,0.00568295046949204,-0.00521267464382577,0.017064491196583,0.297082381919088
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCN2,Transcobalamin-2,40012,0.00299880012305018,0.00288410844671888,-0.00265405243251882,0.00865165267861919,0.298463835088902
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYBB2,Beta-crystallin B2,37388,0.00582129028807008,0.00560238180051506,-0.00515937804093945,0.0168019586170796,0.298788807970718
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAN,Brevican core protein,39749,-0.00339018830415818,0.00328221437944882,-0.00982332848787787,0.00304295187956152,0.301667978061285
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,37388,0.0028440705895059,0.00276086627689449,-0.0025672273132073,0.00825536849221909,0.302964100901562
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.00921619618782716,0.00901750883153308,-0.026890513497632,0.00845812112197767,0.306783911458412
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNIP4,Kv channel-interacting protein 4,39489,0.00525802442011373,0.00517700144650698,-0.00488889841503995,0.0154049472552674,0.309811541190231
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNC5D,Netrin receptor UNC5D,37056,0.00266829987202828,0.00262728144011904,-0.00248117175060503,0.00781777149466159,0.309832570241831
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.00295533874718409,0.00291054150781942,-0.00866000010251015,0.00274932260814198,0.309937469734487
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00627009492645814,0.00623977387698703,-0.00595986187243644,0.0185000517253527,0.314982864560277
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.00511645758887648,0.00511405704091608,-0.015140009389072,0.00490709421131902,0.317101791869758
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVPL,Envoplakin,37169,-0.00324961091418594,0.00324829070524568,-0.00961626069646748,0.0031170388680956,0.317132046624796
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.00264569865413731,0.00265736677248991,-0.00785413752821754,0.00256274021994291,0.319454968664449
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD5L,CD5 antigen-like,37380,0.00458696498445097,0.0046098013035503,-0.00444824557050761,0.0136221755394096,0.319731633129252
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,37056,-0.00422492302004747,0.00428163328874252,-0.0126169242659828,0.00416707822588787,0.323780856022655
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,37169,0.007099037490071,0.00720771296033574,-0.00702807991218706,0.0212261548923291,0.324680125211797
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.0122774712026572,0.0125237363988253,-0.0122690521390404,0.0368239945443547,0.326935414889859
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00389046069556571,0.00397597246478602,-0.00390244533541489,0.0116833667265463,0.327848603131118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,39866,0.00394863015025487,0.00404036468560514,-0.00397048463353121,0.0118677449340409,0.328437659751849
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KDM3A,Lysine-specific demethylase 3A,37056,-0.00892369083509426,0.00919274185448346,-0.0269414648698818,0.00909408319969332,0.3316994280508
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP1,DNA topoisomerase 1,37382,0.0107962640804962,0.0112329215328143,-0.0112202621238198,0.0328127902848122,0.336505505475443
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRN1,Neuritin,37411,-0.00333643585556906,0.00347380599277384,-0.0101450956014058,0.00347222389026766,0.336843185011835
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,37021,0.0094688435318507,0.00988137908987981,-0.00989865948431373,0.0288363465480151,0.337953699150692
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDAN1,Codanin-1,37388,0.00212825729376904,0.00222380207854675,-0.00223039478018258,0.00648690936772066,0.338566493969216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL14,C-X-C motif chemokine 14,39587,0.00582515628769321,0.00609247778223616,-0.00611610016548965,0.0177664127408761,0.339024945536448
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF7,Fibroblast growth factor 7,36962,-0.00749868126179764,0.0078529173228885,-0.0228903992146591,0.00789303669106381,0.339650362318269
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AREG,Amphiregulin,39788,-0.00439320407266271,0.00460678084092397,-0.0134224945208737,0.00463608637554828,0.340281077045414
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORN4,MORN repeat-containing protein 4,36962,0.00750286605228117,0.00786961237749485,-0.00792157420760873,0.0229273063121711,0.340406470745104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00552841328649908,0.00580229851776502,-0.0169009183813185,0.00584409180832035,0.340710414532416
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17F,Interleukin-17F,39587,-0.00727517146231941,0.00764154572343631,-0.0222526010802546,0.00770225815561576,0.341083743788265
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.00502374252778608,0.00529776578234042,-0.00535987840560115,0.0154073634611733,0.343006067349643
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASQ2,Calsequestrin-2,37021,0.00454642515749331,0.00481137571084644,-0.00488387123576571,0.0139767215507523,0.344710697712663
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.0067242018865719,0.00712465549248768,-0.00724012287870396,0.0206885266518478,0.345292666172696
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,0.00663810485016515,0.00717688982579844,-0.0074285992083998,0.0207048089087301,0.355017440833071
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHH,Sonic hedgehog protein,37056,-0.00397960570447606,0.00430890139271895,-0.0124250524342052,0.00446584102525309,0.355723059307207
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00491064691968207,0.00540009056425854,-0.0154948244256288,0.00567353058626466,0.363174846706277
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,37056,0.0108585828430158,0.0119421403326213,-0.0125480122089219,0.0342651778949535,0.36322630977775
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00420395741590492,0.0046287444213595,-0.0132762964817695,0.0048683816499597,0.363774133038435
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,-0.00229694918776531,0.00253269419670517,-0.00726102981330744,0.00266713143777682,0.364465613039124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00684826846110755,0.00757563172385439,-0.0216965066398621,0.00799996971764706,0.36601916798197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NENF,Neudesin,37368,0.00978539480004867,0.0108370719968856,-0.0114552663138471,0.0310260559139445,0.366565563419384
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL4,Interleukin-4,39587,0.00796296033962988,0.00890097384006911,-0.00948294838690558,0.0254088690661653,0.371005682460305
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP4,Caspase-4,37169,-0.0145509576338845,0.016268502073411,-0.0464372216977702,0.0173353064300012,0.371110627988633
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00331627018908913,0.00371959827278941,-0.00397414242557811,0.0106066828037564,0.37263883206374
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.00564462552825787,0.00634928075140378,-0.0180892158010093,0.00679996474449355,0.374006679496186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZPR1,Zinc finger protein ZPR1,36991,0.00840718122019626,0.00947847313960011,-0.01017062613342,0.0269849885738125,0.37510789450487
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.00692133037061126,0.00784474285447431,-0.00845436562415838,0.0222970263653809,0.377634109780102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESR1,Estrogen receptor,37056,0.00512737556960572,0.00586905589425437,-0.00637597398313284,0.0166307251223443,0.382336398397773
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRP15,RRP15-like protein,36991,0.00774480327247654,0.00892347316036564,-0.0097452041218401,0.0252348106667932,0.385457521315273
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,0.00604745200771762,0.00696921317396694,-0.00761220581325758,0.0197071098286928,0.385550620817058
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00441793527966597,0.00510590614078829,-0.014425511315611,0.00558964075627908,0.386911986108621
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00347163216296357,0.0040280981189861,-0.0113667044761763,0.00442344015024918,0.388783584010524
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00293641507823291,0.00340991423598759,-0.00961984698076859,0.00374701682430277,0.389176381433734
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.00363170160249518,0.00426764052086841,-0.00473287381840691,0.0119962770233973,0.394792294263791
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP15,Matrix metalloproteinase-15,37437,0.00415500857172527,0.00488785858458471,-0.00542519425406076,0.0137352113975113,0.395302680635582
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPO,Lactoperoxidase,39344,-0.00498359739393326,0.00589285018726822,-0.016533583760979,0.00656638897311245,0.397731866696841
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR1,TGF-beta receptor type-1,37056,0.00180589158554325,0.00214993366712659,-0.00240797840202486,0.00601976157311136,0.400937346972774
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL21R,Interleukin-21 receptor,37056,-0.00450791180013107,0.00536713440728175,-0.0150274952384033,0.00601167163814117,0.400973864162963
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00456235254962538,0.00555372597939027,-0.0154476554692303,0.00632295036997955,0.411379823065621
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00331250874348066,0.00404758197946508,-0.0046207519362709,0.0112457694232322,0.41314784166889
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLGAP5,Disks large-associated protein 5,37411,-0.0042334080987764,0.00517668466769286,-0.0143797100474544,0.00591289384990161,0.413495112379531
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEBP1,Heme-binding protein 1,39585,-0.00433386540031428,0.00530041013541543,-0.0147226692657285,0.00605493846509996,0.413571067487218
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STC2,Stanniocalcin-2,39831,0.00212908392800626,0.00261119259888414,-0.00298885356580665,0.00724702142181917,0.414873626566064
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A16,Protein S100-A16,39456,-0.00498912405570584,0.00613034722235715,-0.0170046046115259,0.00702635650011417,0.415748829363498
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00609981182043635,0.00749738091619961,-0.0207946784161876,0.00859505477531488,0.415893269350368
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00290776050619323,0.00357943438658419,-0.00992345190389825,0.00410793089151178,0.416602004720457
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00294648036075795,0.00363337682341386,-0.00417493821313323,0.0100678989346491,0.417410068380865
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.0051340003315314,0.00637487621888743,-0.0176287577205508,0.00736075705748797,0.420632849381711
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RUVBL1,RuvB-like 1,39477,0.00803979980451178,0.0100197809997071,-0.0115989709549141,0.0276785705639377,0.422338005508856
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00328339674198766,0.00411278305825485,-0.0113444515361672,0.00477765805219185,0.424687928910676
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS2,"Nitric oxide synthase, inducible",37021,0.0031161116768022,0.00390420494299354,-0.00453613001146514,0.0107683533650695,0.424802233899246
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXDC1,Plexin domain-containing protein 1,39477,0.00269159098302693,0.00339489240489901,-0.00396239813057512,0.00934558009662899,0.427885754749647
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF20B,Kinesin-like protein KIF20B,36991,0.00587574948354471,0.00741329659930615,-0.00865431185109534,0.0204058108181848,0.428027539500999
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,-0.00262395878117171,0.00331472779272533,-0.00912082525491335,0.00387290769256994,0.428604712406992
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,0.00458471373278149,0.00580829962365635,-0.00679955352958495,0.0159689809951479,0.42992848825569
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDSN,Corneodesmosin,39992,0.00328761630420597,0.00417043171566058,-0.00488642985848876,0.0114616624669007,0.430523719228156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00671713411379408,0.00853878138554893,-0.02345314562947,0.0100188774018818,0.431493811324095
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.0036272635635769,0.00461426880831141,-0.00541670330071347,0.0126712304278673,0.431824284343114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANK2,Ankyrin-2,37021,-0.00549985767633777,0.00700861508542908,-0.0192367432437788,0.00823702789110321,0.432627088308224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKIV2L,Helicase SKI2W,37021,0.00311529207463839,0.0039723404339025,-0.0046704951758105,0.0109010793250873,0.432909896026628
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTOA,Otoancorin,36991,-0.00406333748696002,0.00522915538568329,-0.0143124820428993,0.00618580706897923,0.437140754222722
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTR,Methionine synthase,37021,0.00493309456581859,0.0063546309169423,-0.00752198203138832,0.0173881711630255,0.437586326546759
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCNA,Proliferating cell nuclear antigen,36962,0.00486486469417035,0.00630818059396729,-0.00749916927000553,0.0172288986583462,0.440602694319748
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,39990,0.0047105460329578,0.00613142470541489,-0.00730704638965538,0.016728138455571,0.442342267218256
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPA33,Cell surface A33 antigen,39788,0.00991973176894705,0.0129348325693102,-0.0154325400669009,0.035272003604795,0.443151941584023
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.00294038620226278,0.00383944548292,-0.00458492694426041,0.010465699348786,0.443787420408791
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKKL1,Dickkopf-like protein 1,39788,-0.00634815200606556,0.0082907938451778,-0.022598107942614,0.00990180393048292,0.44387398602931
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL3A1,Collagen alpha-1(III) chain,37437,0.00175529524085575,0.00229485124284058,-0.00274261319511178,0.00625320367682328,0.444353853547035
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC4A1,Band 3 anion transport protein,37437,-0.00352028717725075,0.00460349578432362,-0.012543138914525,0.00550256456002354,0.44446427943556
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A3,Protein S100-A3,37368,0.00340376098615837,0.0044548310260229,-0.0053277078248465,0.0121352297971633,0.444844459994243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00461535579636682,0.00604240551890982,-0.00722775902069643,0.0164584706134301,0.44498335840918
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSD1,Tryptase delta,37411,0.0027482225721984,0.00360931018913899,-0.00432602539851403,0.00982247054291082,0.446415921085582
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00421209811069086,0.00556417908410486,-0.00669369289415466,0.0151178891155364,0.449061909029317
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00572255708939247,0.00756938435863346,-0.0205585504323141,0.00911343625352911,0.449654259225031
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,0.00859619879753682,0.0114123502443809,-0.0137720076814497,0.0309644052765233,0.451320893041693
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRING1,SREBP regulating gene protein,36962,0.00441061111564268,0.0059086070567076,-0.00717025871550422,0.0159914809467896,0.455395591452324
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00205571410284597,0.00276751704752239,-0.00748004751598986,0.00336861931029792,0.457613098769831
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAG,Myelin-associated glycoprotein,37039,-0.00337955313997833,0.00455286512363107,-0.0123031687822952,0.00554406250233857,0.457923962013667
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00409750023224049,0.00554059555682356,-0.0149570675236147,0.00676206705913369,0.459591482668349
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,36991,0.00849964768781415,0.0114986574200601,-0.0140377208555037,0.031037016231132,0.459807215531589
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DENND2B,DENN domain-containing protein 2B,37021,-0.00371677561945576,0.00508765421915282,-0.0136885778889953,0.00625502665008376,0.465068287536509
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.003454108536411,0.00479076090650341,-0.00593578284033567,0.0128439999131577,0.47092621324224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD70,CD70 antigen,39866,-0.00298367565374187,0.00416623568819191,-0.011149497602598,0.00518214629511427,0.473905332980597
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR2,Toll-like receptor 2,37169,-0.00159236377532244,0.00223986131283562,-0.00598249194848026,0.00279776439783537,0.477145835237365
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGF,Beta-nerve growth factor,39749,0.000859164843884531,0.0012118902962646,-0.00151614013679409,0.00323446982456316,0.478368355533737
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBQLN3,Ubiquilin-3,37021,-0.00328575375316539,0.0046366443269224,-0.0123735766339333,0.00580206912760252,0.478554820243429
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,-0.00301153792122244,0.00427526465313641,-0.0113910566413698,0.00536798079892493,0.481189767797588
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA8,Carbonic anhydrase-related protein,37056,0.00179639902980946,0.00257529993551442,-0.0032511888437988,0.00684398690341771,0.485471299319164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00413748058740736,0.00593528735179983,-0.0074956826221203,0.015770643796935,0.485753361686386
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00449245228447787,0.0064651574985651,-0.0171641609816655,0.00817925641270973,0.487148101451586
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00368490410495051,0.00533096244642162,-0.0141335904999369,0.00676378229003587,0.489435081612321
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.00389708612928751,0.00563887593525589,-0.00715511070381403,0.0149492829623891,0.489506144692476
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,37382,-0.00316896974317749,0.00459183285291178,-0.0121689621348846,0.0058310226485296,0.490123168931739
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YY1,Transcriptional repressor protein YY1,37056,-0.00188435821340897,0.00274126691542888,-0.00725724136764957,0.00348852494083164,0.491840173376244
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPEP2,Dipeptidase 2,39788,-0.00196658729569051,0.00286478109370089,-0.00758155823934427,0.00364838364796324,0.492426544719712
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL6,Fc receptor-like protein 6,39866,0.00445372654470591,0.00650438588470682,-0.00829486978931946,0.0172023228787313,0.493526325281445
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RSPO1,R-spondin-1,39749,0.00236741210983785,0.00347831090094462,-0.00445007725601361,0.00918490147568931,0.496121131987823
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEX101,Testis-expressed protein 101,37039,0.00326414322724135,0.00479809404919421,-0.0061401211091793,0.012668407563662,0.496326495296532
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PI16,Peptidase inhibitor 16,37445,-0.00160152882811774,0.00235607875237593,-0.00621944318277457,0.00301638552653908,0.496678574013952
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF6,Fibroblast growth factor 6,37056,0.00274158720630261,0.00404637455506838,-0.00518930692163143,0.0106724813342366,0.498074245377996
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRC1,Protein regulator of cytokinesis 1,37368,-0.00308576281827929,0.00455484610792923,-0.0120132611898206,0.00584173555326201,0.498120622527372
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.00412303489836347,0.00617692582229515,-0.016229809510062,0.00798373971333501,0.504471061582104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00447496793259964,0.00670878720918977,-0.0176241908626116,0.0086742549974123,0.504764001722766
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.00316415194516423,0.00475603820265521,-0.0124859868223684,0.00615768293203998,0.50587573021991
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.0044589148073599,0.00670495268692381,-0.00868279245901078,0.0176006220737306,0.506050447882952
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00337677045019535,0.00508188444899021,-0.00658372306982547,0.0133372639702162,0.506399540132239
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00207255081961928,0.00313958645911062,-0.00408103864023753,0.00822614027947609,0.509176886758475
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD2,T-cell surface antigen CD2,37021,0.00249140145568414,0.00378705994473382,-0.00493123603599415,0.00991403894736243,0.510631762012085
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STEAP4,Metalloreductase STEAP4,36991,-0.00477710071792143,0.00741722960989309,-0.0193148707533119,0.00976066931746903,0.519551289567886
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TG,Thyroglobulin,37368,0.00689707715361197,0.0107254315816856,-0.0141247687464919,0.0279189230537158,0.520197225728516
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA2,Protein disulfide-isomerase A2,36962,0.00251888942069104,0.00391828943456032,-0.00516095787104719,0.0101987367124293,0.520329860212727
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00495977613441932,0.00773049794493647,-0.0201115521064948,0.0101919998376562,0.521153336498772
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBS2,Thrombospondin-2,39858,-0.00227466168446525,0.00355538353649295,-0.00924321341599143,0.00469389004706093,0.522325089958874
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,37039,0.00650086339758247,0.0102047314227029,-0.0135004101909152,0.0265021369860801,0.524107218915334
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,39866,0.00222999471943504,0.00352581599271375,-0.0046806046262839,0.00914059406515398,0.52708478671507
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,39822,-0.00293600160551756,0.00467026586172523,-0.012089722694499,0.00621771948346388,0.529581749958261
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EXOSC10,Exosome component 10,37021,-0.00377917523829102,0.00601504501856648,-0.0155686634746813,0.00801031299809929,0.529826777957706
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.00314750140690045,0.00502259708164799,-0.0129917916869305,0.00669678887312962,0.530887562291859
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPGN,Epigen,37368,-0.00304127353301352,0.00492585943415434,-0.012695958023956,0.00661341095792899,0.536974914439253
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00466327488833666,0.00758683975255539,-0.0102069310266719,0.0195334808033452,0.538794422814744
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,37039,0.00218578261731993,0.00358555106818337,-0.00484189747631948,0.00921346271095934,0.542131650476763
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL4,Early placenta insulin-like peptide,37368,-0.00320515402116242,0.00527641905955101,-0.0135469353778824,0.00713662733555756,0.543563373120684
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEB,Nebulin,37021,-0.00223881383685507,0.0037043675295855,-0.00949937419484264,0.00502174652113251,0.545607155669879
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.0049992732535256,0.00828259924006006,-0.0112346212569921,0.0212331677640433,0.546128322821607
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOS,Proto-oncogene c-Fos,36931,-0.00208317336286843,0.0034872058988392,-0.00891809692459327,0.00475175019885641,0.550266673366066
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR3,Folate receptor gamma,39858,-0.0111101293025407,0.0186425750603579,-0.0476495764208422,0.0254293178157608,0.551213953962912
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00228608203170874,0.00384810403392064,-0.00525620187477572,0.00982836593819319,0.552468750686144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.0028287365730794,0.00481410707589232,-0.0122643864418283,0.00660691329566955,0.556815503865885
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCL2,Phosducin-like protein 2,36962,-0.0030727278952111,0.00524086934289374,-0.0133448318072828,0.00719937601686063,0.557683236494679
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MB,Myoglobin,40052,0.00297674701287869,0.005112028579358,-0.007042829002663,0.0129963230284204,0.560371050765579
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCIN,Adseverin,36991,0.00418887166050649,0.00729651455973961,-0.0101122968765832,0.0184900401975961,0.565915285141609
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPT1,Translationally-controlled tumor protein,39587,0.00368342364222747,0.0064334291691594,-0.00892609752932496,0.0162929448137799,0.566961420650376
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17A,Interleukin-17A,39558,0.00239005778472059,0.0041746142121112,-0.00579218607101736,0.0105723016404585,0.566976697460084
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOX2,Transcription factor SOX-2,37391,0.00134113737070439,0.00234438359875469,-0.0032538544828548,0.00593612922426358,0.567288146058949
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRAS,GTPase Hras,37161,0.00548648370812518,0.00964425025248044,-0.0134162467867365,0.0243892142029868,0.569442777168665
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.00382807950784459,0.00673842964023576,-0.0170354016027067,0.00937924258701749,0.569978716659896
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMCN2,Hemicentin-2,37100,0.0031691138281181,0.00560602447525364,-0.00781869414337905,0.0141569217996152,0.571875887477961
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",37388,0.00333710055047785,0.00590655622699333,-0.00823974965442906,0.0149139507553848,0.572095076556066
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAC1,Cartilage acidic protein 1,40052,0.00167602335415536,0.00296784983767334,-0.00414096232768438,0.0074930090359951,0.572267652034127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBR1,T-box brain protein 1,37039,-0.00268341073512324,0.00475640537910583,-0.0120059652781707,0.00663914380792419,0.572649543477878
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FH,"Fumarate hydratase, mitochondrial",36991,0.00451832908728027,0.00816373757539945,-0.0114825965605026,0.0205192547350632,0.579955631891378
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PITHD1,PITH domain-containing protein 1,36931,-0.004308378837617,0.00780448065093959,-0.0196051609134586,0.0109884032382246,0.58093097116684
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP1,Retinol-binding protein 1,37039,0.00382305902306364,0.00693048815517586,-0.00976069776108105,0.0174068158072083,0.581211839714664
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,39962,0.00161692090588771,0.00293550750779533,-0.00413667380939113,0.00737051562116656,0.581768296846181
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00275137831016565,0.00503790710619846,-0.0126256762383146,0.00712291961798333,0.584982262673253
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.00260147316039261,0.00484512924677838,-0.00689498016329301,0.0120979264840782,0.591328192747081
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.00150525804415168,0.00282062687377215,-0.00402317062844174,0.0070336867167451,0.593583547867111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD2,Bromodomain-containing protein 2,36991,-0.00178070072828427,0.00334133532074742,-0.00832971795694922,0.00476831650038068,0.594090456137133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPB41L5,Band 4.1-like protein 5,37039,0.003370446503457,0.00633698143914785,-0.00905003711727278,0.0157909301241868,0.594825418643748
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENOPH1,Enolase-phosphatase E1,37368,0.00290848509917733,0.00550784489850429,-0.00788689090189108,0.0137038611002457,0.597464788881513
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,0.00386038387273577,0.00736332007632985,-0.0105717234768707,0.0182924912223423,0.600096683944681
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00335568761343583,0.00647515287889677,-0.0160469872560735,0.00933561202920183,0.604298972154502
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNW1,Interferon omega-1,37021,-0.00181046758716365,0.00349412278205961,-0.00865894824000049,0.00503801306567319,0.604364749555239
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00195110593223195,0.00378601703118882,-0.00937169931336204,0.00546948744889814,0.606320420685311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF20,Fibroblast growth factor 20,37056,-0.00218562444143657,0.00424283335105432,-0.010501577809503,0.0061303289266299,0.606468553138797
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP2BP,LRP2-binding protein,37039,-0.00404601759446487,0.00786801844066968,-0.0194673337381774,0.0113752985492477,0.607095689047469
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.00257250256651733,0.00501266808214313,-0.0123973320075179,0.0072523268744832,0.60781985780539
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00461275513566027,0.00904808313826421,-0.0131214878153376,0.0223469980866581,0.610196874128322
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00247287793776059,0.00488484729638482,-0.0120471786386748,0.00710142276315366,0.612699226204426
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00198790624375522,0.00392969294533528,-0.00969010441661237,0.00571429192910194,0.612957750289694
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00111958371622462,0.00222437102969578,-0.0032401835019791,0.00547935093442834,0.614743508506325
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN4,Prefoldin subunit 4,36962,0.00265627614758217,0.00536900805203933,-0.00786697963441492,0.0131795319295793,0.620790234935949
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAD2,Glutamate decarboxylase 2,37056,-0.00226348745551803,0.00459938955494889,-0.0112782909832178,0.00675131607218179,0.622637188534109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.00284934608265785,0.00582470549312953,-0.00856707668387602,0.0142657688491917,0.624719028646675
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTNL10,Butyrophilin-like protein 10,36962,-0.0018625943701917,0.00389550374035625,-0.00949778170128996,0.00577259296090655,0.632558868024268
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD177,CD177 antigen,39844,-0.00587515533401535,0.0123147014733366,-0.0300119702217552,0.0182616595537245,0.633308350471873
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00360150155004952,0.00762510881692367,-0.0185467148312199,0.0113437117311209,0.63670505256592
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNPO1,Transportin-1,37169,-0.00164134243840301,0.00349466296642632,-0.0084908818525986,0.00520819697579259,0.638597664432773
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,39788,0.00249468414367141,0.00535687605430718,-0.00800479292277067,0.0129941612101135,0.641438361860106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00299364774469794,0.00672191915456728,-0.0101813137982539,0.0161686092876498,0.65606974211812
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXK,Tyrosine-protein kinase TXK,37169,-0.00324104651380077,0.00732242314640156,-0.0175929958807478,0.0111109028531463,0.658048245791827
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.00133072067000744,0.00303056535131538,-0.0046091874185707,0.00727062875858558,0.660595143350575
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMA1,Proteasome subunit alpha type-1,39477,0.00198810918727059,0.00458504115518215,-0.00699857147688643,0.0109747898514276,0.664579325567908
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABO,Histo-blood group ABO system transferase,37445,0.00591405615471721,0.0141575573833931,-0.0218347563167333,0.0336628686261677,0.676150119593711
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00144640523013386,0.0034724029047765,-0.00535950446322809,0.0082523149234958,0.67701947014165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL25,Interleukin-25,36903,-0.00140200771536259,0.00338757837873862,-0.00804166133769029,0.00523764590696511,0.678978141681307
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGN,Cingulin,37039,0.00158198241016058,0.00383509873442757,-0.00593481110931745,0.00909877592963862,0.67997889141622
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM25,RNA-binding protein 25,36962,-0.00185316692486719,0.00450668431853476,-0.0106862681891953,0.00697993433946095,0.680929631145962
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL3,Interleukin-3,36962,-0.00241548799598255,0.00588353092056692,-0.0139472086002937,0.00911623260832861,0.681408701221473
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,-0.00139315198631437,0.0034415865370704,-0.00813866159897236,0.00535235762634362,0.685630552272598
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL22,Interleukin-22,37368,-0.00259146630617432,0.00646140944956615,-0.015255828827324,0.0100728962149753,0.688376205360265
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REN,Renin,39868,0.00260425311486054,0.00650005461733995,-0.0101358539351258,0.0153443601648468,0.688682468727595
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,0.00172707726405922,0.00439129079958161,-0.00687985270312073,0.0103340072312392,0.69410603757875
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GJA8,Gap junction alpha-8 protein,36962,0.00227700198642703,0.00589447894967062,-0.00927617675492737,0.0138301807277814,0.69928519938459
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00134219346284898,0.00349679376375504,-0.00551152231411089,0.00819590923980885,0.701106584008153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMCH,Pro-MCH,37021,-0.00313723282227047,0.00817754141582813,-0.0191652139972936,0.0128907483527527,0.701251410169132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBZ,Hemoglobin subunit zeta,37437,-0.00398545502878135,0.0104094437001337,-0.0243879646810434,0.0164170546234807,0.701822768203419
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,-0.000962650270460493,0.00255741460960117,-0.00597518290527879,0.0040498823643578,0.706614158847007
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAGEA3,Melanoma-associated antigen 3,37169,0.00309326904606732,0.00826695130427645,-0.0131099555103145,0.0192964936024492,0.708281654309268
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA11,Carbonic anhydrase-related protein 11,39477,0.00115801028976757,0.00309499365658618,-0.00490817727714134,0.00722419785667649,0.708293374668187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00160109679105526,0.00438271188923226,-0.00698901851183997,0.0101912120939505,0.714877507033543
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSV,Cathepsin L2,39967,-0.00146223945294462,0.00403837328950894,-0.00937745110038214,0.0064529721944929,0.717292326271835
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC123,Cell division cycle protein 123 homolog,36962,0.002270617742303,0.00627830471857348,-0.010034859506101,0.014576094990707,0.717611232716408
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCN15,Lipocalin-15,37411,0.00220329608503661,0.00611741955560059,-0.00978684624394054,0.0141934384140138,0.718727444387242
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,0.00286924819164686,0.00803440134597808,-0.0128781784464702,0.0186166748297639,0.721007464848449
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF830,Zinc finger protein 830,37368,-0.00278100218324487,0.00795441724342356,-0.018371659980355,0.0128096556138653,0.726631347467068
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTLA,B- and T-lymphocyte attenuator,36962,0.00298807608227322,0.00855936843013046,-0.0137882860407825,0.0197644382053289,0.727019797217862
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN7,Tetraspanin-7,36991,0.00318794215681383,0.009299988852996,-0.0150400359950583,0.021415920308686,0.731762019256689
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY2B,Alpha-amylase 2B,38832,0.00160882852990502,0.00474628886370526,-0.00769389764295729,0.0109115547027673,0.734640418078623
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMMR,Hyaluronan mediated motility receptor,36942,-0.00157970549859296,0.00468649782203746,-0.0107652412297864,0.00760583023260045,0.736065087482618
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,37169,0.00252302033221041,0.00757112922078386,-0.012316392940526,0.0173624336049468,0.738956657949297
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,37368,0.00188243093356016,0.00565729166517751,-0.00920586073018777,0.0129707225973081,0.739332553168022
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSTN,Osteocrin,37039,-0.00137266659174347,0.00412669331004405,-0.0094609854794298,0.00671565229594286,0.739418044753821
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,36991,0.00141625317719417,0.00428586291364699,-0.00698403813355394,0.00981654448794228,0.741067040775813
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,0.00121304583792797,0.00375832537510389,-0.00615327189727565,0.00857936357313159,0.746879472252849
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.000992567448282611,0.00312486625066503,-0.00513217040302084,0.00711730529958607,0.750766725761889
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPBGL,Trophoblast glycoprotein-like,37039,0.00125120312356951,0.00400011818914428,-0.00658902852715328,0.00909143477429231,0.754443993436181
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELL,L-selectin,37453,0.000689154643605269,0.00223267692861634,-0.00368689213648276,0.0050652014236933,0.75757925416249
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00139040447077999,0.00451090950175866,-0.00745097815266698,0.010231787094227,0.757911038557945
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALMS1,Alstrom syndrome protein 1,37169,0.00136047964286815,0.00442008669849236,-0.00730289028617688,0.0100238495719132,0.758243305178568
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.000993087590974625,0.00323019930427303,-0.00533810304540052,0.00732427822734977,0.758514500898491
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS1,"Nitric oxide synthase, brain",39489,0.00163003927540686,0.00532631232746434,-0.00880953288642325,0.012069611437237,0.759581890213884
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG1A,Lithostathine-1-alpha,39804,-0.0013800324835763,0.00458339806775546,-0.010363492696377,0.00760342772922439,0.763346937822407
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM2,Intercellular adhesion molecule 2,40052,0.00092261201654832,0.00308748002882777,-0.0051288488399541,0.00697407287305074,0.765078448350845
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNB2,Ephrin-B2,37039,-0.00175841282603499,0.00594377053937745,-0.0134082030832148,0.00989137743114481,0.767355939253055
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.00118548086606137,0.00403188933402405,-0.0090879839607485,0.00671702222862576,0.76874255774445
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGS8,Regulator of G-protein signaling 8,39587,0.00190391973397687,0.00648623687430935,-0.0108091045396695,0.0146169440076232,0.769119222248432
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMP,Olfactory marker protein,36991,0.00140582142955081,0.00479823818721481,-0.00799872541739021,0.0108103682764918,0.769536715257042
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY96,Lymphocyte antigen 96,39749,-0.00100267348385534,0.00348252712162772,-0.00782842664224566,0.00582307967453499,0.773415188761849
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL4,Myosin light chain 4,37043,0.00146988007651427,0.00512556873382093,-0.00857623464177475,0.0115159947948033,0.774289844791034
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.0014142969403417,0.00497144401461281,-0.0083297333282994,0.0111583272089828,0.776043855869554
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,36991,-0.00168029021820301,0.00594502974372417,-0.0133325485159024,0.00997196807949635,0.777458944287734
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY2A,Pancreatic alpha-amylase,39246,0.00130726894777036,0.00463940752285639,-0.00778596979702816,0.0104005076925689,0.778119848900971
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,39788,0.00125639523030117,0.00455491794187912,-0.00767124393578191,0.0101840343963842,0.782680159193216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.00244712307575089,0.0089823890408616,-0.0151583594443378,0.0200526055958396,0.78529132007719
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,37056,0.000846031555224168,0.00315369858441008,-0.0053352176702196,0.00702728078066793,0.788498414577005
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TET2,Methylcytosine dioxygenase TET2,37161,-0.00260391710831258,0.00975795916042781,-0.0217295170627511,0.0165216828461259,0.789588341780448
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.00129887884961306,0.00487575019567903,-0.00825759153391783,0.010855349233144,0.789937939122093
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PYDC1,Pyrin domain-containing protein 1,37043,-0.00108596451617683,0.00407782230568743,-0.0090784962353242,0.00690656720297054,0.790004701728974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMOD2,Leiomodin-2,36991,-0.00166763797035561,0.00633037924675792,-0.0140751812940011,0.0107399053532899,0.792220118360033
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR1,Toll-like receptor 1,37056,0.000678411212292904,0.0025764513730877,-0.00437143347895899,0.0057282559035448,0.792314028489481
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPK3A,Uroplakin-3a,36991,-0.0012186188541982,0.00471113531700476,-0.0104524440755275,0.00801520636713113,0.795895645558129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NLGN1,Neuroligin-1,37039,-0.00166388665110874,0.00663847420979222,-0.0146752961023015,0.011347522800084,0.802094091931551
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHC1,SHC-transforming protein 1,36962,-0.00285550036376927,0.0114052976422938,-0.025209883742665,0.0194988830151265,0.802308136683063
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53BP1,TP53-binding protein 1,37056,0.00213768674755871,0.00868491377044847,-0.0148847442425203,0.0191601177376377,0.805579285996107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL5,Interleukin-5,39587,0.00350010454304577,0.0142270313094326,-0.0243848768234421,0.0313850859095336,0.805671576960286
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,37382,0.0012017120600958,0.00490846284578639,-0.00841887511764552,0.0108222992378371,0.806596022338594
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,37039,-0.0010201218707877,0.004221680859268,-0.00929461635495299,0.00725437261337759,0.809063819009808
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.000979631215158516,0.00409110008471391,-0.00899818738119779,0.00703892495088076,0.810757103312301
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,-0.00106126789620737,0.00447512410406668,-0.00983251114017806,0.00770997534776332,0.812544799798462
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAU,Urokinase-type plasminogen activator,39858,-0.00066800536378021,0.00282258505479634,-0.00620027207118103,0.00486426134362061,0.812920194670706
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,39866,0.0010104485569695,0.00431129979371916,-0.00743969903872006,0.00946059615265905,0.814699083508792
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.00115226445963185,0.00500127797785828,-0.0109547692962341,0.00865024037697037,0.817789169936604
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2,Interleukin-2,39587,0.000696358607086005,0.00307256041073938,-0.00532585979796319,0.0067185770121352,0.820708272714541
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,36962,0.000715285562327901,0.0032455167086124,-0.00564592718655241,0.00707649831120821,0.825569394654337
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.00285767094031328,0.0132728101751498,-0.0288723788836069,0.0231570370029804,0.82953461310335
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,-0.000885451086758048,0.00412925800629594,-0.00897879677909808,0.00720789460558199,0.830212367763576
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC51B,Organic solute transporter subunit beta,37021,0.00157516187351732,0.00747936830539876,-0.0130844000050642,0.0162347237520989,0.83320195184313
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDAC9,Histone deacetylase 9,36991,-0.00131489855896514,0.00633952763339651,-0.0137403727204223,0.011110575602492,0.835690779500417
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,37169,0.000778447249439564,0.00388195854973234,-0.00683019150803582,0.00838708600691494,0.841069544375321
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HK2,Hexokinase-2,39585,-0.000533135964332379,0.0026972657672689,-0.00581977686817941,0.00475350493951466,0.8433152631844
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,39908,0.000950964922492138,0.00484981523985157,-0.00855467294761694,0.0104566027926012,0.844547910553481
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH4,Cadherin-4,36991,-0.000903381084699822,0.00461958378694167,-0.0099577653071055,0.00815100313770586,0.844961785693009
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF3,Fibroblast growth factor 3,37056,0.000583680134542425,0.00303909276515393,-0.00537294168515928,0.00654030195424413,0.847700229723272
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,36991,0.00111468210110503,0.00585245616666752,-0.0103561319855633,0.0125854961877734,0.848948509734402
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,39720,-0.000591617811136145,0.00325603684827726,-0.00697345003375958,0.00579021441148729,0.85582147241273
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MLLT1,Protein ENL,36962,-0.00122003790605379,0.00704304134668293,-0.0150243989455523,0.0125843231334447,0.862476460586853
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSCA,Prostate stem cell antigen,37382,0.00432447299721671,0.0250438762902922,-0.0447615245317561,0.0534104705261895,0.862908800218711
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.00100056966565196,0.00579661533311463,-0.0103607963872527,0.0123619357185566,0.862958496063044
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,0.000927317099938507,0.00546641554834366,-0.00978685737481506,0.0116414915746921,0.865296677253213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVI2B,Protein EVI2B,36962,-0.000683094568965174,0.00406897318415126,-0.00865828200990164,0.00729209287197129,0.866681174503683
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLNS1A,Methylosome subunit pICln,37039,-0.000535521622816853,0.00332328842750545,-0.00704916694072754,0.00597812369509384,0.871983965129283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IKZF2,Zinc finger protein Helios,39477,0.0014924237892168,0.00927752894680247,-0.016691532946516,0.0196763805249496,0.872202311209606
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,39585,0.000761731555051945,0.00483912137854107,-0.00872294634688854,0.0102464094569924,0.874922864879023
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00097022555577848,0.00635624627143852,-0.013428468247798,0.011488017136241,0.878683511000222
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC25A,M-phase inducer phosphatase 1,36962,-0.000625990524767082,0.00411216975125227,-0.00868584323722154,0.00743386218768737,0.879008850735578
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,-0.00107992981313976,0.00768930071849714,-0.0161509592213941,0.0139910995951146,0.888309937875359
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.000442472312539555,0.00317648716847763,-0.00666838716275571,0.0057834425376766,0.889218303034012
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN3B,Sodium channel subunit beta-3,36991,-0.00060698660416323,0.00439023259235042,-0.00921184248517006,0.0079978692768436,0.890038309058891
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00156480356225768,0.0114303982411061,-0.0239683841148257,0.0208387769903103,0.891113174622657
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRR5,Proline-rich protein 5,37056,-0.00064229057903916,0.00470046111000436,-0.00985519435464772,0.00857061319656939,0.891314150535172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC1A4,Neutral amino acid transporter A,37039,-0.000667874279845135,0.00506519916289256,-0.0105956646391145,0.00925991607942427,0.89510061368363
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFL4,Insulin growth factor-like family member 4,37056,-0.000977998541550893,0.0075863614718307,-0.0158472670263391,0.0138912699432373,0.897426585005011
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,37411,0.000397659557350831,0.00330389228460501,-0.00607796932047498,0.00687328843517664,0.904199021846207
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,37021,-0.000848514354490686,0.00706675661902372,-0.0146993573277772,0.0130023286187958,0.904428533526408
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALLD,Palladin,37056,0.000482786577320394,0.00402171366481408,-0.00739977220571519,0.00836534536035598,0.904449336151018
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN7,Septin-7,37169,0.000584340718803744,0.00506432095577026,-0.00934172835450596,0.0105104097921134,0.908142640468283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGR,Progesterone receptor,37056,0.00118644975246332,0.0103704876464916,-0.0191397060346603,0.0215126055395869,0.908917412391819
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,0.000264046856281347,0.00235677054903059,-0.00435522341981861,0.0048833171323813,0.910795273296336
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.000410544938526646,0.00368190716701247,-0.0068059931088178,0.00762708298587109,0.911218919301229
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUOX2,Dual oxidase 2,39585,0.000746949861969178,0.00703373582779043,-0.0130391723605001,0.0145330720844384,0.915428734714161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAGE2A,G antigen 2A,36962,0.000634936604243214,0.00601910945878341,-0.0111625179349723,0.0124323911434587,0.915991157319375
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,L1CAM,Neural cell adhesion molecule L1,39913,-0.000284916415387715,0.0028181923533309,-0.00580857342791627,0.00523874059714084,0.919473138217933
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,37039,-0.000346264766385193,0.00353297915891119,-0.00727090391785112,0.00657837438508074,0.921926409839014
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPN3,Calpain-3,37368,-0.000358533190730469,0.00371588893989425,-0.0076416755129232,0.00692460913146227,0.923135611215919
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,-0.000508830509155683,0.00553502426877884,-0.0113574780759622,0.0103398170576508,0.926755671361421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,36962,-0.000480510735049211,0.00536391196039938,-0.010993778177432,0.0100327567073336,0.928620643431216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB7,Integrin beta-7,40030,-0.000395388696116017,0.00448580170961316,-0.0091875600469578,0.00839678265472577,0.929764700740398
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFRC,Transferrin receptor protein 1,39918,-0.000313625598899186,0.00385177860922618,-0.00786311167298251,0.00723586047518413,0.93510611300264
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,39585,0.000242557985801533,0.00316085948976044,-0.00595272661412894,0.006437842585732,0.938832962804897
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.00103301198233167,0.0142076054227253,-0.0288799186108732,0.0268138946462099,0.942039289308828
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,36962,0.000445281951043719,0.00626303163794292,-0.0118302600593244,0.0127208239614118,0.943321743755294
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSG1,Tryptase gamma,37056,0.000172113904663,0.00265600064668409,-0.00503364736283781,0.00537787517216381,0.948332705336068
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRX,Cone-rod homeobox protein,39585,0.000682580009685908,0.0106735789152563,-0.0202376346642165,0.0216027946835883,0.949010506336449
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRND,Prion-like protein doppel,37388,0.000310106096111267,0.00501167109095939,-0.00951276924216913,0.0101329814343917,0.950661868818295
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,-0.000209148208273921,0.00355717978102693,-0.00718122057908671,0.00676292416253887,0.953115401920516
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KHDC3L,KH domain-containing protein 3,36962,0.000359152037362883,0.00656029396066496,-0.0124990241255404,0.0132173282002662,0.956341391060333
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN6,Prefoldin subunit 6,37039,0.000345816472519011,0.00651191691853282,-0.0124175406878053,0.0131091736328433,0.95764891495614
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,37422,-0.000108614485417553,0.00240740405366101,-0.00482712643059313,0.00460989745975803,0.964014835706735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARG2,"Arginase-2, mitochondrial",37368,-0.000188622771039061,0.00432920138855976,-0.00867385749261619,0.00829661195053807,0.965247907731675
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNL2,Interferon lambda-2,36991,0.000255840377393509,0.00611568834251758,-0.0117309087739409,0.012242589528728,0.966632100586468
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADA2,Adenosine deaminase 2,39782,0.00016912946124968,0.00406819753742921,-0.00780453771211158,0.00814279663461094,0.966839171016897
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK3,Prostate-specific antigen,37437,-0.0002741288017597,0.0077668483090855,-0.0154971514875673,0.0149488938840479,0.971845245686351
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,39913,9.33122874685841e-05,0.00267567580531977,-0.00515101229095816,0.00533763686589533,0.97218041728773
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL6B,Myosin light chain 6B,37039,0.000307464108351262,0.00912322612241862,-0.0175740590915892,0.0181889873082917,0.973115893954249
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAX,Integrin alpha-X,37169,0.00017345539318278,0.0052175761502657,-0.010052993861338,0.0103999046477035,0.973480158849074
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTF,Ciliary neurotrophic factor,36991,-8.93505696685368e-05,0.00334933010472296,-0.00665403757492554,0.00647533643558847,0.978717646534794
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,0.000104267045129259,0.00409565135235087,-0.00792320960547845,0.00813174369573697,0.979690039593664
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF174,Zinc finger protein 174,37056,5.19770341529059e-05,0.00377016935200811,-0.00733755489578299,0.0074415089640888,0.989000607197559
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCLN,Nicalin,39587,-6.45029338899148e-05,0.00519761214780088,-0.0102518227435796,0.0101228168757998,0.99009857711128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,39587,5.41439088773647e-05,0.00577531667111836,-0.0112654767665146,0.0113737645842694,0.992520017196726
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-1.85783989461203e-05,0.00294473687621692,-0.00579026267633127,0.00575310587843903,0.994966257762388
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAM1,Neural cell adhesion molecule 1,39931,1.52556361656489e-05,0.00295396091867594,-0.00577450776443919,0.00580501903677049,0.995879433264009
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL24,Interleukin-24,39587,2.28178999861744e-05,0.00465579893624059,-0.00910254801504537,0.00914818381501772,0.996089674819171
